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Chapter 1 . Introduction 
The Golgi apparatus is a membranous organelle essential for intracellular protein and lipid 
trafficking and modification. In mammalian cells, the Golgi consists of dozens of stacks of 5-7 
parallel-aligned flattened cisternae; Golgi stacks are highly concentrated in the pericentriolar 
region of the cell. In most cells, the enrichment of the Golgi stacks nearby the centrosome 
mediated by the microtubule minus end-directed motor protein dynein is likely required for 
lateral linking of the Golgi stacks into a ribbon, as treatment of cells by microtubule 
depolymerizing drugs disperses the Golgi ribbon into individual stacks. The Golgi structure is 
well maintained in a dynamic equilibrium between input and output of membranes from and to 
other organelles including the endoplasmic reticulum (ER), the endosome-lysosome system, and 
the plasma membrane [1].  
 
The mitotic division of cells requires the duplication and partitioning of all cellular 
components. It is generally believed that the Golgi apparatus exists as an autonomous organelle 
and its division does not rely on other cellular organelles such as the ER [2, 3]. In mammalian 
cells, biogenesis of the Golgi during each cycle of cell division occurs through a unique 
disassembly and reassembly process. The Golgi is fragmented at the onset of mitosis, first with 
the stacks unlinked, which then undergo further unstacking and vesiculation, yielding thousands 




In telophase, Golgi vesicles fuse to form new cisternae that are aligned as stacks. The Golgi 
stacks then accumulate in the pericentriolar region and form a ribbon in each daughter cell 
during cytokinesis. Thus mitotic Golgi disassembly could be divided into three steps: ribbon 
unlinking, cisternal unstacking and vesiculation. Conversely, post-mitotic Golgi reassembly 
includes membrane fusion/cisternae regrowth, cisternae stacking, and ribbon linking [4, 5]. 
Many factors are involved in the regulation of Golgi membrane dynamics during the cell cycle; 
these include Golgi matrix proteins, kinases and phosphatases, ubiquitin ligases and 
deubiquitinating enzymes, vesicle budding and fusion machineries, as well as actin and 
microtubule cytoskeleton. In this review we summarize recent findings on the mechanisms that 
regulate these three processes in mitotic Golgi disassembly and post-mitotic Golgi reassembly 
during the mammalian cell cycle, especially on Golgi stacking proteins in Golgi stack formation, 
ubiquitin in post-mitotic Golgi membrane fusion, and golgins and cytoskeleton in Golgi ribbon 
linking.  
 
Golgi cisternal stacking and its regulation in the cell cycle 
Golgi stacks are the basic structural and functional units of the Golgi in mammalian cells. 
Our current understanding of the mechanism of Golgi stacking largely benefits from an in vitro 
assay that reconstitutes the cell cycle regulated Golgi disassembly and reassembly process. 
Briefly, highly purified rat liver Golgi stacks [6] are incubated with mitotic cytosol to generate 
mitotic Golgi fragments (MGFs). After re-isolation, these MGFs reassemble into Golgi stacks 
upon incubation with interphase cytosol or purified cytosolic components. This provides a 
readily manipulatable biochemical system within which the sequence of morphological events 




8]. This approach has contributed to the discovery and characterization of many proteins that 
mediate Golgi membrane tethering, fusion, cisternal stacking, and regulation [4, 9-11]. 
 
The role of GRASP65 and GRASP55 in Golgi cisternal stacking 
The mechanism and biological significance of Golgi stacking in protein trafficking and 
processing remain as interesting and significant questions to be answered in the field. So far the 
only proteins that are shown to directly participate in Golgi stacking are the Golgi reassembly 
stacking proteins (GRASPs), which include GRASP65 and GRASP55 in mammalian cells 
(Figure 1.1A). GRASP65 was first identified as a peripheral Golgi protein that is accessible to N-
ethylmaleimide (NEM) only when the Golgi stacks are disassembled, and NEM treatment of the 
Golgi membranes abolished Golgi cisternae re-stacking in the in vitro reassembly assay 
described above. GRASP65 localizes to the cis-Golgi; its homologue GRASP55 was 
subsequently discovered based on sequence similarity that stacks the medial-to-trans cisternae 
[12]. Several lines of evidence support the idea that GRASPs are involved in Golgi stacking. 
Antibodies against GRASP65 or GRASP55 inhibited the stacking of newly formed cisternae in 
the in vitro assay [12, 13], whereas microinjection of anti-GRASP65 antibodies into mitotic cells 
inhibited subsequent Golgi stack formation in the daughter cells [14]. Furthermore, depletion of 
GRASP65 or GRASP55 in mammalian cells by RNA interference (RNAi) reduced the number 
of cisternae per stack [15-17]. Since GRASP65 and GRASP55 localize to the cis- and medial-to-
trans Golgi, respectively [12], the reduced cisternae number by knocking down each individual 
GRASP protein was possibly due to losing either the cis or the medial-to-trans cisternae from the 
Golgi stacks. Simultaneous depletion of both GRASPs resulted in complete disassembly of the 




polarized stacked structure of the Golgi [4, 16]. GRASPs are peripheral membrane proteins that 
form stable homodimers, and dimers from adjacent cisternae oligomerize in trans through their 
N-terminal GRASP domains to zip the cisternae into stacks. The oligomerization state of 
GRASPs is regulated by mitotic phosphorylation at the C-terminal Serine/Proline-Rich (SPR) 
domain discussed below (Figure 1.1) [4, 16, 18].  
 
Cell cycle regulation of GRASP65 and GRASP55 in Golgi stacking 
The Golgi apparatus undergoes cisternae unstacking and restacking during the cell cycle 
[14, 16, 17]. This process depends on the mitotic phosphorylation and post-mitotic 
dephosphorylation of the GRASP proteins. The phosphorylation of GRASP65 on multiple sites 
in the SPR domain by cdc2 (cdk1) and polo-like kinase 1 (Plk1) during mitosis changes its 
conformation, leads to GRASP65 de-oligomerization and thereby allows the Golgi cisternae to 
separate [18]. After mitosis, GRASP65 is de-phosphorylated by the phosphatase PP2A, reforms 
trans-oligomers and stacks Golgi cisternae [7]. GRASP55 is regulated in a similar way [16]; it is 
phosphorylated by MEK1/ERK during mitosis and is dephosphorylated by a phosphatase yet to 
be identified [16]. When phospho-deficient mutants of GRASP65 or GRASP55 are expressed in 
cells, mitotic Golgi fragmentation is at least partially inhibited [17, 18]. Conversely, expression 
of their phosphomimetic mutants, or inhibition of their dephosphorylation, accelerates mitotic 
Golgi disassembly and reduces Golgi reassembly [16].  
 
GRASP65 has multiple phosphorylation sites localized to the C-terminal SPR domain that 
are phosphorylated by cdc2 during mitosis [19, 20]. It is recently shown that these sites are 




of a Threonine 220/Threonine 224 site, which is physically close to the GRASP domain at the 
amino acid level, is likely the most important in regulating Golgi unstacking [20-23]. Besides the 
many phosphorylation sites in the SPR domain, Serine 189 in the N-terminal GRASP domain 
has been identified as a plk1 site in both GRASP65 and GRASP55. Phosphorylation of this site 
also interrupts GRASP oligomerization and is required for mitotic Golgi disassembly [24, 25]. 
Since expressing the GRASP domain including S189 inhibits Golgi fragmentation [16, 17], it is 
possible that S189 phosphorylation alone may not be sufficient to regulate GRASP 
oligomerization. Alternatively, phosphorylation of the SPR domain by cdc2 may be a 
prerequisite of S189 phosphorylation by plk1, as it has been shown that phosphorylation by cdc2 
is required for docking plk1 onto GRASP65 [19]. 
 
It is worth noting that GRASPs have multiple functions. Their roles in Golgi ribbon 
formation will be discussed in the later sections in this review. Other functions, including 
unconventional secretion and cell cycle regulation have been discussed elsewhere [22, 23]. 
GRASPs are also involved in vesicle mediated Golgi transport. Inhibition of GRASP65 function 
by microinjecting GRASP65 antibodies into the cell accelerated protein trafficking, possibly 
because unstacked Golgi cisternae have more surface area to generate vesicles [26]. During 
mitosis, Golgi unstacking by GRASP phosphorylation facilitates the vesiculation of Golgi 








Figure 1.1. GRASPs and golgins in Golgi stacking and ribbon linking during the cell cycle. 
(A) GRASP65 (locates to cis-Golgi) and GRASP55 (locates to medial-to-trans-Golgi) homodimers on adjacent 
membranes form trans-oligomerizers, bring the membrane closer to each other to (a) form stacks when GRASPs 
localize between the cisternae, and to (b) form a ribbon when GRASPs are at the rims of the Golgi stacks. In 
addition to GRASPs, golgins are also required for the maintenance of Golgi ribbon integrity by either (c) tethering 
vesicles/transport carriers to Golgi membranes, such as GM130, or by (d) tethering membranes from neighboring 
stacks, as GMAP210. (B) During mitosis, GRASPs and GM130 are phosphorylated by mitotic kinases, which 
disrupts their oligomerizations and allows ribbon unlinking and cisternae unstacking. (C) The resulted single 
cisternae by unstacking undergo continuous vesicle budding to further disassemble Golgi membranes into vesicles 
and tubular structures. In cells, Golgi ribbon unlinking occurs in G2 phase, while Golgi unstacking and vesiculation 
take place in prophase and prometaphase. The reverse processes, Golgi membrane fusion, stacking and ribbon 
linking, occur in telophase and cytokinesis. 
 
 
Golgi cisternae vesiculation and regeneration during the cell cycle 
During interphase, COPI vesicles are generated from one Golgi subcompartment and fuse 
with another for intra-Golgi and Golgi-to-ER trafficking [27]. During mitosis, the Golgi 
membranes disassemble via continuous COPI vesicle budding while fusion is inhibited. In post-
mitotic Golgi reassembly, those COPI vesicles fuse to generate new cisternae (Figure 1.1). This 
vesiculation and cisternae regeneration process is mediated by vesicle budding and fusion 
machineries, which are modulated by the vesicle tethers. 
 
Golgi vesiculation during mitosis 
During prophase and prometaphase, Golgi cisternae undergo extensive COPI-dependent 
vesiculation [28, 29]. Treatment of unstacked Golgi membranes (induced by kinase treatment) 
with purified Arf1 and coatomer is sufficient to transform the Golgi cisternal membrane into 
vesicles in vitro [7], suggesting that Arf1 and coatomer are sufficient to trigger Golgi membrane 
vesiculation. Not all of the Golgi membranes are turned into vesicles during mitosis; some 
remain as tubulovesicular structures. These membranes contain Golgi matrix proteins including 
GRASPs and golgins and may serve as templates in late mitosis for the formation of new Golgi 





Post-mitotic Golgi membrane fusion  
Post-mitotic Golgi membrane fusion requires tethering proteins like p115, giantin and 
GM130, soluble NSF attachment protein (SNAP) receptors (SNAREs), and two AAA ATPases, 
N-ethylmaleimide sensitive fusion protein (NSF) and valosin-containing protein p97 [VCP] with 
their adaptors (Figure 1.2) [32]. NSF and its adaptors /-SNAPs catalyze the disassembly of 
cis-SNARE complex after membrane fusion therefore allows a new round of fusion to take 
place. In interphase, this process is required for both ER-to-Golgi and intra-Golgi transport 
(Figure 1.2A). In post-mitotic Golgi reassembly, two steps of NSF function are required for post-
mitotic Golgi reassembly. At the onset of mitosis when the Golgi is vesiculated, NSF drives 
SNARE dissociation by hydrolyzing ATP, similar to its function in interphase. At the second 
step in late mitosis, NSF catalyzes the complex formation between GATE-16 and the v-SNARE 
GS28. The binding with GATE-16 precludes GS28 from binding its cognate t-SNARE syntaxin-
5. This process appears to be important for post-mitotic Golgi membrane fusion and is 







Figure 1.2. NSF and p97 pathways in interphase Golgi membrane fusion and post-mitotic Golgi reassembly 
(A-B) Interphase Golgi membrane fusion mediated by NSF (A) and p97/p37 (B). Vesicles or Golgi membranes are tethered by the p115/GM130 complex, which 
facilitates SNARE-mediated fusion. The SNARE complexes are disassociated by NSF or p97 by ATP hydrolysis to allow next round vesicle fusion. (C-D) 
Ubiquitin involved post-mitotic Golgi fusion by NSF (C) and p97/p47 (D). During mitosis, GM130 phosphorylation interrupts its interaction with p115 and 
facilitates Golgi vesiculation. After mitosis, ubiquitination operates as a general mechanism for Golgi cisternae regrowth. In the NSF pathway (C), GATE-16, a 
ubiquitin-like protein, recruits NSF onto the membranes. NSF then catalyzes GATE-16 to form a complex with GS28 and inhibits GS28-syntaxin 5 interaction in 
an ATP-hydrolysis independent manner. GATE-16 is released from the membrane by an unknown mechanism to allow SNARE complex assembly and membrane 
fusion. In the p97/p47 pathway (D), HACE1 attaches ubiquitin onto unknown substrates on the Golgi membranes during mitosis; ubiquitination of these Golgi 
proteins may inhibit vesicle fusion. In late mitosis, the ubiquitin bound to a Golgi protein interacts with the UBA domain of p47 and recruits the p97/p47/VCIP135 
complex onto Golgi vesicles. VCIP135 removes ubiquitin from Golgi proteins and allows p97/p47 to fuse the Golgi fragments into new cisternae. How p97/p47 
regulates SNARE pairing and membrane fusion in this process is still unclear. (E) Ubiquitin is not involved in post-mitotic Golgi fusion by p97/p37. During 
mitosis, p37 is phosphorylated and thus membrane fusion is inhibited. After mitosis, dephosphorylation of p37 allows membrane fusion similar to that in interphase 





The other AAA ATPase p97, with its adaptor p47, promotes post-mitotic cisternae regrowth 
but not interphase trafficking [33]. Unlike NSF, p97/47-mediated post-mitotic Golgi reassembly 
requires neither p115 tethering nor GS28; however uses syntaxin 5 as a shared receptor. 
Therefore, it is proposed that NSF pathway mediates heterotypic fusion between vesicles and 
Golgi remnants, while p97 pathway mediates homotypic fusion between Golgi remnants (Figure 
1.2D) [32]. Another p97 adaptor, p37 is involved in both post-mitotic reassembly and interphase 
maintenance of the Golgi complex. The p97/p37 pathway for Golgi reassembly requires p115 
and GS15 but not syntaxin 5, suggesting a mechanism different from either the NSF pathway or 
the p97/p47 pathway (Figure 1.2B&E) [34].  
 
The role of ubiquitin in post-mitotic Golgi membrane fusion  
One exciting finding in cell cycle regulated Golgi dynamics concerns the involvement of 
ubiquitin in post-mitotic membrane fusion [32]. The first evidence that indicates the role of 
ubiquitin in post-mitotic Golgi fusion came from the domain analysis of p47. p47 contains a 
ubiquitin-associated (UBA) domain that binds mono-ubiquitin; inhibition of p47-ubiquitin 
interaction suppresses p97/p47-mediated Golgi membrane fusion [35]. Mono-ubiquitination of 
Golgi proteins occurs during mitotic Golgi disassembly and is required subsequently at the end 
of mitosis for targeting p97/p47 complex onto the Golgi remnants for reassembly [36, 37]. This 
process does not involve the proteasomes [36]. Both the ubiquitin ligase and the deubiquitinating 
enzyme (DUB) have been recently discovered. The ubiquitin E3 ligase was identified as HACE1 
(the HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1) [37], a HECT 




regulated in a variety of tumors [38]. And VCIP135 (valosin-containing protein p97/p47 
complex-interacting protein, p135) was identified as the deubiquitinating enzyme (DUB). 
VCIP135 forms a quaternary complex with syntaxin 5 and the p97/p47 complex via a ubiquitin 
fold domain and its enzymatic activity is required for post-mitotic Golgi membrane fusion [36]. 
Furthermore, VCIP135 interacts with WAC, which enhances the DUB activity of VCIP135. 
Depletion of WAC by RNAi in cells resulted in extreme Golgi vesiculation and VCIP135 mis-
localization from the Golgi [39]. These results indicate a cycle of ubiquitination and 
deubiquitination in p97/p47-mediated Golgi dynamics.  
 
The ubiquitin moieties on these substrates, added by HACE1 during mitosis, likely serve as 
receptors for the p97/p47/VCIP135 complex at the end of mitosis to carry on fusion reactions 
after the removal of the ubiquitin tags by VCIP135 (Figure 1.2D) [36, 37]. It has been proposed 
that during mitosis when the Golgi membranes are disassembled, HACE1 attaches 
monoubiquitin onto a Golgi membrane protein(s), which subsequently recruits the p97/p47 
complex onto the Golgi fragments through the UBA domain of p47. The deubiquitinase 
VCIP135, which is associated with the p97/p47 complex, removes the ubiquitin moiety and thus 
allows p97/p47 to fuse the membranes after mitosis  (Figure 1.2D) [37]. The underlying 
mechanism, however, remains largely unknown. For example, it has not been determined 
whether p97/p47-mediated membrane fusion requires cognate SNARE pairing and whether p97 
drives SNARE disassociation by hydrolyzing ATP. In addition, since the substrates of HACE1 
and VCIP135 on the Golgi membranes are still unidentified, it is not clear whether membrane 
association of the p97/p47 complex depends on the level of ubiquitin on the Golgi membranes 




trafficking during mammalian cell division. Unlike p47, p37 lacks a ubiquitin-binding domain 
that interacts with ubiquitin, thus the p97/p37 pathway does not need ubiquitin and WAC. 
However, the p97/p37 pathway requires VCIP135 for disassociating the p37-GS15 complex, 
although its deubiquitinating activity is not required (Figure 1.2E) [34, 39], suggesting that 
VCIP135 has a ubiquitin-independent role in regulating SNARE pairing. 
 
The other AAA ATPase, NSF, although does not interact with ubiquitin as the p97/p47 
complex, requires a ubiquitin like protein GATE-16 to drive the post-mitotic cisternal regrowth 
[32]. GATE-16 recruits NSF/SNAPs complex onto vesicles through direct interaction with NSF. 
NSF then catalyzes GATE-16 binding to the Golgi v-SNARE GS28, which blocks the interaction 
between GS28 and syntaxin-5 and thus negatively regulates their pairing [40]. Releasing GATE-
16 allows SNARE pairing and subsequent membrane fusion. In this way, GATE-16 serves as a 
receptor for the NSF/SNAPs complex, like ubiquitin for the p97/p47 complex, with the 
membrane association and dissociation of GATE-16 possibly through a lipidation/de-lipidation 
cycle [32], which requires further confirmation. So far it has not been shown whether GATE-16 
can be covalently linked to proteins in a similar way as ubiquitin. In addition, NSF does not 
hydrolyze ATP to disassemble SNARE complexes during post-mitotic membrane fusion. 
Instead, it catalyzes GATE-16 to interact with GS28 to negatively regulate SNARE pairing. How 
this results in membrane fusion remains as a mystery. Nevertheless, these observations suggest 
that ubiquitination operates as a general mechanism for Golgi cisternae regrowth after mitosis 
(Figure 1.2C&D). 
 




Golgins are long coiled-coil proteins that play key roles in vesicle tethering, trafficking and 
Golgi ribbon formation (Box 1). In interphase, vesicles are tethered to the Golgi membranes by 
golgins before SNARE-mediated fusion [41]. Some golgins are phosphorylated during mitosis, 
which disrupts their tethering function and facilitates mitotic Golgi disassembly. For example, 
GM130, p115 and giantin form a complex that captures COPI vesicles to the cis-Golgi in 
interphase cells [42]. During mitosis, phosphorylation of GM130 on Serine 25 by cdc2 prevents 
p115 binding, while subsequent dephosphorylation of GM130 by PP2A after mitosis resumes its 
interaction with p115 and restores NSF and p97/p37 mediated fusion. Another golgin, golgin-84, 
which tethers vesicle for intra-Golgi trafficking, may be regulated similarly to GM130 in the cell 
cycle [11, 43, 44]. Besides their function in tethering vesicles, many golgins are required for 
maintaining Golgi ribbon integrity, as discussed in the next section. 
 
Golgi ribbon formation and cell cycle regulation 
Unlinking of the Golgi ribbon at the onset of mitosis is likely to be important for 
partitioning the Golgi membranes into the two daughters [4] and for mitotic progression [45]. 
Golgi ribbon unlinking occurs in late G2 phase, prior to Golgi cisternal unstacking and 
vesiculation that start in prophase [46]. So far the exact mechanism for Golgi ribbon linking is 
not well understood, but involves a number of proteins including the GRASP proteins, several 
golgins, CtBP/BARS, as well as the microtubule and actin cytoskeleton [4, 47, 48].  
 
Cell cycle regulation of GRASP65 and GRASP55 in Golgi ribbon linking 
In addition to Golgi cisternal stacking, GRASP65 and GRASP55 also link the Golgi stacks 




ribbon breakdown in the cell [16, 49-51]. It has been proposed that GRASP trans-oligomers also 
exist at the rims of Golgi stacks for stack tethering, which is also regulated by phosphorylation 
and dephosphorylation during the cell cycle [24, 46, 50, 51]. In late G2 phase, MEK and ERK 
kinases are activated and phosphorylate GRASP55, which promotes Golgi unlinking [46]. 
GRASP65, on the other hand, is phosphorylated at Serine 277 and Serine 376 by cdc2 and Serine 
189 by plk in late G2 phase, correlating to Golgi ribbon disassembly [19, 20, 24]. Expressing a 
phospho-deficient mutant of GRASP55 inhibited Golgi disassembly in G2 phase [46]; whereas 
expression of phospho-mimic mutant of GRASP65 or GRASP55 leads to Golgi fragmentation in 
interphase cells [24, 51]. As in cisternae stacking, GRASPs must be dephosphorylated at the end 
of mitosis to allow Golgi ribbon to reform (Figure 1.1).  
 
CtBP/BARS in Golgi ribbon unlinking in G2 phase 
CtBP/BARS is a protein that plays a dual role in gene transcription and Golgi membrane 
fission. In addition to its function in helping vesicle fission in interphase Golgi transport, 
CtBP/BARS is also required for Golgi ribbon unlinking at late G2 phase, earlier than the mitotic 
vesiculation of Golgi membranes. In cells that CtBP/BARS is depleted or inhibited by 
microinjected antibodies, the Golgi remains connected during mitosis and cell mitotic 
progression is arrested [52, 53]. However, how CtBP/BARS coordinates with GRASPs and 
golgins in regulating Golgi ribbon linking in the cell cycle remains elusive. 
 
Golgins in Golgi ribbon formation 
Golgins are long coiled-coil proteins that are associated with the cytoplasmic face of Golgi 




GTPases (Rabs, Arf and Arls). Many golgins have multiple Rab binding sites, which may 
facilitate capturing membranes bearing specific Rabs and excluding other cellular organelles like 
ribosomes from the Golgi region [54]. Based on their locations, golgins can be simply divided 
into cis-golgins, golgins on the rim of the stacks and trans-golgins [1, 55, 56].  
 
Well-characterized cis-golgins include GM130, GMAP210 and golgin-160. GM130 targets 
to the Golgi membranes through its interaction with GRASP65 and other adaptors such as Rab1, 
mediates ER-to-Golgi transport and the formation of cis-Golgi cisternae. When GM130 is 
depleted Golgi, ribbon breaks down [57]. GMAP210 contains an N-terminal ALPS motif that 
forms an amphipathic -helical structure and interacts with the curved membrane structures (e.g. 
the Golgi rims and vesicles), and a C-terminal GRAB domain that can be recruited to the Golgi 
cisternae flat surface through interaction with Arf1 GTPase. The C-terminus can also bind to -
tubulin in the centrosome [58-61]. GMAP210 is required for maintaining Golgi ribbon integrity, 
possibly by pulling one Golgi stack to a neighboring stack, and by directing Golgi stacks to the 
centrosome [58-61]. The ALPS motif of GMAP210 may also be required to tether vesicles to the 
Golgi for ER-to-Golgi transportation [62]. The third cis-golgin, golgin-160, is the Golgi receptor 
for dynein, which is required for the localization of the Golgi membranes in the pericentriolar 
region and ribbon formation [63]. 
 
Three golgins that localize to the rim through the whole stack, giantin, golgin-84 and 
CASP, have transmembrane domains at their C-terminus required for membrane anchoring. 
Giantin is involved in anterograde whereas golgin-84 and CASP play a role in retrograde 





Trans-golgins include the GRIP domain golgins GCC88, GCC185, golgin-97 and golgin-
245 (also known as p230 or tGolgin-1). These four golgins all contain C-terminal GRIP domains 
that dimerize and simultaneously interact with two small GTPases [55]. Localization of golgin-
97 and golgin-245 to the trans-Golgi is mediated by Arl1-GTP, whereas the recruitment of 
GCC88 and GCC185 is still controversial [64]. GCC88 and GCC185 localize to different 
domains of the TGN and mediate different retrograde transport pathways from endosome to the 
TGN [65]. GCC185 was also shown to recruit microtubule +end binding proteins CLASPs to the 
TGN, which is required for Golgi-derived microtubule formation and Golgi ribbon integrity [66]. 
ARL4A, an Arf/Arl family protein, is shown to interact with GCC185 and regulate GCC185-
mediated recruitment of CLASPs [67]. 
 
Golgins are also ideal candidates in Golgi ribbon formation due to their long rod shape. The 
best example is perhaps GM130, a golgin that interacts with GRASP65. Knockdown of GM130 
causes Golgi ribbon unlinking, similar to GRASP65 depletion [57]. Since the gaps between the 
stacks in the ribbon are relatively larger and more heterogeneous (10s to 100s nm) compared to 
those between the cisternae in the stack, it is reasonable to speculate the long coiled-coil proteins 
like GM130 as better candidates for stack tethering. Another possible mechanism for GRASP65 
and GM130 in Golgi ribbon formation depends on their vesicle tethering function, as continuous 
membrane input from the ER to the Golgi is required to maintain Golgi ribbon integrity. A 
similar hypothesis applies to GRASP55 and its interacting protein golgin-45 as well as several 





In addition to GM130, depletion of many other golgins including p115, GMAP210, golgin-
160, giantin, golgin-84, GCC185 and golgin-245 by RNAi, or impairing golgin-97 function by 
microinjection of inhibitory antibodies, all lead to Golgi fragmentation [1]. Since most of these 
proteins function in membrane tethering, their function in maintaining Golgi integrity may relies 
on membrane trafficking. Alternatively, some golgins including GM130, p115, golgin-160, 
GMAP210 and GCC185 interact with microtubules, which regulate the centralization and lateral 
linking of the Golgi stacks (see below and in Box 2). A third mechanism, suggested by the cis-
Golgi golgin GMAP210, is to directly link membranes from adjacent stacks. In addition to its 
interaction with -tubulin, GMAP210 binds the cis-Golgi by interacting with Arf1 via its C-
terminal GRAB domain and highly curved membranes (vesicles or the rim of a neighboring 
stack) by its N-terminal ALPS motif, therefore directs homotypic fusion of cis-cisternae between 
two stacks (Figure 1.1A) [61]. Despite the findings about golgins in maintaining Golgi integrity 
in interphase, how they are regulated during the cell cycle is largely unknown.  
 
The role of microtubule organization in Golgi positioning and ribbon linking during the cell 
cycle 
Assembly of Golgi ribbon in the cell center requires an intact microtubule network with 
microtubule arrays shooting from the microtubule organization centers (MTOCs) (including the 
centrosome and the Golgi membranes) to the cell periphery (Box 2). The microtubule minus end-
directed motor, the dynein/dynactin complex, brings Golgi membranes and ER-derived vesicles 
to the cell center [68]. During mitosis, microtubules are reorganized into a mitotic spindle and 
the Golgi disassembles. The derived vesicles disassociate from the spindle microtubules, while 




serve as Golgi templates in the reassembly [69]. In telophase, Golgi ministacks form by 
membrane fusion and stacking in a microtubule-independent manner. Subsequently, 
microtubules generated from both the Golgi ministacks and the centrosome direct Golgi stacks 
moving towards each other and to the cell center for new ribbon assembly (Figure 1.3) [70].   
 
The role of microtubule cytoskeleton in Golgi ribbon formation is highlighted by a recent 
finding that a cis-Golgi protein golgin-160 recruits dynein to the Golgi by direct interaction. 
Depletion of golgin-160 abolished ER-to-Golgi trafficking and caused Golgi ribbon unlinking, 
similar to the effect caused by nocodazole treatment. Golgin-160 is recruited to the cis-Golgi by 
interacting with Arf1 GTPase while its seventh coiled-coil domain cc7 binds to dynein [63]. 
During mitosis, golgin-160 disassociates from Golgi membranes through an unknown 





Figure 1.3 Microtubules cytoskeleton in post-mitotic Golgi ribbon formation  
(A) Golgi disassembly in mitosis. During mitosis, centrosome-derived microtubules are assembled into a mitotic 
spindle while Golgi-derived microtubules are depolymerized. Golgi membranes are disassembled into vesicles and 
mitotic Golgi clusters, the latter of which are partially associated with spindle microtubules. (B) Golgi clustering in 
telophase. At mitotic exit, Golgi ministacks start to form. In the initial stage, ministacks move by dynein motor 
proteins towards each other along Golgi derived microtubules that are stabilized by CLASP. (C) Golgi ribbon 
formation in later telophase and cytokinesis. After the initial Golgi clustering directed by Golgi-derived 
microtubules Golgi clusters are captured by centrosome-derived microtubules and carried by dynein to the minus 
end of microtubules. The high concentration of Golgi membrane in the cell center allows further membrane fusion 
and ribbon formation. (D) Maintenance of the Golgi ribbon in interphase. Golgi is positioned surrounding the 
centrosome, with cis-golgins (GMAP210 or AKAP450/GM130) associate with microtubules derived from 
centrosomal -tubulin. Golgi-associated -tubulin also nucleates microtubules on the cis-Golgi. These microtubules 
are elongated through the trans-Golgi where they are stabilized by CLASP (through interaction with trans-golgin 
GCC185) towards the cell periphery. Dynein is required for maintaining Golgi ribbon in the pericentriolar region 
and for the directional movement of newly formed pre-Golgi transport carriers from cell periphery to the Golgi 







Golgi-derived microtubules and microtubule-regulated Golgi reassembly 
Golgi reassembly depends on microtubules. Conversely, Golgi serves as an unconventional 
MTOC and regulates microtubule organization. Several recent studies have demonstrated the 
formation of Golgi-derived microtubules and their roles in Golgi assembly and maintenance [66, 
70-72]. Microtubules require -tubulin complexes to initiate the growth. Two cis-golgins, 
GM130 (through AKAP450) [72] and GMAP210 [73, 74], anchor -tubulin complexes to the 
cis-side of the Golgi complex. Golgi-derived microtubules need to be stabilized by CLASPs 
(CLASP1/2) that are tethered to trans-Golgi membranes through trans-golgin GCC185 [66, 67]. 
In addition, CAP350 and Hook3 may be involved in microtubule stabilization on the Golgi [75, 
76].  
 
Golgi-derived microtubules concert with centrosome-derived microtubules in Golgi 
reassembly at mitotic exit and in the assay after nocodazole washout. The reassembly of the 
Golgi ribbon from cell periphery includes two stages. First, Golgi ministacks generated by 
simple vesicle fusion and stacking undergo initial clustering at the cell periphery, which is 
referred as the Golgi stage. At this stage, the Golgi clusters stay far away from centrosome and 
spindle, but linked by peripheral microtubules derived from the Golgi. During this stage of Golgi 
reassembly, the size of each Golgi particle is doubled and total number of Golgi particles 
reduced. Depleting CLASP from the cell abolishes Golgi-derived microtubule formation and the 
initial clustering of Golgi ministacks. In the second stage, Golgi clusters move towards the cell 
center along centrosome-derived radial microtubule arrays to complete Golgi ribbon assembly. 
This stage is called centrosome stage. Without the Golgi-derived microtubules by CLASP 




microtubules, but remain more fragmented [70]. On the other hand, when centrosome-derived 
microtubules were disrupted by laser ablation of the centrosome, a large portion of the Golgi 
clusters can still move towards each other and finally to the cell center [77]. However, some 
small fragments are blocked by the nucleus and remain uncaptured in the absence of centrosomal 
microtubules. Interestingly, once the Golgi is presented in the cell center, Golgi-derived 
microtubules are sufficient to support Golgi integrity, and the centrosome becomes dispensable 
[77]. Both stages of Golgi assembly require the function of dynein [70, 77]. This is consistent 
with the fact that when the Golgi anchor of dynein, golgin-160, is depleted, Golgi fragments into 
ministacks throughout the cell [63].  
 
Actin filaments in Golgi biogenesis 
In addition to microtubules, actin filaments are also involved in Golgi trafficking and 
structure maintenance but the underlying mechanism remains largely unknown. Impairing actin 
dynamics by treating cells with either actin depolymerizing or stabilizing drugs both give a 
compact morphology of the Golgi [78]. Actin polymerization facilitates membrane deformation 
to drive vesicle formation, fission and fusion, and short-range movement [79]. Not much is 
known about the function of actin in Golgi dynamics in mitosis. The only indication came from 
the study in Drosophila S2 cells, in which Golgi stacks are duplicated and exist as pairs before 
cell division. At late G2 phase, depolymerization of actin filaments induces scission of the 
paired-Golgi and the number of total Golgi stacks in the cell doubles. This process is mediated 
by inactivation of the actin nucleation promoting factors WAVE/Scar/Abi [80]. These paired 
Golgi stacks have been observed in human cells, however whether Golgi pairing and unpairing is 






Golgi inheritance during cell division is a dynamic process that requires the cooperation of 
many factors including Golgi matrix proteins, membrane tethers, vesicle budding and fusion 
machineries, cytoskeletons, as well as kinases and phosphatases that transmit signals onto the 
Golgi membranes. During the cell cycle, these factors coordinately regulate mitotic ribbon 
unlinking, cisternae unstacking and membrane vesiculation; and post-mitotic cisternae growth, 
cisternae stacking and ribbon formation. Although much progress has been made in elucidating 
the mechanisms of Golgi membrane dynamics during the cell cycle, a number of questions 
remain to be addressed. First, the GRASP proteins are certainly important for Golgi structure 
formation, but whether they are involved in Golgi stacking, ribbon linking or both is still under 
debate. Second, although ubiquitin is required for post-mitotic Golgi membrane fusion, how 
ubiquitin and GATE-16 promote p97/p47- and NSF-mediated membrane fusion, what are the 
ubiquitinated substrates in the p97/p47 pathway and how GATE-16 is added onto or removed 
from the Golgi membranes, remain unknown. Third, whether the two functions of golgins, 
membrane tethering and Golgi ribbon linking, are coupled, and how they coordinate with the 
reorganization of the microtubule cytoskeleton during the cell cycle, require further exploration. 
Fourth, actin filaments play important roles not only in regulating Golgi transport but also in 
Golgi morphology maintenance. However, the mechanism is largely unknown. Finally, Golgi 
defects have been observed in several diseases such as cancer, neurodegeneration and viral 
infection [81, 82]. These defects may affect the trafficking, sorting and modification of a large 




cellular functions. Defining the cause of the Golgi defects at the molecular level may provide 




Chapter 2 . The role of GRASP65 in Golgi cisternal stacking and cell cycle 
progression 
Abstract 
In vitro assays identified the Golgi peripheral protein GRASP65 as a Golgi stacking factor 
that links adjacent Golgi cisternae by forming mitotically regulated trans-oligomers. These 
conclusions, however, require further confirmation in the cell. In this study, we demonstrated 
that the first 112 amino acids at the N-terminus (including the first PDZ domain, PDZ1) of the 
protein are sufficient for oligomerization. Systematic electron microscopic analysis showed that 
expression of non-regulatable GRASP65 mutants in HeLa cells enhanced Golgi stacking in 
interphase and inhibited Golgi fragmentation during mitosis. Depletion of GRASP65 by small 
interference RNA (siRNA) reduced the number of cisternae in the Golgi stacks; this reduction 
was rescued by expressing exogenous GRASP65. Further experiments revealed that inhibition of 
mitotic Golgi disassembly by expressing non-regulatable GRASP65 mutants did not affect equal 
partitioning of the Golgi membranes into the daughter cells. However, it delayed mitotic entry 
and suppressed cell growth; this effect was diminished by dispersing the Golgi apparatus with 
Brefeldin A treatment prior to mitosis, suggesting that Golgi disassembly at the onset of mitosis 






The Golgi apparatus is the central conduit for protein trafficking, processing and secretion 
in almost all eukaryotic cells. In interphase mammalian cells, the Golgi apparatus consists of 
stacks of parallel aligned flattened membrane cisternae, which are further linked laterally by 
tubules to form a ribbon-like structure [83]. During mitosis, the Golgi apparatus undergoes 
extensive disassembly; the generated vesicles are equally partitioned into the two daughter cells 
where these membranes are reassembled into new Golgi stacks [84]. In vitro assays that 
reconstitute the cell cycle-regulated Golgi disassembly and reassembly processes demonstrated 
that mitotic Golgi disassembly consists of two reactions: Golgi unstacking mediated by 
phosphorylation of Golgi structural proteins and vesiculation mediated by COPI vesicle 
formation; while post-mitotic Golgi reassembly requires vesicle fusion for single cisterna 
formation and stacking of the newly formed cisternae [7]. The molecular mechanism of Golgi 
stacking remains unclear. Accumulating evidence suggests that stack formation requires the 
Golgi reassembly stacking protein GRASP65. GRASP65 was first identified as a Golgi 
peripheral protein that is accessible to the alkylating reagent N-ethylmaleimide (NEM) only when 
the Golgi stacks were disassembled [13]. Further experiments showed that adding GRASP65 
antibodies to the in vitro Golgi reassembly assay inhibited stacking of newly formed Golgi 
cisternae [13]. Consistently, microinjection of GRASP65 antibodies into mitotic cells inhibited 
subsequent Golgi stack formation in the daughter cells [14].  
 
Biochemical experiments revealed a possible mechanism for GRASP65 in Golgi stacking. 
GRASP65 forms homodimers that further oligomerize in trans to hold the adjacent Golgi 
membranes into stacks. Oligomerization is mitotically regulated. During mitosis, GRASP65 is 




GRASP65 de-oligomerization and thus Golgi unstacking [14, 18]. Oligomerization of GRASP65 
is mediated by the N-terminal GRASP domain, while its phosphorylation occurs at the C-
terminal SPR (serine/proline rich) domain [18]. Further studies showed that, when targeted to the 
outer membranes of mitochondria, GRASP65 is capable of tethering mitochondria into clusters 
[85]. Finally, expression of a caspase-resistant form of GRASP65 partially prevented Golgi 
fragmentation in apoptotic cells [86]. GRASP65 is concentrated in the cis Golgi membranes, 
while its homolog, GRASP55, is primarily localized to the medial-trans cisternae [12]. These 
studies provided evidence that GRASP65 is both necessary and sufficient to hold the cis Golgi 
membranes into stacks, while GRASP55 may stack the medial-trans cisternae in a similar 
manner [16, 87]. During mitosis, phosphorylation of the GRASP proteins allows unstacking of 
the Golgi cisternae, which may facilitate COPI vesicle formation and fragmentation of the Golgi 
membranes [8, 16, 26, 28]. Subsequent dephosphorylation of GRASP and other Golgi structural 
proteins is required for post-mitotic Golgi reassembly [8, 9]. 
 
However, the hypothesis that Golgi stacking is the primary role of GRASP65 has recently 
been challenged based on studies of GRASP65 homologs in other species [88, 89] and 
knockdown experiments of mammalian GRASP65 [15, 49]. In Drosophila, knockdown of the 
sole GRASP protein, dGRASP, and its interaction protein GM130, resulted in at least partial 
disassembly of the Golgi stacks into single cisternae and vesicles in S2 cells [89]. In mammalian 
cells, depletion of GRASP65 using small interference RNA (siRNA) led to either Golgi ribbon 
unlinking [49] or an arrest in cell division accompanied by irregular mitotic spindle formation 
and cell death, with the number of cisternae in the stacks decreased [15]. Obviously, the siRNA 




knockdown experiments [15, 49] and the experiments using forced ectopic targeting of 
GRASP65 [85] may not be able to exclude the possibility of side effects. In addition, the roles 
(e.g. stacking, ribbon linking and cell cycle control) of GRASP65 in the cell may be related to 
each other. Therefore, a re-evaluation of GRASP65 functions in vivo is necessary and important. 
 
The exact role of mitotic Golgi disassembly is so far unknown, but it is thought to facilitate 
equal partitioning of the Golgi membranes into the daughter cells [9, 10]. In addition, Golgi 
ribbon unlinking at late G2 phase may function as a new check point for cell cycle progression 
into mitosis, as inhibition of Golgi ribbon cleavage at the onset of mitosis by blocking the 
activity of the Golgi fission protein BARS [45] or MEK1 kinase [46] delayed mitotic entry of the 
cells. This delay was rescued when the cells were treated with Brefeldin A (BFA), a fungi 
product that disassembles the Golgi apparatus, prior to mitosis [46, 90]. Interestingly, 
interrupting GRASP65 function by microinjection of either a C-terminal fragment of GRASP65 
or antibodies to this fragment into normal rat kidney cells (NRK) prevented cell entry into 
mitosis [90]. Further studies showed that phosphorylation of GRASP65 on serine 277 plays an 
important role in cell cycle regulation, as a peptide containing this site, but not its serine to 
alanine (S277A) mutant, delayed mitotic entry when microinjected into NRK cells [91]. The 
underlying mechanism for GRASP65 in cell cycle control is so far unclear. One possibility is 
through its regulation on mitotic kinases. Since GRASP65 is a substrate of cdc2 and plk, 
manipulation of GRASP65 level may affect the localization and activity of these kinases in cell 
cycle progression, as suggested by a previous study [19]. Alternatively, physical disruption of the 
Golgi structure mediated in part by GRASP65 phosphorylation and thus de-oligomerization may 




progression [21]. If this is the case, inhibition of GRASP65 phosphorylation may delay Golgi 
disassembly at the onset of mitosis and thus interrupt cell cycle progression.  
 
In this study, we have applied biochemical and cell biology approaches to study the 
function of GRASP65 in mammalian cells. We established stable cell lines in which endogenous 
GRASP65 was depleted by siRNA and exogenous wild-type GRSAP65 or its phosphorylation 
defective mutants was expressed under an inducible promoter. This allowed us to determine the 
role of GRASP65 in Golgi stacking by systematic EM analysis. Our results support that 
GRASP65 stacks Golgi cisternal membranes. In addition, we found that exogenous expression of 
the PDZ1 region, which is necessary and sufficient for Golgi targeting and promotion of cisternal 
stacking but lacks the entire phosphorylation domain, delays mitotic progression, indicating that 
Golgi disassembly, instead of GRASP65 phosphorylation itself, is important for the regulation of 
mitotic progression. Our study provides evidence and a molecular mechanism demonstrating that 
GRASP65 directly functions as a Golgi stacking factor and that mitotic Golgi disassembly is 






The N-terminal 112 amino acids (PDZ1) of GRASP65 are sufficient for dimerization and 
oligomerization 
Previous results showed that GRASP65 forms both dimers and oligomers [14] and 
subsequent studies revealed that the N-terminal GRASP domain (aa1-201) is both necessary and 
sufficient for dimerization and oligomerization [18]. Since the GRASP domain has two PDZ-
containing domains, PDZ1 (aa1-112) and PDZ2 (aa113-201; Figure 2.1A), we first tested 
whether PDZ1 or PDZ2 is sufficient to mediate GRASP65 oligomerization using an established 
co-purification assay [14, 18]. Recombinant MBP (Maltose Binding Protein)- and GST 
(glutathione S-transferase)-tagged PDZ1 and PDZ2 were expressed in bacteria and purified 
separately, then mixed and incubated. Protein complexes were re-isolated using amylose beads 
or glutathione beads and the co-purified proteins were determined by Western blotting. As 
shown in Figure 2.1B, only MBP-PDZ1 and GST-PDZ1 co-purified, regardless of the beads that 
were used (Figure 2.1B, lane 3). However, MBP-PDZ1 was not able to interact with GST-PDZ2 
(Figure 2.1B, lane 6), nor MBP-PDZ2 with GST-PDZ1 or GST-PDZ2 (Figure 2.1C, lanes 3 and 
6). The results suggest that PDZ1 interacts with itself to form oligomers, while PDZ2 is not 
sufficient for oligomerization.  
 
We then analyzed PDZ1 oligomerization by non-denaturing electrophoresis. As shown in 
Figure 2.1D, GST-PDZ1 exhibited four bands on the gel, as indicated by arrows (lane 2). The 
lowest band of 82 kDa was about twice the size of the estimated molecular weight of monomeric 
GST-PDZ1 (41 kDa); the upper bands exhibited molecular weights of 185, 307 and 424 kDa. 




oligomeric properties of GRASP65 shown in previous studies [14, 18]. GST-PDZ2 (Figure 2.1D, 
lane 3), however, exhibited only one band of 64 kDa on the gel, which was about twice the 
molecular weight of GST-PDZ2 (33 kDa), indicating that PDZ2 forms dimers but not oligomers. 
All these bands were excised from the gel and further confirmed by denaturing electrophoresis 
and Western blotting. As GST itself forms homodimers [92], this result was confirmed using 
His-tagged PDZ1 and PDZ2 (not shown). We also analyzed PDZ1 dimerization and 
oligomerization using other biochemical techniques. In a sedimentation gradient (Figure 2.1E), 
MBP-tagged PDZ1 was concentrated in two groups of fractions, dimers in fraction 4-7 and 
oligomers in heavier fractions including 13-14; in gel filtration (Figure 2.1F), His-tagged PDZ1 
was eluted as two peaks, one sharp peak of 48 kDa (dimer) and another broad one of 116-980 
kDa (6-48mer). Since PDZ1 was the smallest fragment that is capable of oligomerization, it was 
further characterized in the following experiments. 
 
We employed a well established bead aggregation assay [14] to test whether PDZ1 is 
sufficient to link adjacent surfaces. When incubated with bovine serum albumin (BSA), a 
significant amount (19.7 ± 1.1%) of the Dynal beads coated with His-tagged PDZ1 formed 
aggregates, similar to those coated with full length GRASP65 (23.1 ± 1.7%). In contrast, only 
6.7 ± 0.6% of the beads coated with BSA formed aggregates under the same condition (Figure 
2.1 I-J). Incubation with interphase cytosol (IC) greatly enhanced the aggregation of Dynal beads 
coated with PDZ1; 80.2 ± 3.2% of the beads were in aggregates, similar to those coated with full 
length GRASP65 (81.0 ± 1.7%; Figure 2.1, M vs. K; N).  In addition, an excess amount of His-
PDZ1, when added into the reaction, inhibited the aggregation of beads coated with full length 




PDZ1, when expressed and targeted to the outer membrane of mitochondria, linked mitochondria 
to form clusters [85]. Taken together, these results demonstrate that PDZ1 of GRASP65 is both 
necessary and sufficient to hold surfaces together through oligomerization. 
Figure 
2.1. The N-terminal half of the GRASP domain (PDZ1) is sufficient to form dimers and oligomers.  
(A) Domain structure of GRASP65. Indicated are the N-terminal GRASP domain with myristoylated N-terminal 
glycine (myr), and the C-terminal Serine/Proline Rich (SPR) domain with phosphorylation sites (*). The GRASP 
domain contains two PDZ subdomains, PDZ1 (aa1-112) and PDZ2 (aa113-201). (B) PDZ1 is sufficient to form 
oligomers as shown by a co-purification assay. Separately purified recombinant MBP-tagged PDZ1 was mixed and 
incubated with GST-tagged PDZ1 or PDZ2. The protein complexes were isolated using either amylose or 
glutathione (GSH) beads, as indicated. Equal proportions of the input (I), unbound (U) or bound (B) fractions were 
analyzed by immunoblotting for GRASP65. Note that PDZ1 co-purified with itself (lane 3), but not with PDZ2 (lane 
6). (C) PDZ2 does not form oligomers. As in B but using MBP-PDZ2 as the bait. Note that PDZ2 did not co-purify 
with PDZ1 (lane 3) or itself (lane 6). (D) Analysis of oligomerization of PDZ1 and PDZ2 by non-denaturing gels. 
GST-tagged PDZ1 and PDZ2 were incubated at 37ºC and analyzed by non-denaturing electrophoresis and stained 




oligomers (arrows), while PDZ2 formed dimers (arrowhead) only.  (E) Analysis of PDZ1 oligomerization by 
velocity gradient. Purified recombinant MBP-tagged PDZ1 was sedimented in 10-35% glycerol gradients. Shown is 
the Western blot for GRASP65 in each fraction. PDZ1 is found in both the upper (4-7; dimers) and deep fractions 
(13-14; higher-order structures). (F) Gel filtration analysis of PDZ1. Purified His-tagged PDZ1 was analyzed by gel 
filtration using a Sephacryl S-300 column. The protein was separated into two peaks: a broad peak of 116-980 kDa 
(6-48mer) and a sharp peak of 48 kDa (dimer). Sizes were calculated according to the calibration with a gel filtration 
molecular weight standard (Sigma).  (G-I) Bead aggregation assay showing that PDZ1 is sufficient to form 
oligomers. Beads coated with His-tagged full length (FL) GRASP65 (G), PDZ1 (H) or bovine serum albumin (BSA, 
I) were incubated with BSA at 37ºC for 60 min. After incubation, the beads were placed on glass slides and random 
fields were photographed. A representative image of each condition is shown. Bar, 50 µm. Note that full-length and 
PDZ1-coated beads formed aggregates.  (J) Quantitation of the percentage of beads in aggregates in G-I from 3 
independent experiments. ***, p<0.001, compared to BSA-coated beads. (K-M) Bead aggregation assay showing 
that soluble PDZ1 inhibits oligomerization of full length GRASP65. Beads coated with His-tagged full length (FL) 
GRASP65 (K-L) or PDZ1 (M) were incubated with interphase cytosol at 37ºC for 60 min. In L, purified 
recombinant PDZ1 was added into the reaction. After incubation, the beads were placed on glass slides and random 
fields were photographed. A representative image of each condition is shown. Bar, 50 µm. Note that PDZ1 can 
inhibit the aggregation of GRASP65-coated beads. (N) Quantitation of the percentage of beads in aggregates in K-
M. Results in J and N expressed as the mean ± SEM from 3 sets of independent experiments. ***, p<0.001, 
compared with full length GRASP65-coated beads in the absence of PDZ1 added to the reaction.  
 
Expression of non-regulatable GRASP65 mutants enhances Golgi stacking in interphase cells 
To test the function of GRASP65 in the cell, we expressed the wild type protein or its 
mutants using a retroviral tet-inducible mammalian expression system (tet-on) [16, 93]. The 
coding sequence was integrated into the genome but the exogenous protein is not expressed 
unless induced by doxycycline. This is particularly important, as continuous over-expression of 
GRASP65 or its mutants may affect cell growth [15]. Establishment of stable cell lines 
expressing the exogenous protein in an inducible manner also allowed a systematic analysis by 
electron microscopy (EM). The expression level of the exogenous proteins was well controlled, 
thus nonspecific effects caused by protein over-expression was not a concern in our study. Five 
lines of HeLa cells were generated that express: 1) GFP (enhanced green fluorescent protein), 
and GFP-tagged 2) wild type (WT) GRASP65, 3) non-phosphorylatable GRASP65 mutant, mG, 
with 7 phosphorylation sites mutated to alanines 
(S216A/S217A/T222A/T224A/S277A/S367A/S376A) [18, 94], 4) the GRASP domain (aa1-
201), and 5) PDZ1 (aa1-112) of rat GRASP65. The last three mutants form oligomers, but their 




non-regulatable mutants. The GRASP domain has been examined previously [18] and was used 
as a positive control in this study. Other constructs, such as PDZ2 (Figure 2.1) and the SPR-
domain [18], do not form oligomers and thus were not examined in this experiment. The 
cytoplasmic soluble mutant (G2A) of the protein was originally included in this study but did not 
show significant effect on the Golgi structure [18] and thus was not further characterized. The 
exogenous proteins were well expressed when induced by doxycycline, as shown by Western 
blot analysis (Figure 2.2L). Fluorescence microscopy (Figure 2.2, A-E) showed that the 
expressed GRASP65 WT-GFP, mG-GFP and GRASP domain-GFP localized to the Golgi in 
interphase cells, indicated by co-localization with the Golgi marker GM130 (Figure 2.2, B-D); 
while PDZ1-GFP (Figure 2.2E) was partially Golgi-localized and GFP (Figure 2.2A) was found 
in the nucleus and cytosol. Expression of GRASP65 and its mutants did not significantly affect 
the overall Golgi organization at the light microscopic level when using GM130 (Figure 2.2, A-








Figure 2.2. Expression of non-regulatable GRASP65 mutants enhances Golgi stacking in interphase cells. 
(A-E) Confocal images of interphase HeLa cells stably expressing indicated GRASP65 constructs using an (tet-on) 
inducible retroviral expression system. Cells were treated with 1 µg/ml doxycycline for 72 h, fixed and stained for 
GM130. (F-J) Representative EM images of interphase cells expressing indicated GRASP65 constructs. Bar, 0.5 
µm. Note that the number of cisternae in the Golgi stacks were increased in cells expressing the mG mutant (H), the 
GRASP domain (aa1-201, I) and PDZ1 (aa1-112, J) compared to cells expressing GFP (F) and wild type GRASP65 
(G). (K) Quantitation of F-J. Results expressed as the mean ± SEM. The number of stacks quantified for each cell 
line was indicated. Statistical significance was assessed by comparison to the GFP cell line. ***, p<0.001. Bar 
charts indicating the actual frequency of each value of cisternal numbers are shown in Figure 2.S1. (L) Western blot 
images of cells described in A-E. Cells were lysed in SDS buffer followed by Western blotting for GFP and other 
indicated proteins. ‘End. p65’, endogenous GRASP65. 
 
When analyzed under the electron microscopy (EM), cells expressing non-regulatable 
GRASP65 showed improved cisternal alignment in the Golgi stacks in comparison to cells 
expressing GFP or wild type GRASP65 (Figure 2.2, F-J; 2.S1). The number of cisternae per 
stack significantly increased in mG (7.1 ± 0.2), GRASP domain (6.9 ± 0.1) or PDZ1 (6.5 ± 0.2) 




wild type GRASP65 (5.7 ± 0.1; Figure 2.2K). Further analysis of the EM micrographs showed 
that most Golgi stacks in cells expressing the non-regulatable GRASP65 mutants contained 7-8 
cisternae, a significant increase from 5-6 cisternae per stack in cells expressing GFP or wild type 
GRASP65 (Figure 2.S1). These results provided direct evidence that GRASP65 plays a critical 
role in Golgi stacking in vivo. In addition, since wild type GRASP65 did not enhance stacking as 
its non-regulatable mutants, it suggests that phosphorylation of GRASP65 may regulate stacking 
in interphase, which may be important for Golgi remodeling under certain conditions such as cell 
migration in wound healing [21]. 
 
Figure 2.S1. Expression of non-regulatable GRASP65 mutants enhances Golgi stacking in interphase cells.  
Bar charts of Figure 2.2K indicating the actual frequency of each value of number of cisternae per stack in HeLa 
cells expressing GFP or indicated GFP-tagged GRASP65 constructs. Note that expression of non-regulatable 
GRASP65 mutants, but not the wild type protein, increased the number of cisternae in the stacks. 
Expression of non-regulatable GRASP65 mutants inhibits mitotic Golgi disassembly 
Previous reports demonstrated that GRASP65 phosphorylation at the onset of mitosis is 




membranes [7, 14]. Consistently, expression of the GRASP domain of GRASP65 inhibited Golgi 
fragmentation in mitosis [18], suggesting that the expressed non-regulatable GRASP65 mutants 
may inhibit mitotic Golgi disassembly as they remain as oligomers during mitosis. We therefore 
examined mitotic Golgi fragmentation in the cell lines described above. After 72 h doxycycline 
induction, cells were fixed, stained for DNA to select metaphase cells and GM130 to reveal the 
Golgi membranes. As shown in Figure 2.3, the Golgi membranes were extensively fragmented in 
metaphase cells expressing GFP or GRASP65-GFP. However, in cells expressing either the 
GRASP65 mG mutant, the GRASP domain, or PDZ1, the Golgi were observed as large dots, or 
mitotic Golgi clusters, indicated by the Golgi marker GM130. Quantitation of the images showed 
that a significant higher amount of the Golgi membranes remained as clusters in cells expressing 
non-regulatable GRASP65 mutants compared to that in cells expressing GFP or wild-type 
GRASP65-GFP (Figure 2.3F). The exogenous GRASP65 mG-GFP and the GRASP domain-GFP 
co-localized with the endogenous GM130 on the mitotic Golgi clusters, suggesting that the 
reduced Golgi disassembly was caused by the expressed exogenous proteins. Although the PDZ1 
was only partially localized to the Golgi, it inhibited Golgi fragmentation to the same extent as 







Figure 2.3. Expression of non-regulatable GRASP65 mutants inhibits mitotic Golgi disassembly at the light 
microscopy level.  
(A-E) Confocal images of mitotic HeLa cells stably expressing the indicated GRASP65 proteins. Cells were induced 
by doxycycline for 72 hrs and fixed, and stained for DNA and GM130. Note that cells expressing the mG mutant 
(C), the GRASP domain (aa1-201, D) and PDZ1 (aa1-112, E) had more mitotic clusters compared to those 
expressing GFP (A) and wild type GRASP65 (B). Scale bar, 20 µm. (F) Relative distribution (%) of the Golgi 
membranes in mitotic Golgi clusters in the indicated cell lines. The fluorescence intensity of GM130 was quantified 
using the ImageJ software for the total fluorescent intensity and a threshold was used to filter the fluorescence in 
Golgi haze to quantify the fluorescent intensity in mitotic Golgi clusters. The average percentage of fluorescent 
intensity in Golgi clusters (mean ± SEM) from 10 cells in each cell line is shown. Statistical significance was 






Figure 2.4. Expression of non-regulatable GRASP65 mutants inhibits mitotic Golgi disassembly when 
examined by EM.  
(A-E) Representative EM images of Golgi clusters (asterisks) in mitotic cells expressing indicated GRASP65 
constructs. Mitotic cells were collected by shake-off of cells released from a double-thymidine block and processed 
for EM. Bar, 0.5 µm. Note that the mitotic Golgi clusters were larger and more compact in cells expressing the mG 
mutant (C), the GRASP domain (D) and PDZ1 (E), with an increased number of remaining Golgi cisternal structures 
(arrowheads) in the clusters. (F-G) Quantitation results of A-E to determine the number of mitotic clusters per 
mitotic cell profile (F) and the number of cisternae per mitotic cluster (G). Only cells with condensed chromosomes 
but no detectable nuclear envelope were counted. The number of cells (F) and clusters (G) quantified for each cell 
line was indicated and results expressed as the mean ± SEM. Statistical significance was assessed by comparison to 
the GFP cell line. ***, p<0.001. 
 
We then examined these cells under the EM. Mitotic HeLa cells were collected by shake-
off after double thymidine block and release. Unlike mitotic cells expressing GFP or wild type 
GRASP65 in which the Golgi complex was extensively disassembled and diffused, considerable 
amounts of Golgi membranes remained as Golgi clusters in cells expressing non-regulatable 
GRASP65 mutants (Figure 2.4, C-F, asterisks). These clusters consisted of short cisternae 
(arrowheads), tubular structures or even ministacks that were surrounded by vesicles. 
Quantitation of the EM images showed that the number of mitotic clusters per mitotic cell profile 
(with condensed chromosomes but no nuclear envelope) was significantly increased in cells 




expressing GFP (2.4 ± 0.6) or wild type GRASP65 (2.8 ± 0.4; Figure 2.4F). The mitotic clusters 
in cells expressing the non-regulatable mutants were also larger in size and more compact. In 
addition, each mitotic Golgi cluster contained more remaining Golgi cisternae in cells expressing 
mG (3.7 ± 0.2), the GRASP domain (3.6 ± 0.2) and PDZ1 (3.9 ± 0.3) compared to those 
expressing GFP (1.1 ± 0.2) and wild type GRASP65 (0.9 ± 0.2; Figure 2.4G). These results 
suggest that expression of the non-regulatable GRASP65 mutants inhibited the disassembly of 
Golgi membranes during mitosis. 
 
Depletion of GRASP65 reduced the number of cisternae per Golgi stack, which was rescued 
by expressing exogenous GRASP65 
If GRASP65 plays a direct role in Golgi stacking, depletion of GRASP65 would reduce the 
number of cisternae in the stack. Indeed, it has been reported that knockdown of GRASP65 
reduced the number of cisternae per stack from 6 to 3 [15]. However, in another report, 
GRASP65 depletion in the same cell line using identical siRNA oligos led to Golgi ribbon 
unlinking [49]. It is not clear whether the discrepancy was caused by different knockdown 
efficiencies between the two groups, off-target effects of the siRNA, or a limitation of the 
methods employed to analyze the effects. Therefore we have re-evaluated the possible 
phenotypes in cells in which GRASP65 was efficiently depleted by both immunofluorescence 
microscopy and EM. Both Western blotting (Figure 2.5O) and immunofluorescence microscopy 
(Figure 2.5B) showed that endogenous GRASP65 was efficiently depleted (94.1 ± 2.9% 
depletion, quantified from Western blot results) 96 h after transfection with GRASP65 siRNA 
oligos. At the fluorescence microscopy level, no obvious change in the Golgi morphology was 




per Golgi stack in GRASP65-depleted cells (4.0 ± 0.1) was significantly reduced compared to 
cells transfected with control siRNA (5.9 ± 0.2; Figure 2.5, I vs. H; 2.5Q; 2.S2A), in agreement 
with a previous report [15]. As GRASP65 is concentrated to the cis Golgi [12], this result 
indicates that GRASP65 is essential for stacking the cis Golgi membranes.  
 
To ensure that the observed effect was specific for GRASP65 depletion, we expressed 
exogenous rat GRASP65 in cells in which the endogenous GRASP65 was knocked down. We 
took advantage of the HeLa cell lines described above that stably express rat GRASP65 or its 
mutant in an inducible system. These cells were first transfected with siRNA targeted to human 
but not rat GRASP65; 24 h after transfection, doxycycline was added into the tissue culture 
medium followed by an additional 72 h incubation to induce the expression of exogenous 
GRASP65 proteins. As shown by the Western blot results (Figure 2.5P), 95.4 ± 0.6% of the 
endogenous GRASP65 was depleted in the GFP cell line, while the exogenous GFP or GFP-
tagged GRASP65 and its mutants were well expressed. At the fluorescence microscopy level 
using GM130 (Figure 2.5) and Gos28 (not shown) as Golgi markers, the overall Golgi structure 
did not exhibit any obvious differences between GFP- and GRASP65-expressing cells in which 
the endogenous GRASP65 was depleted (Figure 2.5, D vs. C). When examined under the EM, 
cells expressing GRASP65-GFP had an increased number of cisternae per stack (5.7 ± 0.1) 
compared to those expressing GFP (4.0 ± 0.1; Figure 2.5R; 2.S2B). A similar result was obtained 
in cells expressing GFP-tagged mG (5.7 ± 0.1), the GRASP domain (5.8 ± 0.1), or PDZ1 (5.6 ± 
0.1; Figure 2.5R; 2.S2B). These results showed that the reduction of Golgi stacking in cells 





Figure 2.5. Depletion of GRASP65 reduces the number of cisternae per stack, which can be rescued by 
expression of exogenous GRASP65. 
(A-B) Confocal fluorescence images of GRASP65 knockdown cells. HeLa cells transfected with indicated siRNA 
oligos were fixed and immunostained for GRASP65 and GM130. (C-G) Confocal fluorescence images of HeLa 
cells in which endogenous GRASP65 was replaced by exogenous GRASP65 or its mutants. HeLa cells expressing 
indicated proteins were transfected with siRNA oligos for human GRASP65. Doxycycline was added 24 h after 
transfection. Cells were fixed 96 h after transfection and immunostained for GM130. (H-N) Representative EM 
micrographs of cells described in A-G. Arrowheads indicate Golgi stacks. Note that the number of cisternae per 
stack was reduced in GRASP65 depleted cells (I), which was restored by expression of rat GRASP65 or its mutants 




GRASP65 was 94.1% ± 2.9%. (P) Immunoblots of HeLa cells described in C-G, in which endogenous GRASP65 
was replaced by rat GRASP65 or its mutant. Lane 1, control cells with neither GRASP65 depleted nor exogenous 
protein expressed; lane 2-6, cells with GRASP65 knocked down and indicated exogenous protein expressed. The 
knockdown efficiency for GRASP65 was 95.4 ± 0.6% for the GFP cell line and was similar in other cell lines, while 
GM130 expression level was not significantly affected. (Q) Quantitation of the EM images in H-I in one 
representative experiment from 3 sets of independent experiments. Only stacks with 3 or more cisternae were 
counted. The numbers of Golgi stacks quantified were indicated. Results expressed as the mean ± SEM. Note that 
GRASP65 depletion reduced the average number of cisternae per stack. ***, p<0.001. (R) Quantitation of the EM 
images in J-N. Note the increase of cisternal number per stack by expression of GRASP65 and its mutants in 
GRASP65 knockdown cells. Statistical significance was assessed by comparison to the GFP cell line. ***, p < 
0.001.  Bar charts indicating the actual frequency of each value of Golgi cisternae are shown in Figure 2.S2. 
 
 
Figure 2.S2. Knockdown of GRASP65 reduces the number of cisternae per stack, which can be rescued by 
expression of exogenous GRASP65. 
(A) Bar charts of Figure 2.5Q showing the actual frequency of Golgi cisternal numbers in the stacks in HeLa cells 
transfected with control or GRASP65 siRNA. Note the shift of the bars to lower numbers when GRASP65 was 
depleted (lower panel) compared to the control siRNA transfected cells (upper panel). (B) Bar charts of Figure 2.5R 
showing the actual frequency of Golgi cisternal numbers in the stacks in HeLa cells in which endogenous GRASP65 
was replaced by GFP, rat GRASP65 or its mutants, as indicated. Note that expression of GRASP65 and its mutant 
increased the number of cisternae in the stacks compared to the GFP cell line. 
 
Expression of GRASP65 mutants does not affect equal distribution of Golgi membranes into 




Golgi disassembly during mitosis in mammalian cells is generally thought to facilitate its 
equal partitioning into the two daughter cells [9, 95]. However, it has also been suggested that 
mitotic Golgi clusters may undergo ordered inheritance [96]. Therefore it is necessary to evaluate 
whether inhibition of mitotic Golgi disassembly affects Golgi partitioning. We took advantage of 
the cell lines expressing non-phosphorylatable GRASP65 mutants in which mitotic Golgi 
disassembly is inhibited (Figure 2.3) and quantified the amount of the Golgi membranes in the 
two daughter cells using GM130 as the marker. At least 10 pairs of daughter cells in cytokinesis 
in each cell line were observed under confocal microscopy and the fluorescence intensity in each 
daughter cell was quantified (Figure 2.6). No statistical difference in GM130 distribution in the 
two daughter cells was detected between the cell lines examined. This result demonstrated that 
although mitotic Golgi fragmentation is inhibited in the cells that express GRASP65 mutants, 
Golgi partitioning into the two daughter cells is as accurate as control GFP-expressing cells. 
Similar results were obtained using other Golgi markers such as Gos28 (not shown). Consistent 
with this observation, it has been shown that inhibition of mitotic Golgi fragmentation by 
microinjection of a non-phosphorylatable p47 mutant did not affect equal distribution of Golgi 
membranes into the daughter cells [97]. These results imply that either partial disassembly of the 
Golgi in mitosis (e.g. fragmentation of the Golgi ribbon into stack) is sufficient for its equal 
partitioning into the daughter cells, in which case an ordered partitioning mechanism may be 






Figure 2.6. Expression of non-regulatable GRASP65 mutants does not significantly affect Golgi membrane 
distribution into the two daughter cells.  
(A-E) Confocal images of indicated HeLa cell lines in cytokinesis. Cells were induced by doxycycline for 72 hrs 
and fixed, stained for DNA and GM130. Asterisks indicate the two daughter cells. Scale bar, 20 µm. (F) Relative 
distribution of the Golgi membranes in the two daughter cells using GM130 as a marker. The fluorescence intensity 
of GM130 in 10 pairs of daughter cells in each cell line was quantified using the NIH ImageJ software. The average 
(mean ± SEM) intensity in the daughter cells with relatively lower intensity compared to their pairs is shown in blue, 
and the average intensity in the cells with relatively higher GM130 signal is shown in red. The distribution of 





Inhibition of mitotic Golgi disassembly delays cell cycle progression 
Previous reports suggested that the Golgi structure (and/or its mitotic disassembly) plays a 
role in cell cycle control [46, 53]. Since expression of the non-regulatable GRASP65 mutants 
inhibited mitotic Golgi fragmentation, these cell lines provided us with excellent tools to 
determine the relationship between mitotic Golgi fragmentation and cell cycle progression. To 
evaluate whether inhibition of mitotic Golgi fragmentation affects mitotic entry, cells expressing 
GFP or GFP-tagged GRASP65 constructs (induced by doxycycline) were synchronized to G1/S 
phase by double thymidine block and the mitotic index of each cell line was determined over 
time after thymidine release. As shown in Figure 2.7A, the mitotic index of the GFP-expressing 
cells peaked at 7 h after thymidine release. Cells expressing wild type GRASP65 showed a 
similar cohort of mitotic index, demonstrating that expression of wild type GRASP65 protein did 
not affect mitotic entry. However, when the mG mutant, the GRASP domain or PDZ1 was 
expressed, the peak mitotic index was delayed for 1 - 2 h, suggesting that inhibition of mitotic 
Golgi fragmentation delayed cell cycle progression, which is consistent with previous reports 







Figure 2.7. Inhibition of mitotic Golgi fragmentation by expression of non-regulatable GRASP65 mutants 
delays mitotic entry and inhibits cell proliferation. 
(A) Inhibition of mitotic Golgi fragmentation delayed cell cycle progression. The percentage of cells in mitosis 
(mitotic index) at the indicated time points of release from double thymidine block was determined for cells 
expressing GFP or GRASP65 constructs as indicated. Note that the cells expressing GFP or wild type GRASP65 
passed through mitosis in a cohort that peaks at 7 h. This peak was significantly delayed in the cells expressing the 
mG mutant, the GRASP domain or PDZ1 of GRASP65. (B) Brefeldin A (BFA)-induced Golgi disruption in cells 
expressing non-regulatable GRASP65 mutants rescued mitotic progression. As in (A), except that 5 µg/ml BFA was 
added to the tissue culture medium 4 h after the release from the double thymidine block. Note that the BFA 
treatment suppressed the mitotic delay in cells expressing the GRASP domain or PDZ1. (C) Expression of non-
regulatable mutants of GRASP65 reduced the cell growth rate. The cell number of each cell line was measured by 
staining the cells with crystal violet at indicated time points and normalized with the cell number at the starting 
point. Note that expression of the mG mutant, the GRASP domain or PDZ1 reduced the cell growth rate compared 
to expression of GFP or wild type GRASP65.  
 
The fact that disrupting GRASP65 function by expression or microinjection of a C-terminal 
fragment of the protein leads to a delay in cell mitotic entry has been described previously [90, 
91]; however, the mechanism remains unknown. One possible mechanism is that GRASP65 




has been shown that expression of the wild type GRASP65 C-terminal SPR domain but not the 
phosphorylation defective mutant caused a delay in cell cycle progression [19]. However, the 
non-regulatable GRASP65 mutants used in our study were not substrates of the mitotic kinases, 
since the phosphorylation sites were either mutated or deleted. In addition, these proteins are 
localized on the Golgi when expressed in the cell, which is different from the cytosolic SPR 
domain used in previous studies [19, 90]. Expression of these constructs also showed no effect 
on the expression level and localization of cdc2, cyclin B1 and plk in the cell (not shown). 
Therefore, it is unlikely that the delay in mitotic entry observed in this study occurred through 
inhibition or modulation of the mitotic kinases.  
 
Another possible explanation for the cell cycle progression delay is that Golgi disassembly 
is required for mitotic entry, as suggested by previous reports [21, 90]. In this model, GRASP65 
has no direct role in cell cycle control, but inhibition of mitotic Golgi fragmentation by 
interrupting GRASP65 function may delay mitotic entry. If this is the case, physical disruption of 
the Golgi by BFA before mitosis [46] may abolish the mitotic delay caused by the expression of 
non-regulatable GRASP65 mutants. To test this possibility, we added BFA into the tissue culture 
medium 4 h after final release from the double thymidine block and measured the mitotic index 
at later time points. As shown in Figure 2.7B, BFA treatment abrogated the 2 h mitotic delay 
caused by expression of the GRASP domain or PDZ1. In contrast, disruption of the Golgi 
structure by BFA treatment did not affect mitotic entry of cells expressing GFP or wild type 
GRASP65-GFP. This result indicated that the cell cycle delay caused by expression of non-






Next, we examined the growth of cells that express non-regulatable GRASP65 mutants. 
Equal numbers of cells were plated into 24-well plates. After two days of doxycycline induction 
to express the exogenous proteins, the number of cells was measured over time using crystal 
violet, a DNA-binding dye. As shown in Figure 2.7C, the increase of the cell number was 
reduced in cells expressing the mG mutant, the GRASP domain or PDZ1 compared to those 
expressing GFP or GRASP65 wild type protein at all time points examined. The effect was most 
significant on day 3, with p < 0.01 when comparing cells expressing mG, the GRASP domain or 
PDZ1 with those expressing GFP (Figure 2.7C). It became less significant on day 4, possibly 
because the cells were confluent on the dish. The effect was observed only when the exogenous 
proteins were induced, but not in the absence of doxycycline. These results suggest that 
inhibition of mitotic Golgi disassembly delays cell cycle progression and slows down cell 
growth. To summarize, our study demonstrate that oligomerization of GRASP65 through its N-
terminal 112 amino acids is essential for Golgi stacking in tissue culture cells, and inhibition of 





In this study we have examined the role of GRASP65 in Golgi stacking using a 
combination of biochemical approaches, an inducible expression system, the siRNA technique 
and systematic EM analysis. We first showed that its first PDZ domain oligomerizes with itself, 
which is sufficient to hold surfaces together. Our results further demonstrated that expression of 
non-regulatable GRASP65 mutants enhances Golgi stacking and inhibits Golgi fragmentation in 
mitotic cells. GRASP65 is required for full stacking as GRASP65-depletion reduces the number 
of cisternae in the stack; this effect can be rescued by expression of exogenous GRASP65. 
Furthermore, using non-regulatable GRASP65 as a tool, we showed that inhibition of Golgi 
fragmentation at the onset of mitosis does not significantly affect the accuracy of Golgi 
inheritance, but it delays mitotic entry and slows down cell growth, supporting a model in which 
Golgi fragmentation is needed for proper cell cycle progression. Our results revealed the 
mechanism for GRASP65 as a Golgi stacking factor, which holds the adjacent cisternal 
membranes by forming trans-oligomers through the N-terminal PDZ1 domain. Although 
GRASP65 does not seem to play a direct role in cell cycle control, physical disruption of the 
Golgi is required for mitotic entry. 
 
GRASP65 has multiple functions that are possibly carried out by different domains. The 
first PDZ domain interacts with itself and plays a significant role in Golgi stacking. The second 
PDZ domain interacts with GM130, a protein that plays a role in protein trafficking [98-101]. 
Therefore, GRASP65 may also coordinate with GM130 through the second PDZ domain and 
function in membrane trafficking [102]. The C-terminal SPR-domain contains all the 
phosphorylations sites and thus is important for mitotic regulation of GRASP65 oligomerization 




different pathway. Mutants that affect one function but not the others may serve as useful tools to 
further dissect the functions of the GRASP65 as well as the biological significance of Golgi 
stacking in mammalian cells.  
 
One interesting observation concerns PDZ1 targeting to the Golgi membranes. GRASP65 is 
myristoylated, which serves as the anchor to the Golgi membranes. Deletion of this 
myristoylation site by mutating the N-terminal glycine to alanine (G2A) led to the loss of Golgi 
membrane targeting and thus the protein became cytosolic [18, 103]. GRASP65 function 
requires correct Golgi localization, as the G2A mutant of the protein did not exhibit significant 
effect on Golgi stacking in our study [18]. GRASP65 and GM130 form a stable complex, which 
is directly targeted to the Golgi membranes right after their biosynthesis. It was originally 
proposed that GRASP65 targets GM130 to the Golgi membranes, as it contains a membrane 
anchor [103, 104]. However, GM130 is found on the Golgi membranes in GRASP65-depleted 
cells (Figure 2.5), consistent with a previous observation [49]. Furthermore, PDZ1 (aa1-112, 
tagged with GFP), which lacks the GM130 binding site, was largely concentrated on the Golgi 
(Figure 2.2E). Interestingly, the Golgi localization of PDZ1 did not depend on (the 
oligomerization with) the endogenous GRASP65, as it was found enriched on the Golgi 
membranes in cells in which the endogenous GRASP65 was depleted (Figure 2.5G). In general, 
one myristoylation modification may not be sufficient to target the protein to certain membranes. 
However, as GRAS65 forms oligomers, multiple myristic acid moieties on the protein complex 
may be sufficient for Golgi membrane localization. In this case, the interaction with GM130 may 
enhance and specify the Golgi targeting of GRASP65, but may not be absolutely required for its 





Another interesting observation concerns the different effects caused by expression of 
GRASP65 wild type protein versus its non-regulatable mutants. Expressing the non-regulatable 
GRASP65 mutants enhanced Golgi stacking during interphase and inhibited Golgi fragmentation 
during mitosis, while expression of wild type GRASP65 had little, if any, effect. These results 
suggest that GRASP65 may be regulated during both mitosis and interphase, consistent with the 
report that GRASP65 is phosphorylated by the MAP kinase ERK on S277 when the Golgi 
structure is remodeled for cell migration in a wound healing assay [21]. From an evolutionary 
point of view, it is not known what controls the number of cisternae in each stack. For example, 
the budding yeast Saccharomyces cerevisiae has a GRASP65 homolog but lacks stacked Golgi 
under normal conditions; while in mammalian cells, the number of cisternae per stack is highly 
conserved in different cell types, at least in the cell lines and tissues that we have examined. In 
this study, the number of cisternae per stack (7.1 ± 0.2) in cells expressing the non-
phosphorylatable GRASP65 was significantly increased compared to that of 5.6 ± 0.1 in control 
cells expressing GFP (Figure 2.2K), while depletion of the endogenous GRASP65 reduced the 
number to 4.0 ± 0.1, suggesting that studies on GRASP65 and its homolog protein, GRASP55 
[16], may shed light on the molecular control of the cisterna number in the Golgi stacks. Future 
EM analysis will determine the identity of the additional cisternae in cells expressing GRASP65 
mutants and the lost cisternae in GRASP65-depleted cells. 
 
Although GRASP65 was originally discovered as a Golgi stacking factor and many studies 
support this idea, it has also been shown that GRASP65 depletion in HeLa cells led to Golgi 




stacks, it is possible that Golgi ribbon unlinking in GRASP65-depleted cells was caused, at least 
in part, by disassembly of the Golgi stacks. In all the conditions examined in this study, we 
observed by both light and electron microscopy that the Golgi membranes were concentrated in 
the perinuclear region and thus we were unable to obtain evidence that GRASP65-depletion 
leads to scattered Golgi as previously reported [49], even though the number of cisternae in the 
stacks was reduced (Figure 2.5), which is consistent with a different report [15]. In addition, the 
observed phenotype was rescued by expression of rat GRASP65, which validated the specificity 
of the effect. A recent report showed that GRASP65, when targeted to the outer membrane of the 
mitochondria, caused mitochondria clustering [85]. This result was used to support the role of 
GRASP65 in Golgi ribbon formation. However, it can also be interpreted as evidence for Golgi 
stacking, since it indicates oligomerization of the protein. In general, a protein involved in Golgi 
ribbon linking should localize (and possibly concentrate) on the Golgi rims where Golgi ribbon 
linking occurs, as suggested by the Golgi ribbon linking protein GMAP210 [61]. However, 
GRASP65 was discovered as a Golgi membrane protein that is accessible to the alkylating 
reagent, NEM, only when the Golgi membranes were disassembled by mitotic cytosol [13], 
suggesting that the protein is not concentrated on the rims of the Golgi cisternae. Instead, 
immuno-EM showed that GRASP65 is distributed on the body of the Golgi cisternae [12]. 
Therefore it is more likely that GRASP65 is primarily involved in Golgi stacking. Indeed, results 
from the expression and knockdown experiments in this study provided strong evidence that 
GRASP65 is directly involved in Golgi stacking. Whether GRASP65 plays a direct role in Golgi 





Golgi disassembly is related to cell cycle progression, as inhibition of Golgi fragmentation 
at the onset of mitosis delays mitotic entry [46, 53, 90]. So far it is unclear what role GRASP65 
plays in cell cycle control, nor the biological significance of mitotic Golgi disassembly. It has 
been suggested that Golgi dispersal during mitosis may aid in equal partitioning of Golgi into the 
new daughter cells [10]. In our study, the inhibition of Golgi fragmentation during mitosis by 
expression of the non-regulatable mutants of GRASP65 did not lead to an unequal distribution of 
the Golgi membranes (Figure 2.6), suggesting that extensive Golgi fragmentation may not be 
required for accurate Golgi inheritance.  
 
An alternative possible role for mitotic Golgi disassembly is to allow the separation of the 
duplicated centrosomes for mitotic spindle formation, as an intact Golgi complex may physically 
block centrosome separation during prometaphase. Consistent with this speculation, our results 
showed that inhibition of Golgi fragmentation by expression of non-regulatable GRASP65 
mutants delayed mitotic entry, while disruption of the Golgi by BFA treatment diminished this 
effect. Previous studies demonstrated that microinjecting recombinant GRASP65 or its 
antibodies, or expressing its C-terminal fragment, caused a delay in mitotic entry [90, 91], 
possibly through modulation of the related mitotic kinases [19]. In contrast to the previous 
studies, expression of Golgi-localized non-regulatable GRASP65 does not affect mitotic kinase 
expression or subcellular localization, since these constructs are not substrates of the mitotic 
kinases. Therefore, our results suggest that the observed mitotic delay may occur through 
inhibition of mitotic Golgi disassembly, which is generally regulated through GRASP65 
phosphorylation and de-oligomerization. Furthermore, the mitotic index of cells expressing non-




mitotic cells when the mutants were expressed, or these cells require a longer period to complete 
mitosis. In the latter case, an extended time period required for complete Golgi disassembly may 
contribute largely to the delay in cell cycle progression. Alternatively, the cells may need a 
longer time period to equally distribute the mitotic clusters (than completely disassembled Golgi 
vesicles) into the two daughter cells. In summary, our results demonstrate that GRASP65 stacks 
Golgi cisternae by oligomerization through its N-terminal PDZ1 domain. The disassembly of 
GRASP65 trans-oligomers caused by phosphorylation is essential for Golgi unstacking and 
fragmentation, which in turn regulates the cell cycle progression and cell growth. Future 
directions include determination of the effects caused by the expression of GRASP65 with single 
point mutation of the phosphorylation sites (e.g. S277), the dynamic of mitotic Golgi 
disassembly and post-mitotic Golgi reassembly in cells expressing GRASP65 mutants, the 
signaling pathways that regulate Golgi membrane dynamics during the cell cycle, and especially 





Materials and Methods 
Reagents 
All reagents were from Sigma Co., Roche or Calbiochem, unless otherwise stated. The 
following antibodies were used: monoclonal antibodies against Gos28 and GM130 (Transduction 
Laboratories), and -tubulin (K. Gull); polyclonal antibodies against green fluorescence protein 
(GFP, J. Seemann), GM130 (N73, J. Seemann), human GRASP65 (J. Seemann), rat GRASP65 
[18], and human GRASP55 (Proteintech Group, Inc.).  
 
Preparation of GRASP65 fusion proteins 
GRASP65 cDNAs [13, 14, 18] were cloned into pMAL-c2X (New England Biolabs), 
pGEX (GE Healthcare), or pET30a (Novagen) vectors by PCR or restriction digestion and 
confirmed by DNA sequencing. GRASP65 point mutations were introduced using the 
QuikChange mutagenesis kit (Stratagene) and confirmed by DNA sequencing. Proteins were 
expressed in BL21-CodonPlus(DE3)RILP bacteria and purified on amylose (New England 
Biolabs), nickel (Qiagen), or glutathione-Sepharose (GE Healthcare) beads. 
 
GRASP65 dimerization and oligomerization 
To test the oligomerization of GRASP65 fragments, separately expressed and purified 
MBP-tagged or GST-tagged GRASP65 fragments were mixed and incubated in the presence of 
an ATP-regenerating system (10 mM creatine phosphate, 0.1 mM ATP, 20 µg/ml creatine 
kinase, 20 µg/ml cytochalasin B) at 37
 
ºC for 1 h. The protein complex was isolated using 





For sedimentation analysis, purified MBP tagged PDZ1 (120 µg) was incubated at 37ºC for 
1 h in gradient buffer (25 mM Hepes-KOH, pH7.4, 150 mM KCl, 5 mM MgCl2, 1 mM DTT) in 
a final volume of 150 µl. Top-loaded glycerol gradients (10-35% w/v) were centrifuged for 4 h at 
55,000 rpm (260,000 g) in a VTI65.1 rotor and portions of the 1 ml fractions were analyzed by 
Western blotting.  
 
For non-denaturing electrophoresis, purified GST-tagged PDZ1 or PDZ2 domain was 
incubated with KHM buffer (20 mM Hepes-KOH, pH 7.4, 0.2 M sucrose, 60 mM KCl, 5 mM 
Mg(OAc)2, 2 mM ATP, 1 mM GTP, 1 mM glutathione with protease inhibitors) at 37ºC for 1 h, 
mixed with non-denaturing sample buffer and loaded onto a 4-12% NuPAGE Novex Bis-Tris 
mini gel (Invitrogen) [16, 105]. After electrophoresis, the gel was stained with Coomassie Blue. 
Major bands were excised from the gel and further analyzed by denaturing electrophoresis and 
Western blotting. 
 
For gel filtration, His-tagged PDZ1 was incubated with an ATP regeneration system at 
37ºC with KHM buffer for 1 h and analyzed by a Sephacryl-S300 column. 2 ml fractions were 
collected at a flow rate of 0.5 ml/min. Proteins in the peak fractions were confirmed by Western 
blotting.  
 
Bead aggregation assay was performed as previously described [14, 18]. Briefly, His-
tagged recombinant GRASP65 full-length and PDZ1 were subjected to centrifugation at 15,000 
rpm for 30 min in a tabletop centrifuge at 4ºC. The proteins in the supernatant were then cross-




with either bovine serum albumin (BSA), or interphase cytosol prepared from HeLa S3 cells 
[14], in KHM buffer to allow the aggregation. In some experiments, an excess amount (0.5 
µg/µl) of purified His-PDZ1 was included in the reaction. For quantitation of the beads, 15 
random phase contrast digital images of each reaction were captured with a 20x lens and a Spot 
Slider2 Camera (Diagnostic Instruments). Images were analyzed with the MATLAB7.4 software 
to determine the surface area of objects, which was used to calculate the number of beads in the 
clusters. Aggregates were defined as those with ≥ 6 beads. For large aggregates, only visible 
surface beads were counted; therefore, the number of beads in these aggregates was 
underestimated. Results were expressed as the mean ± SEM from 3 independent experiments; 
statistical significance was assessed by Student’s t-test. 
 
Cell culture, siRNA, and establishment of stable cell lines  
HeLa cells were transfected with Stealth siRNA oligos (Invitrogen) prepared according to 
the reported sequence for human GRASP65 (5’-CCTGAAGGCACTACTGAAAGCCAAT-3’) 
[15] using lipofectamine RNAiMAX (Invitrogen) following the manufacturer’s instructions. 
Control non-specific siRNA oligos were purchased from Ambion. Assays were performed 96 h 
after transfection. The knockdown efficiency of endogenous GRASP65 was analyzed using the 
ImageJ software from Western blotting results and normalized with tubulin as a loading control.  
 
To establish stable cell lines, rtTAm2 HeLa cells were infected with retroviral particles 
encoding indicated exogenous genes cloned in the pRevTRE2 vector. Wild type rat GRASP65, 
the mG mutant in which seven phosphorylation sites were mutated to alanines 




were first cloned into pEGFP-N2 vector via the EcoRI and ApaI sites. GFP (enhanced green 
fluorescent protein), GRASP65-GFP, GRASP65 mG-GFP and GRASP domain-GFP cDNA 
were then excised by HindIII and NotI and re-ligated into the pRevTRE2 vector. For GRASP65 
PDZ1 (aa1-112)-GFP, GFP cDNA was first cloned into the pRevTRE2 vector through the 
HindIII and NotI sites. The PDZ1 coding sequence was inserted in frame into the BamHI and 
HindIII sites at the N-terminus of GFP. Procedures for viral preparation, infection and cell 
selection were previously described [93]. GFP positive cells were enriched by flow cytometry. 
The expression of exogenous proteins was induced with 1 µg/ml doxycycline for 72 h. For the 
gene replacement experiment, GRASP65- or GFP-cell lines were transfected with GRASP65 
siRNA for 24 h followed by induction with doxycycline for 72 h.  
 
Microscopy and quantitation 
Immunofluorescence microscopy and collection of mitotic cells were previously reported 
[28]. Pictures were taken with a Leica SP5 confocal laser-scanning microscope using a 100x oil 
lens. For metaphase cells, images were captured using fixed parameters with 0.3 µm intervals at 
the Z-axis and then processed for maximum-value projection. Images were analyzed using the 
NIH ImageJ software, and a threshold was introduced to exclude cytoplasmic staining and the 
Golgi haze [34]. All pixels above this threshold value were counted as Golgi remnants and 
summed up as the fluorescence intensity in Golgi clusters. The percentage of fluorescence 
intensity in Golgi clusters was calculated versus total fluorescence intensity in the cell above 
background. Cells in cytokinesis were defined as two daughter cells linked with a thin 
connection (contractile ring); chromosomes are concentrated in the center of each daughter cell 




completed. Fluorescence intensity for indicated Golgi proteins in each daughter cell (above the 
background of the image) was measured; the percentage of the Golgi membrane inherited by one 
daughter cell was calculated against the total fluorescence intensity of the cell pair. More than 10 
cells or cell pairs were quantified for each cell line in each experiment. The average (mean ± 
SEM) percentage of fluorescence intensity in the daughter cells with relative lower fluorescence 
level compared to their pairs was calculated and presented in Figure 2.6F. 
 
For EM analysis, Golgi stacks and clusters were identified using morphological criteria and 
quantified using standard stereological techniques [18]. For interphase cells, the profiles had to 
contain a nuclear profile with an intact nuclear envelope; only the obvious stacked structures 
with 3 or more cisternae were counted. For mitotic cells, the profile had to contain one or more 
profiles of condensed chromosomes and lack a nuclear envelope; very often multiple condensed 
chromosomes were aligned in the center of the cell. A low magnification (normally 1600x) 
image and serial images of higher magnification (normally 11,000x) were taken to cover the 
entire cell. About 20 cells were quantified. To quantify the cisternae number in each mitotic 
Golgi cluster, a cisterna was defined as a membrane-bound structure in the Golgi cluster whose 
length is at least 4 times its width, normally 20-30 nm in width and longer than 150 nm [106].  
 
Mitotic index and growth rate analysis 
The mitotic index analysis of cells after double thymidine block and release was performed 
as previously described [46]. Briefly, cells of about 40% confluence were incubated in growth 
medium with 2 mM thymidine for 24 h, then washed with phosphate-buffered saline (PBS) and 




thymidine for an additional 20 h before the final release. At different time points after release, 
cells were assayed for mitotic index by tallying the number of cells displaying clear mitotic 
(rounded perimeter, discernible mitotic plate) and interphase characteristics using an inverted 
microscope and a 20x phase contrast objective [46]. About 300 cells were counted at each time 
point within 5 min. For the stable cell lines, 1 µg/ml doxycycline was added at the starting time 
of the first thymidine block. In some experiments, 5 µg/ml Brefeldin A (BFA) from a 5 mg/ml 
stock, or an equal volume of ethanol, was added 4 h after the final thymidine release to disperse 
the Golgi structure. The experiment was repeated at least 3 times and the results were expressed 
as the mean ± SEM. 
 
To analyze the growth rate of the stable cell lines, 5,000 cells were added into each well of 
24-well plates and incubated in growth medium with 1 µg/ml doxycycline to induce the 
expression of the exogenous proteins. Two days later, cell numbers were measured every 24 h 
for 4 days by crystal violet staining [107]. Briefly, cells were washed with pre-warmed PBS, 
fixed in 4% formaldehyde for 30 min and stained with 0.5% crystal violet (in 30% methanol) for 
15 min. After extensively washing with H2O, DNA bound dye was extracted with 1 ml 10% 
acetic acid and measured for OD at 590 nm. The cell numbers at different days were normalized 
to the cell number from the first measurement. The results were shown as the mean ± SEM, n = 
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BSA, bovine serum albumin; GFP, enhanced green fluorescent protein; EM, electron 
microscopy; GRASP65, Golgi reassembly stacking protein of 65 kDa; IC, interphase cytosol; 
NEM, N-ethylmaleimide; NRK, normal rat kidney cells; PBS, phosphate-buffered saline; plk, 






















Chapter 3 . Sequential phosphorylation of GRASP65 orchestrates mitotic 
Golgi disassembly 
Abstract 
GRASP65 phosphorylation during mitosis and dephosphorylation after mitosis are required 
for Golgi disassembly and reassembly during the cell cycle. At least eight phosphorylation sites 
on GRASP65 have been identified, but whether they are modified in a coordinated fashion 
during mitosis is so far unknown. In this study, we raised phospho-specific antibodies that 
recognize phosphorylated T220/T224, S277 and S376 residues of GRASP65, respectively. 
Biochemical analysis showed that cdc2 phosphorylates all the three sites, while plk1 enhances 
the phosphorylation. Microscopic studies using these antibodies for double and triple labeling 
demonstrate sequential phosphorylation and dephosphorylation during the cell cycle. S277 and 
S376 are phosphorylated from late G2 phase through metaphase until telophase when the new 
Golgi is reassembled. T220/224 is not modified until prophase, but is highly modified from 
prometaphase to anaphase. In metaphase, phospho-T220/224 signal localizes on both Golgi haze 
and mitotic Golgi clusters that represent dispersed Golgi vesicles and Golgi remnants, 
respectively; while phospho-S277 and S376 labeling is more concentrated on mitotic Golgi 
clusters. Expression of a phosphorylation-resistant GRASP65 mutant T220A/T224A inhibited 
mitotic Golgi fragmentation to a much larger extent than the expression of the S277A and S376A 




This study provides evidence that GRASP65 is sequentially phosphorylated and 
dephosphorylated during mitosis at different sites to orchestrate Golgi disassembly and 






In mammalian cells, the Golgi apparatus consists of over a hundred stacks of parallel-
aligned membrane cisternae, which are further laterally linked to form a Golgi ribbon [83]. This 
complex structure undergoes dramatic morphological changes during the cell cycle. In early 
mitosis, the Golgi is disassembled into vesicles that can be observed as Golgi haze, and into 
tubulovesicular structures that are seen as mitotic Golgi clusters observed by fluorescence 
microscopy. In telophase, these fragments are evenly distributed into the two daughter cells 
where they are reassembled into a new Golgi apparatus each. The exact details of how the Golgi 
structure is maintained and how their assembly and disassembly is orchestrated are not well 
understood. One key element is a protein network called the “Golgi matrix” [108], which is 
comprised of golgins, GRASP proteins and other Golgi structural proteins. The two GRASP 
proteins, GRASP65 and GRASP55, were first identified as Golgi stacking factors in an in vitro 
system that reconstitutes mitotic Golgi disassembly and post-mitotic Golgi reassembly [12, 13]. 
Later research demonstrated that these proteins are involved in additional functions, including 
Golgi ribbon linking, cell cycle progression, trafficking, and unconventional secretion [15, 49-
51, 89, 102, 109-111].  
 
At the molecular level, it has been shown that each GRASP protein forms trans-oligomers 
through the PDZ domains at each respective N-terminus. This oligomerization possibly mediates 
tethering of the cisternae into stacks as well as linking of Golgi stacks into a ribbon [14, 16, 18, 
49, 85, 112]. Whether the oligomerization of the GRASP proteins is also helping to regulate 
protein trafficking and unconventional secretion remains unknown. Oligomerization of the 




be the major target of mitotic kinases on the Golgi membranes [14]. The protein is 
phosphorylated by cdc2 (also called cdk1) and polo-like kinase 1 (plk1) during mitosis [7, 19, 
113, 114]. GRASP55, on the other hand, is phosphorylated by the MAP kinase ERK2 [16, 115]. 
Phosphorylation of GRASP65 and GRASP55 causes their de-oligomerization and thus disrupts 
Golgi cisternal stacking and Golgi ribbon linking [14, 16, 22, 51]. This subsequently allows 
Golgi membrane vesiculation that yields a large number of vesicles dispersed throughout the 
cell.  
 
At the end of mitosis, GRASP65 is dephosphorylated by the protein phosphatase PP2A, 
which leads to the reformation of GRASP65 trans-oligomers [7]. Golgi fragments then fuse in a 
coordinated fashion to form new cisternae, which are subsequently tethered into stacks and 
ultimately the Golgi ribbon [4, 9, 22]. It has been shown that the expression of a phospho-
deficient GRASP65 mutant (mG), in which 5 serine residues (S216, S217, S277, S367 and S376) 
and 2 threonine moieties (T220 and T224) were mutated to alanines, inhibited Golgi 
fragmentation during mitosis in the cell [17]. This strongly suggests that GRASP65 
phosphorylation plays an important role in regulating Golgi architecture throughout cell division. 
GRASP65 can also be phosphorylated on residue S277 in interphase cells, particularly upon 
growth factor stimulation, which mediates the remodeling of the Golgi to facilitate membrane 
trafficking in migrating cells [21, 91]. Many features of this Golgi remodeling process during 
interphase are similar to that seen during mitosis, although architectural changes happen to a 
much lesser degree. Finally, the residue S367 is also found to be phosphorylated during 
interphase condition in an in vitro phosphorylation assay [19]. It is not clear whether activation 





One of the previously used phospho-deficient mutant of GRASP65, mG, contains seven 
known/putative phosphorylation sites [17]. Expression of this mutant inhibited Golgi 
fragmentation during mitosis, suggesting that the phosphorylation of at least one of these sites is 
necessary for Golgi disassembly during mitosis. Several lines of evidence suggest that each site 
may be phosphorylated in a distinct fashion to help carry out different functions. For example, 
several distinct phospho-peptides were generated when GRASP65 was treated with either cdc2 
or plk1 followed by trypsinization and 2D gel analysis [113], indicating that cdc2 and plk1 
modify different residues on GRASP65. In another in vitro phosphorylation assay using 
recombinant GRASP65, seven phosphorylation sites were identified by mass spectrometry, Six 
of the seven sites were also present in the mG mutant; an additional site, S400, was identified. In 
this analysis four sites were shown to be phosphorylated by cdc2. Modification of GRASP65 by 
cdc2 recruits plk1 binding and allows plk1 to phosphorylate the protein [19]. Yet another 
phosphorylation site, S189, was identified as a plk1 target [116]. Its activation disrupts 
GRASP65 oligomers [117]. Whether the different phosphorylation sites present in GRASP65 are 
modified simultaneously or sequentially at the onset of mitosis, and whether they are equally 
important for mitotic Golgi fragmentation, remain poorly understood. 
 
In this study we utilized five GRASP65 phospho-specific antibodies that target three 
different phosphorylation sites. We show that the three sites are phosphorylated and 
dephosphorylated sequentially during the process of cell division. In early mitosis, S277 and 
S376 are phosphorylated in late G2 phase, while phosphorylation of T220/T224 by cdc2 begins 




disassembly, as expression of the T220A/T224A mutant of GRASP65 inhibited mitotic Golgi 
fragmentation to a much greater extent than that expression of either S277A or S376A mutants. 
In late mitosis during cytokinesis, S376 is dephosphorylated, prior to T220/T224, while S277 
remains phosphorylated even in late cytokinesis. Our study demonstrated that GRASP65 is 
sequentially phosphorylated and dephosphorylated at different sites during the cell cycle, which 









Development and characterization of phospho-specific antibodies that recognize various 
GRASP65 phosphorylation sites in rodent cells 
To better understand the role of GRASP65 phosphorylation in mitotic Golgi disassembly, 
we raised and subsequently characterized phospho-specific antibodies against different 
phosphorylation sites. We prepared phosphorylated GRASP65 by treatment of recombinant wild 
type (WT) His-tagged rat GRASP65 full-length protein with mitotic cytosol. In a first approach 
this phospho-protein was used to immunize mice. One resulting monoclonal mouse antibody, 
LX108, was found to recognize only phosphorylated GRASP65 but not its non-phosphorylated 
form. In a second approach we generated three single chain monoclonal phospho-specific 
antibodies (scFv antibodies), R3G3, R3F2 and RB7 using an in vitro approach [94] (Table S1). 
To determine the precise epitope of each phospho-specific antibody on GRASP65, purified 
recombinant WT GRASP65 and 10 different phosphorylation-resistant mutants (Figure 3.1A) 
were incubated with either mitotic (Figure 3.1, B-C) or interphase (Figure 3.1,D-E) cytosol 
followed by Western blot analysis using these phospho-antibodies. If mutation of a particular site 
lead to a weakening of the signal of a particular antibody, despite treatment with mitotic cytosol, 
it was assumed that a conformation created by phosphorylation of the non-mutated site was 
specifically recognized by the antibody. As shown in Figure 3.1, LX108 recognized GRASP65 
only after treatment with mitotic but not interphase cytosol. Among the mutants treated with 
mitotic cytosol, LX108 recognized phosphorylated mB, mC, mF and mJ mutants, but not mA, 
mD, mE, mG, mH and mI. Modification of S216/S217 and T220/T224 abolished the signal (mA, 
mD, mE and mG in Figure 3.1B); while mutation of T220/T224 but not S216/S217 also 




constructs affecting the immunoreactivity of LX108 was T220/T224, strongly suggesting that 
LX108 specifically recognizes this site after phosphorylation. Using the same approach, we 
showed that both R3F2 and RB7 scFv antibodies specifically recognize the mitotically 
phosphorylated S376 epitope [94] while the scFv antibody R3G3 recognizes phospho-S277, 
which is phosphorylated in both interphase and mitosis, with a weaker signal after interphase 
cytosol treatment (Figure 3.1), consistent with the previous reports that S277 is phosphorylated 
during interphase [21, 91]. 
 
To determine whether these phospho-specific antibodies recognize GRASP65 in cells, we 
performed Western blot analysis of HeLa cells stably expressing either wild type (WT) rat 
GRASP65-GFP, mG-GFP, or simply GFP. A monoclonal antibody, 7E10, which recognizes rat 
GRASP65 regardless of its phosphorylation state, was used as a control. During interphase, WT 
GRASP65-GFP (but not the mG mutant) was recognized by R3G3 but not by LX108 or R3F2 
(Figure 3.2, A-D). During mitosis, WT GRASP65-GFP was recognized by all three phospho-
antibodies (Figure 3.2E). These results suggest that the phospho-antibodies are able to recognize 
phospho-rat-GRASP65 in vivo, and also indicate that those antibodies do not recognize the 
endogenous human GRASP65 in HeLa cells even after phosphorylation. This was confirmed by 
immunofluorescence microscopy. Rat GRASP65-GFP was recognized by LX108 in mitotic but 
not interphase cells (Figure 3.3, A vs. B), validating that LX108 is a phospho-specific antibody 
for rat GRASP65. LX108 also recognized endogenous GRASP65 in mitotic NRK cells of rat 
origin (Figure 3.3C & 3.S1). Similar results were reported for R3G3, R3F2 and RB7 [94]. 
Furthermore, all phospho-specific antibodies, LX108, R3G3, R3F2 (Figure 3.3, D-I) and RB7 





Figure 3.1. Determination of the phosphorylation sites on GRASP65 that the phospho-specific antibodies 
recognize. 
(A) Schematic illustration of known and putative phosphorylation sites on GRASP65 and its mutants in which 
indicated phosphorylation sites were mutated to alanines. (B-E) Purified His-tagged full-length wild type GRASP65 
or its phosphorylation deficient mutants were incubated with either buffer alone (first lane in each blot) or with 
cytosol from either mitotic cells (panels B and C), or interphase cells (panels D and E) as indicated. Equal amounts 
of protein were analyzed by Western blots. Five anti-GRASP65 antibodies (see Table S1) were used, 7E10 being a 
non-phospho specific anti-GRASP65 antibody. LX108 (a mouse monoclonal antibody) failed to recognize any 
constructs where T220/T224 is mutated or when proteins were incubated with interphase cytosol. R3G3 (scFv 
recombinant antibody) did not bind mutants of S277; R3F2 and RB7 (two different scFv antibodies) both fail to bind 




residues must be phosphorylated in the wild type protein for antibody binding. Thus LX108 recognizes 




Figure 3.2. LX108, R3G3 and R3F2 recognize mitotically phosphorylated GRASP65 in cell lysate by Western 
blot. 
(A-D) HeLa cells (lane 1 in each blot), or HeLa cells stably expressing GFP, GFP-tagged rat wild type (WT) 
GRASP65, or the mG mutant with all 7 phosphorylation sites mutated to alanines (see Figure 3.1A for details) 
(lanes 2-4 in each blot) were analyzed by Western blot using the indicated antibodies. Only S277 (detected by 
R3G3) is phosphorylated in interphase cells but at a relatively lower level than in mitosis (C). (E) Non synchronized 
interphase (Int) or nocodazole-blocked, synchronized mitotic (Mit) HeLa cells expressing WT or mG GRASP65-
GFP were analyzed by Western blot, LX108 and R3F2 were able to detect the phospho-protein in WT transfected 






Figure 3.3. The phospho-specific antibodies LX108, R3G3, R3F2 and RB7 recognize WT GRASP65 but not 
its phosphorylation deficient mG mutant in mitotic cells.  
(A-B) Mitotic (prometaphase, A) or interphase (B) HeLa cells stably expressing WT GRASP65-GFP were stained 
by LX108 (red), GFP (green), and DNA (blue). Note the LX108 signal in mitotic but not interphase cells. (C) Rat 
origin NRK cells were stained by LX108 (red), phospho-Histone H3 (p-Histone H3, green) and DNA (blue). 
Asterisks indicate mitotic cells. (D-I) Immunofluorescence images of mitotic HeLa cells expressing WT GRASP65-
GFP (D, F, and H) or its phosphorylation mutant mG (E, G, and I) were stained with LX108 (T220/T224, D-E), 






Figure 3.S1. The monoclonal antibody LX108 recognizes the endogenous GRASP65 in mitotic NRK cells.  
Normal rat kidney (NRK) cells stably expressing N-acetylglucosamine transferase I (NAGT1) of indicated cell cycle 
phases were immunostained with LX108 and Hoechst (DNA). Scale bar in all panels, 10 µm. 
 
The T220/T224 site is phosphorylated by cdc2 
Previous work has shown that GRASP65 is phosphorylated by cdc2 and plk1 during 
mitosis and by the MAP kinase ERK2 in interphase [19, 91, 113]. To identify the kinase(s) 
responsible for phosphorylation of GRASP65 at different sites of the protein, we treated purified 
rat liver Golgi membranes with mitotic cytosol, or with recombinant cdc2, plk1 or a combination 
of both kinases at various concentrations (Figure 3.4A-B). Phosphorylation of GRASP65 was 
then analyzed by Western blot using LX108 and 7E10. 7E10 recognizes GRASP65 regardless of 
its phosphorylation, though phospho-GRASP65 can be detected by a mobility shift of the 




shift on the 7E10 blot and by the immunoreactivity to LX108. The addition of plk1 increased the 
phosphorylation state in a dose dependent manner (Figure 3.4B, lanes 3-7 and 9). Incubation 
with plk1 alone induced slow migration of GRASP65 compared to non-treated GRASP65 on the 
7E10 blot; but the shifted band was not recognized by LX108 (Figure 3.4A-B, lane 8). These 
results suggest that GRASP65 is phosphorylated on T220/T224 by cdc2. Plk1 enhances cdc2 
activity on this site; and plk1 may, in addition, phosphorylate other sites on GRASP65.  
 
We next confirmed these results in cells. HeLa cells transfected with a GRASP65-GFP 
plasmid were synchronized to mitosis by 18 h nocodazole treatment and further treated with 
different kinase inhibitors. As shown in Figure 3.4C, treatment of the mitotic cells with the 
general kinase inhibitor staurosporine totally abolished GRASP65 phosphorylation on 
T220/T224 on the LX108 blot. The cdc2 inhibitor, roscovitine, largely reduced T220/T224 
phosphorylation, but the plk1 inhibitor BI2536 and MEK inhibitor U0126 had no detectable 
effect on inhibition of T220/T224 phosphorylation. This indicates again that T220/T224 is 






Figure 3.4. The LX108 recognition site, T220/T224, is phosphorylated by cdc2.  
(A) Purified rat live Golgi membranes (20 µg each reaction) were incubated with buffer (lanes 1 and 11), 500 µg 
mitotic cell cytosol (MC, lanes 2 and 10), or 30 µg plk1 (lanes 3-8) in the presence of increasing amount of cdc2 
(lanes 3-7, 0.3, 0.9, 3, 9, and 30 µg, respectively; lane 9, 30 µg). Proteins were solubilized in SDS buffer and 
analyzed by Western blot for GRASP65 using the LX108 and 7E10 antibodies. Note that LX108 immuno-reactivity 
is detected only when the membranes were treated with MC or cdc2 (in a dose dependent manner), but not with 




µg cdc2 (lanes 3-7, 9). Note that plk1 alone does not cause GRASP65 phosphorylation, but adding plk1 increases 
cdc2 activity towards GRASP65 (lanes 3-7 vs. 8). 
Interphase (int) or mitotic (mit) HeLa cells stably expressing WT GRASP65-GFP were treated with staurosporine 
(Stau, a general kinase inhibitor), Roscovitine (Ros, a cdk-specific inhibitor), BI2536 (a plk1 inhibitor) or U0126 (a 
MAPK inhibitor), lysed and analyzed by Western blot for indicated antibodies. Binding is abolished with the general 
kinas inhibitor (Stau) and reduced with the cdk-specific inhibitor (Ros). (D-E) Purified rat liver Golgi membranes 
(D) or recombinant wild type His-GRASP65 full length protein (E) were treated with indicated combinations of 
kinases and analyzed by Western blot for GRASP65 using the indicated antibodies. 20 µg Golgi membranes or 50 
ng recombinant GRASP65 per lane were loaded and Western blot performed using LX108, R3G3 and R3F2; while 
5 µg/lane Golgi membranes or 10 ng/lane recombinant His-GRASP65 was used when 7E10 was used for Western 
blot. Note that cdc2 phosphorylated all three sites during mitosis, while plk1 enhances the activity. 
 
 
To determine the enzymes that phosphorylate residues S277 and S376, we treated purified 
Golgi membranes or recombinant GRASP65 with different combinations of kinases, as indicated 
in Figure 3.4D-E. When analyzing Golgi membranes, cdc2 alone phosphorylated both 
T220/T224 and S277, as indicated by LX108 and R3G3 signals, correspondingly, though only at 
a relatively low level (Figure 3.4D, lane 2). However, a combination of cdc2 and plk1 
phosphorylated all three sites to a much larger degree than either enzyme alone (Figure 3.4D, 
lane 4), suggesting that plk1 enhances GRASP65 phosphorylation on Golgi membranes. The 
S277 site was phosphorylated by ERK2 at a low level (Figure 3.4D, lane 5). Adding active 
MEK1, an activator of ERK2, significantly enhanced S277 phosphorylation. Strong activation of 
ERK2 also led to phosphorylation of all other sites (Figure 3.4D, lane 7). When purified 
recombinant GRASP65 protein was used in the phosphorylation assay, T220/224, S277 and 
S376 were all phosphorylated by cdc2 but not plk1, although a combination of both kinases 
increased the phosphorylation level (Figure 3.4E, lane 2-4). S277 was phosphorylated by ERK2, 
and the activity was enhanced by adding constitutively active MEK1 (Figure 3.4E, lane 5 vs. 7). 
A combination of MEK1 with ERK2 could phosphorylate all the three sites. However, since 




level of ERK2 activity. In conclusion, cdc2 can phosphorylate all three sites during mitosis, 
while plk1 enhances the activity of cdc2. 
 
The phosphorylation cycle of each site on GRASP65 during cell division  
To analyze at what point each site on GRASP65 is phosphorylated and dephosphorylated 
during the cell cycle, we next examined NRK cells progressing through mitosis using 
immunofluorescence microscopy. Cells were co-stained with one of the GRASP65 phospho-
specific antibodies (LX108, R3G3 or R3F2), with an antibody to phospho-Histone H3 (p-Histone 
H3), and for DNA to clearly identify the cell cycle phases. Histone H3 phosphorylation, which 
starts late in G2 phase and remains present until anaphase, was nicely visualized with p-Histone 
H3 (see Figure 3.5). All three phospho-specific GRASP65 antibodies stained the Golgi at some 
point during mitosis, but the exact timing of appearance of the signal was different for each of 
them. The LX108 (T220/T224) signal started to appear in prophase, when the Golgi 
fragmentation was already discernible in light microscopy, and lasted until telophase, albeit with 
a much reduced signal at this point (Figure 3.5A). The R3G3 (S277) signal was weakly detected 
in interphase cells, consistent with previous reports that S277 is activated in interphase by ERK2 
in addition to its mitotic phosphorylation by cdc2 [19, 91]. The R3G3 signal became clearly 
visible already in late G2 phase and remained strong until telophase (Figure 3.5B). In fact, the 
enhanced R3G3 signal appeared earlier and lasted longer throughout mitosis when compared 
with that of the other phospho-specific antibodies. R3F2 (S376) had a weak signal during late G2 
phase, became stronger from prophase and was reduced at telophase (Figure 3.5C). Quantitation 
of the fluorescence images confirmed these results (Figure 3.S2A and B). Overall, these results 






Figure 3.5. Phosphorylation of GRASP65 at three different sites during cell cycle progression. 
NRK cells of indicated cell cycle phases were stained for DNA, phosphorylated Histone H3 (Ser10) and GRASP65 
with LX108 (T220/T224, A), R3G3 (S277, B), or R3F2 (S376, C) antibodies. Note that in late G2 phase, the 
staining of R3G3 was much stronger than in interphase and than that of the other two antibodies. Scale bar in all 





Figure 3.S2. Quantification of total cellular fluorescence intensity of indicated phospho-antibodies throughout 
the cell cycle. 
(A) Total fluorescence intensity of the three phospho-specific antibodies at different cell cycle stages. Values plotted 
as mean ± SEM. (B) As in A, but maximum intensity of each individual antibody in the cell cycle normalized to 
100%. 
 
Sequential phosphorylation and dephosphorylation of GRASP65 during the cell cycle  
To confirm our observation that GRASP65 is phosphorylated and dephosphorylated 
sequentially at the three studied sites while cells progress through mitosis, we performed double 
staining of NRK cells with LX108 (T220/T224), and one of the two scFv antibodies, R3G3 
(S277) or RB7 (S376). Furthermore, in order to better study the chronology of S277 and S376 




antibody from Dr. Nobuhiro Nakamura [91], here referred to as pS277. This collection of 
antibodies allowed us to study the dynamics of phosphorylation and dephosphorylation of all 
three phosphorylation sites in pairs using LX108 vs. R3G3, LX108 vs. RB7, and pS277 vs. RB7, 
at different stages of the cell cycle (Figure 3.6 and 3.S2). In late G2 phase, S277 was the first 
residue to be mitotically phosphorylated as indicated by the enhanced R3G3 and pS277 signals. 
No LX108 signal was detected during this phase, while RB7 showed a weak signal. In early 
prophase, R3G3 and pS277 signals remained strong, sometimes even increased slightly. At the 
same time RB7 signal increased significantly and LX108 signal started to appear. During late 
prophase, LX108 signal became more intense. In prometaphase, LX108 signal reached its 
highest level, while the fluorescence intensity of the other antibodies remained unchanged. 
Quantification and graphic depiction of the observed distinct differences in fluorescence 
intensity for each antibody over time is graphically depicted in Figure 3.S2. In summary, these 
results strongly suggest that during early mitosis GRASP65 is first phosphorylated on residue 
S277, followed by modification of the S376 residue, and eventually activation of T220/T224. 
Upon careful analysis of the fluorescence images we observed that from late prophase to 
telophase, the R3G3-, pS277- and RB7-signals (indicating phosphorylation of S277 and S376) 
were largely localized on the Golgi clusters (the Golgi remnants during mitosis) while the 
LX108-signal (phosphorylated T220/224) appeared in a more dispersed fashion, likely 
representing the Golgi haze (e.g. dispersed mitotic Golgi vesicles and tubules). Since GRASP65 
is a membrane-associated protein that does not detach from the membranes during mitosis [13], 
and since  LX108 antibody staining has little if any background in interphase cells (Figure 3.3B), 
the more homogeneous signal of LX108 likely marks dispersed mitotic Golgi vesicles and 





Figure 3.6. Different phosphorylation sites of GRASP65 are phosphorylated during mitosis and 
dephosphorylated in telophase at distinct times. 
NRK cells of indicated cell cycle phases were double stained by the following antibodies: A. LX108 (T220/T224) 
and R3G3 (S277); B. LX108 and RB7 (S376); and C. a polyclonal antibody pS277 that recognized phosphorylated 
S277 and RB7. Cell cycle stage was determined by the morphology of the DNA. Note that the signals for R3G3 and 
RB7 were detected earlier than that of LX108, indicating that the three recognized sites are activated sequentially 
during mitosis. The intensity of the LX108 signal correlated with the extent of Golgi fragmentation, suggesting that 
T220/T224 phosphorylation is critical for mitotic Golgi disassembly. Scale bar in all panels, 10 µm. 
 
Dephosphorylation also appeared to be sequential (Figure 3.6 and 3.S2). In telophase, both 
LX108 and RB7 signals became reduced significantly, while the signals for R3G3 and pS277 
remained strong. During cytokinesis, no more RB7 signal was discernible, while a faint LX108-
signal remained. R3G3 and pS277 staining was reduced but remained relatively strong. These 
results indicate that dephosphorylation at the end of mitosis is a coordinated process similar to 
that seen for phosphorylation at the onset of cell division. The S376 residue is inactivated first, 





Phosphorylation of T220/T224 is critical for Golgi vesiculation  
LX108 preferentially stained Golgi vesicles, while R3G3, pS277 and RB7 signals, 
respectively, were stronger on the mitotic Golgi clusters (Figure 3.5, 3.6 and 3.S2). For a better 
overall characterization we examined the Golgi morphology using an antibody that recognizes 
the total GRASP65 pool regardless of its phosphorylation state and then evaluated the 
phosphorylation of the protein at different sites. We performed triple labeling of NRK cells with 
LX108, R3G3 or RB7, and “Mary”. Mary is a rabbit polyclonal antibody that recognizes rat 
GRASP65 in both its phosphorylated and non-phosphorylated forms [17, 18]. Our observation 
that phosphorylation of T220/224 is more critical for complete Golgi disassembly during mitosis 
than activation of other sites (see above) was verified. As shown in Figure 3.7, the T220/T224 
residues began to be modified in prophase, at the time when the Golgi apparatus started to 
disassemble; R3G3 and RB7 signals were already easily discernible. In the ensuing 
prometaphase, T220/T224 phosphorylation reached a higher level; at this stage the Golgi 
apparatus was already significantly fragmented. In metaphase, T220/T224 was highly 
phosphorylated; Golgi disassembly was completed. Toward the end of mitosis, during telophase, 
RB7 but not LX108 signal significantly decreased, Golgi reassembly was initiated. Finally 
during cytokinesis, T220/T224 was dephosphorylated and Golgi reassembly was completed. 






Figure 3.7. Sequential phosphorylation and dephosphorylation of GRASP65 orchestrates mitotic Golgi 
disassembly and post-mitotic reassembly. 
NRK cells of indicated cell cycle phases were triple labeled by LX108 (T220/T224), R3G3 (S277) and Mary (total 
GRASP65 regardless of the phosphorylation state) in panel A; and by LX108, RB7 (S376) and Mary in panel B. 
Cell cycle stage was determined by the morphology of the DNA. Note that the intensity of LX108 signal correlates 






Figure 3.S3. The phospho-deficient mutants of GRASP65 are targeted to the Golgi in interphase cells. 
Interphase cells expressing WT, the mA, mB or mC mutants of GRASP65-GFP were stained for GM130 and DNA 




Figure 3.S4. The GRASP65 phospho-deficient mutants are not recognized by the relevant phospho-specific 
antibodies in immunofluorescence. 
Mitotic HeLa cells expressing the mA (A-C), mB (D-F) or mC (G-I) mutants of rat GRASP65-GFP were stained 
with LX108 (T220/T224), R3G3 (S277) or RB7 (S376) antibodies. Note that the signal is markedly reduced when 
the antibody’s specific recognition residue is mutated (mA for LX108, mB for R3G3 and mC for RB7). Scale bar in 
all panels, 10 µm. 
 
To provide further evidence for the critical role of T220/T224 phosphorylation in Golgi 
vesiculation, we established HeLa cell lines stably expressing GFP-tagged GRASP65 mutants 
mA (S216A/S217A/T220A/T224A), mB (S277A), and mC (S367A/S376A), respectively, under 
a tet-inducible promoter [16, 17]. All proteins correctly localize to the Golgi apparatus (Figure 
3.S3) and none of the mutants are recognized by their corresponding phospho-specific antibodies 
as expected (Figure 3.S4). To determine the effects caused by these mutant proteins on the Golgi 
architecture, we analyzed these cells using fluorescence microscopy. Metaphase cells expressing 
WT GRASP65-GFP or the mA, mB, mC mutants were immunostained with GM130. As shown 
in Figure 3.8A, the Golgi membranes were extensively fragmented in cells expressing wild type 
GRASP65-GFP. Expression of mB-GFP or mC-GFP mutants had only a minor if any effect 
(Figure 3.8C-D). However, in cells expressing the mA-GFP mutant (Figure 3.8B), the Golgi was 




cells expressing the GRASP65 mG mutant [17, 18]. Quantification of the fluorescence images 
showed that in mitotic mA-GFP expressing cells, 21.34 ± 3.00% of total GM130 fluorescent 
signal in the cell was found on mitotic Golgi clusters. This was significant higher than the 
percentage seen in WT GRASP65-expressing cells (4.36 ± 0.77%), suggesting that mA 
expression reduced mitotic Golgi disassembly. The intensity of the GM130 signal on mitotic 
Golgi clusters was not significantly affected by the expression of mB-GFP and mC-GFP 
mutants, leading to 2.91 ± 0.62% and 5.43 ± 1.20% of the total GM130 signal on the clusters, 
respectively (Figure 3.8E), suggesting that phosphorylation at other sites is less important for this 
process.  
 
Figure 3.8. Mutation of the phosphorylation sites especially of the residue T220/T224 inhibits mitotic Golgi 
fragmentation. 
(A-D) Expression of the mA mutant of GRASP65 inhibits Golgi fragmentation in mitosis. Cells expressing 
indicated GFP-tagged GRASP65 mutants were stained for GM130 and DNA. Metaphase cells were selected. Note 
the large remaining clusters, likely representing Golgi structures in the mA-expressing cell line. Scale bar in all 
panels, 10 µm. (E) Quantification of fluorescence intensity of GM130 on mitotic Golgi clusters as compared to 
whole-cell fluorescence. The percentage was expressed as the mean ± SEM. Statistical significance was assessed by 
student’s t-test between the indicated pairs. **, p < 0.01; ***, p < 0.001. (F) Quantification of EM images counting 




as indicated. The number of observed mitotic Golgi clusters per cell was expressed as the mean ± SEM. Statistical 
significance was assessed by comparison to the cell line expressing WT GRASP65. **, p < 0.01; ***, p < 0.001. 
 
Finally, analysis by electron microscopy showed that mA-GFP expressing cells contained 
significantly greater amounts of large membranes that remained as clusters of vesicles, short 
cisternae and tubular structures (Figure 3.S5). Quantification of the EM images showed that the 
number of mitotic Golgi clusters per mitotic cell in cells expressing the mA mutant (8.1 ± 1.1) 
was significantly higher than in cells expressing WT GRASP65 (2.2 ± 0.4). In contrast, the 
number of mitotic Golgi clusters per cell was only mildly increased in mB and mC expressing 
cells (4.2 ± 0.5 or 4.1 ± 0.5 respectively), significantly lower than that in the mA expressing cells 
(p<0.01) (Figure 3.8F). These results confirmed that T220/T224 is the key regulation site for 






Figure 3.S5. Expression of the mA mutant of GRASP65 inhibits Golgi fragmentation during mitosis. 
Electron microscopy images of mitotic cells expressing indicated GRASP65 WT (A), mA (B), mB (C) and mC (D) 
constructs. Arrowheads indicate mitotic Golgi clusters; while asterisks mark condensed chromosomes. Note the 







In this study we generated and utilized phospho-specific antibodies, and dissected 
GRASP65 phosphorylation in the cell cycle in more detail by determining the biological 
significance of modification of each of the sites.  The particular importance of T220/T224 
phosphorylation for mitotic Golgi fragmentation was shown using the phospho-specific antibody 
LX108. Using this and four other GRASP65 phospho-specific antibodies, we were able to follow 
the temporal sequence of phosphorylation of three sites, T220/T224, S277 and S376, throughout 
cell cycle progression. These phosphorylation sites had been predicted in previous studies 
according to the amino acid sequence [18] and some had been confirmed by analysis of in vitro 
phosphorylated recombinant GRASP65 by mass spectrometry [19]. In this study, we confirmed 
their phosphorylation in single cells. In combination with an in vitro phosphorylation assay, 
these antibodies also allowed us to determine the mitotic kinases responsible for each site. 
Furthermore, kinase inhibitors were used as a complementary approach to ensure specificity of 
our findings. We confirmed that cdc2 phosphorylates the T220/T224 residues required for Golgi 
disassembly during mitosis. Our in vitro phosphorylation assay using recombinant GRASP65 
protein also suggested that S277 and S376 are phosphorylated by cdc2 during mitosis.  
 
The fact that we were able to use phospho-specific antibodies against GRASP65 residues 
from different species (human, rabbit and mouse) was particularly important. It allowed us to 
perform double or triple labeling for immunofluorescence microscopy and thus to determine the 
sequence of phosphorylation on each site in the same cell and with exact knowledge of the stage 
of the cell cycle by monitoring DNA morphological changes and phosphorylation of Histone H3. 




with an antibody that recognized GRASP65 regardless of its phosphorylation state. Two major 
observations were made. First, GRASP65 is not phosphorylated at the T220/T224 site until 
prophase i.e. until after the beginning of Golgi disassembly. In contrast, residues S277 and S376 
are phosphorylated in late G2 phase, a time when Histone H3 is phosphorylated but the Golgi is 
not yet significantly fragmented. Eventually GRASP65 is highly phosphorylated at the 
T220/T224 site from prophase to anaphase, at the time when the Golgi is severely fragmented. 
Secondly we observed that the phospho-GRASP65 pool, modified on T220/T224 localizes onto 
the Golgi vesicles. In NRK cells, from prometaphase to anaphase, the Golgi apparatus 
disassembles into thousands of vesicles distributed throughout the cytosol that were observed as 
“Golgi haze” under the fluorescence microscopy. Some parts of the Golgi membranes, however, 
remain as tubulovesicular remnants or “mitotic Golgi clusters” that appear to be more 
concentrated near the spindle poles [30, 69]. Unlike the phospho-S277 or phospho-S376 signal 
that was mainly observed on the Golgi clusters, the LX108 signal for phospho-T220/T224 
appeared on both Golgi clusters and Golgi haze. Furthermore, expressing the mA, i.e. 
T220A/T224A, mutant in HeLa cells inhibited Golgi vesiculation during mitosis, while mB or 
mC mutants had a much smaller effect. These results suggest that phosphorylation of T220/T224 
is the key site needed for mitotic Golgi fragmentation. Previous studies have shown that 
GRASP65 exerts its function through oligomerization. This is mediated by the GRASP-domain 
but is regulated by phosphorylation at the C-terminus [14, 18]. Of all the characterized 
phosphorylation sites, the T220/T224 residue is in closest proximity to the GRASP domain, and 





The residue S277 is phosphorylated in mitosis (from late G2 phase to cytokinesis) as well 
as in interphase when cells are stimulated by EGF, although by different kinases [21, 91] and to a 
lesser degree (Figure 3.5B). Phosphorylation of S277 during interphase is directed by the 
MEK/ERK pathway. Mitotic phosphorylation of GRASP65 has been shown to regulate its 
oligomeric state and thereby Golgi cisternal stacking and ribbon linking [4, 9, 22, 23]. In 
interphase cells, partial phosphorylation of GRASP65 is required for dynamic Golgi remodeling 
in migrating cells [21]. Phosphorylation of S277 by MAP kinase partially de-oligomerizes 
GRASP65 complexes, accompanied by partial disassembly of the Golgi apparatus, thus allowing 
the organelle to reorganize and migrate towards the leading edge of the cell. Unlike what is 
observed in mitotic cells, massive Golgi vesiculation has not been observed in migrating cells 
suggesting that the phosphorylation of S277 is required for continuous reorganization of the 
Golgi during interphase, but that their modification may not be enough for a complete organelle 
disassembly during mitosis. Instead, complete collapse of the ribbon requires phosphorylation of 
T220/T224. Expressing the S277A (mB) or S367A/S376A (mC) mutant somewhat raised the 
number of Golgi clusters in mitotic cells compared to expressing the WT protein (Figure 3.8F). 
This indicates that S277 phosphorylation facilitates Golgi fragmentation, but not to the same 
dramatic extent as activation of T220/T224. GRASP65 phosphorylation at different sites leads to 
different effects and thus serves different functions. This elaborate phosphorylation system 
allows the cell and its organelle to adapt to different situations and at the same time to effectively 
divide the single Golgi apparatus to its two daughter cells during cell division.  
 
At the end of mitosis, S376 is the first of the three studied residues to be dephosphorylated, 




interphase. It is likely that S277 is constitutively phosphorylated because of the need of the Golgi 
apparatus to undergo constant remodeling in interphase cells [119]. The role of S376 
phosphorylation is least well understood to date. In addition to the three phosphorylation sites 
characterized in this study, GRASP65 is also modified by kinases on S189, S216, S217 and S367 
at least in vitro [19, 116]. Characterization of these sites and their relationships may provide 








Materials and methods 
Reagents 
All reagents were purchased from Sigma-Aldrich, Roche or Calbiochem, unless otherwise 
stated. The following antibodies were used: monoclonal antibodies against GM130 
(Transduction Laboratories) and -tubulin (Developmental Studies Hybridoma Bank University 
of Iowa); polyclonal antibodies against GFP [37], GRASP65 called “Mary” [14] and phospho-
Histone H3 (Upstate Biotechnology). The monoclonal phospho-specific antibody LX108 was 
generated by immunizing mice with recombinant WT His-GRASP65 full-length protein treated 
with mitotic cytosol; antibodies were collected from the medium of cultured hybridoma and 
subsequently enriched by protein G sepharose. The human single chain (scFv) monoclonal 
antibodies against phosphorylated GRASP65 (R3G3, R3F2 and RB7) were described previously 
[94]. A mouse monoclonal antibody against rat GRASP65, called 7E10, was generously 
provided by Dr. Graham Warren (Max F. Perutz Laboratories, Austria); a rabbit polyclonal 
antibody for GRASP65 phosphorylated at S277 (pS277) was generously provided by Dr. 
Nobuhiro Nakamura (Kyoto Sangyo University, Japan). Secondary antibodies for indirect 
immunofluorescence and immunoblotting were purchased from Jackson Laboratories and 
Invitrogen.  
 
Preparation of GRASP65 recombinant proteins 
The rat GRASP65 cDNA was cloned into the pQE9 (Qiagen) vector; correct insertion was 
confirmed by DNA sequencing. GRASP65 point mutations mA - mJ were introduced using the 




Proteins were expressed in BL21-CodonPlus(DE3)RILP bacteria and purified on Ni-NTA 
agarose (Qiagen). 
 
Characterization of phospho-specific antibodies by Western blot 
For epitope mapping, the purified His-tagged GRASP65 full-length protein and various 
phosphorylation deficient mutants (potential phosphorylation sites mutated to alanines) were 
incubated with interphase cytosol or mitotic cytosol (buffers were used as negative control) at 
37ºC for 1 h and purified with Ni-NTA beads. Bound proteins were analyzed by SDS-PAGE and 
Western blot using antibodies as indicated. 
 
To determine the specificity of GRASP65 phospho-specific antibodies, HeLa cell lines 
stably expressing wild type rat GRASP65 or its phosphorylation deficient mutants as indicated 
were either synchronized with 100 ng/ml nocodazole for 20 h or incubated without 
synchronization. Subsequently, cells were collected, lysed and analyzed by SDS-PAGE and 
Western blot with antibodies as indicated. 
 
In vitro and in vivo GRASP65 phosphorylation assay 
Recombinant GRASP65 proteins or purified rat liver Golgi membranes (RLG) [120] were 
incubated with mitotic cytosol [8] or with different combinations of kinases [14]. Typically, 20 
µg RLG (or 50 ng recombinant GRASP65) were treated with 500 µg HeLa cytosol, or equivalent 
activity of kinases, in MEB buffer (50 mM Tris-HCl, pH7.4, 0.2 M sucrose, 50 mM KCl, 20 mM 




and protease inhibitors) at 37ºC for 60 min. The samples were subsequently analyzed by Western 
blot [28, 121]. 
 
To identify the kinases that phosphorylate GRASP65 in vivo, HeLa cells stably expressing 
wild type rat GRASP65-GFP were first incubated with 100 ng/ml nocodazole for 18 h. Cells 
were then treated with one of the following chemicals: 1) a general kinase inhibitor staurosporine 
(at 2 µM) for 30 min [122], 2) a cdk inhibitor roscovitine (at 40 µM) for 2 h [123], 3) a plk1 
inhibitor BI2536 (at 0.1 µM) for 2 h [124, 125], and 4) a MAPK inhibitor U0126 (at 20 µM) for 
2 h [115, 126]. Cells were subsequently lysed and GRASP65-GFP was immunoprecipitated 
using an anti-GFP antibody. The phosphorylation of rat GRASP65-GFP was revealed via 
Western-blot using the indicated phospho-specific GRASP65 antibodies. 
 
Cell lines and microscopy 
To establish stable cell lines expressing various rat GRASP65 constructs, rtTAm2 HeLa 
cells were infected with retroviral particles encoding indicated exogenous genes cloned in the 
pRevTRE2 vector. Wild type rat GRASP65 and the related mA, mB, mC and mG mutants were 
first cloned into the pEGFP-N2 vector via the EcoRI and ApaI sites. cDNA encoding GFP 
(enhanced green fluorescent protein) alone, or GRASP65-GFP, mA-GFP, mB-GFP, or mG-GFP 
were then excised by Hind III and NotI and religated into the pRevTRE2 vector. Viral 
preparation, infection and cell selection were performed as previously described [16, 17]. GFP-
positive cells were enriched by flow cytometry. The expression of exogenous proteins was 





Immunofluorescence microscopy was performed as previously reported [17]. To enrich 
mitotic cells, NRK cells, or HeLa cell lines expressing rat GRASP65-GFP, were first 
synchronized with 2 mM thymidine for 24 h and then incubated in regular growth medium 
without thymidine for 8 h prior to fixation. Images were obtained with a Leica SP5 confocal 
laser scanning microscope using a 100x oil objective. For metaphase cells, images were captured 
using fixed parameters with 0.3 µm intervals at the z-axis and then processed for maximum 
value projection. For triple labeling of phosphorylated GRASP65 in mitotic NRK cells, three 
secondary antibodies, goat-anti-mouse IgG-FITC, donkey-anti-human IgG-Cy3 and goat-anti-
rabbit IgG-Cy5 were used to stain LX108, R3G3 or RB7, and Mary, respectively. 
 
Quantification of immunofluorescence intensity 
Whole-cell fluorescence intensity, generated by the respective phospho-antibody at 
different cell cycle stages, was quantified using the NIH ImageJ software. For better comparison 
of the relative changes between the three antibodies, the maximum total cellular intensity of each 
antibody detected throughout the cell cycle was normalized to 100%. The cell cycle stages were 
defined based on the chromosome shape, Golgi structure and phospho-Histone H3 staining. Late 
G2 phase cell were distinguished from interphase cells based on phospho-Histone H3 staining. 
Cells in cytokinesis were identified as cell pairs, which were not fully separated and had 
relatively intact nuclei and Golgi structure.  
 
To determine the proportion of fluorescence signal attributed to specific recognition of 
Golgi clusters, mitotic cells expressing various GRASP65 constructs as indicated were 




the NIH ImageJ software and using an adjacent cell free region as background. The light 
intensity on mitotic Golgi clusters (larger bright dots on fluorescence images) was quantified 
using the Analyze Particle function of ImageJ. The percentage of the total fluorescence intensity 
emitted from mitotic Golgi clusters was then calculated. 
 
Electron microscopy 
EM analysis was performed as described previously [17], mitotic Golgi clusters were 
identified using morphological criteria and quantified by standard stereological techniques [18]. 
For a cell to be considered mitotic, the profile had to contain one or more condensed 
chromosomes and lack a nuclear envelope. Often multiple condensed chromosomes were aligned 
in the center of the cell. A low magnification (normally 1,600×) image and serial images of 
higher magnification (normally 11,000×) were taken to cover the entire cell. At least 15 cells 
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BSA, bovine serum albumin; GFP, enhanced green fluorescent protein; EM, electron 
microscopy; GRASP65, Golgi reassembly stacking protein of 65 kDa; IC, interphase cytosol; 
NEM, N-ethylmaleimide; NRK, normal rat kidney cells; PBS, phosphate-buffered saline; plk1, 





















Chapter 4 . The ubiquitin ligase HACE1 regulates Golgi membrane dynamics 
during the cell cycle 
Abstract 
 Partitioning of the Golgi membrane into daughter cells during mammalian cell division 
occurs through a unique disassembly and reassembly process that is regulated by ubiquitination. 
However, the identity of the ubiquitin ligase is unknown. Here we show that the Homologous to 
the E6-AP Carboxyl Terminus (HECT) domain containing ubiquitin ligase HACE1 is targeted to 
the Golgi membrane through interactions with Rab proteins. The ubiquitin ligase activity of 
HACE1 in mitotic Golgi disassembly is required for subsequent postmitotic Golgi membrane 
fusion. Depletion of HACE1 using small interfering RNAs or expression of an inactive HACE1 
mutant protein in cells impaired postmitotic Golgi membrane fusion. The identification of 
HACE1 as a Golgi-localized ubiquitin ligase provides evidence that ubiquitin has a critical role 






Mitosis requires the duplication and even partitioning of all cellular components into the 
daughter cells. In mammalian cells, inheritance of the Golgi apparatus during cell division occurs 
through a unique disassembly and reassembly process [9, 10]. The Golgi is fragmented at the 
onset of mitosis to disperse the stacks, which then undergo further vesiculation. This yields 
thousands of vesicles that are distributed throughout the cytoplasm [127]. Studies using a cell 
free assay that reconstitutes mitotic Golgi fragmentation [7, 8, 128, 129] showed that mitotic 
Golgi disassembly involves two processes: cisternal unstacking and membrane vesiculation. 
Unstacking is mediated by mitotic kinases that phosphorylate the Golgi stacking proteins 
GRASP65 and GRASP55 [14, 16-18]. In interphase cells, GRASP proteins form oligomers that 
hold the membranes in stacks. During mitosis, phosphorylation of GRASPs leads to de-
oligomerization of the proteins and cisternal unstacking. Vesiculation of the unstacked cisternae 
occurs through continuous formation of COPI vesicles, which is mediated by the small GTPase 
ARF1 (ADP-ribosylation factor 1) and the coatomer complex [28]. Phosphorylation of Golgi 
tethering proteins, such as GM130, disrupts membrane fusion, and continuous COPI vesicle 
budding without fusion results in vesiculation of the Golgi membranes during mitosis [130]. 
During telophase, Golgi vesicles are distributed equally between daughter cells, where they are 
assembled into stacks and ribbons. Post-mitotic Golgi reassembly is mediated by membrane 
fusion to form single cisternae and by cisternal stacking. Post-mitotic Golgi membrane fusion is 
mediated by two AAA (ATPases Associated with various cellular Activities) ATPases, N-
ethylmaleimide-sensitive factor (NSF) and p97 (also referred to as valosin-containing protein, 




membrane restacking is mediated by dephosphorylation and subsequent re-oligomerization of 
Golgi stacking proteins [7, 9, 14, 16-18, 36].  
 
Several converging lines of evidence have suggested that monoubiquitination plays an 
essential role in the regulation of post-mitotic Golgi membrane fusion. First, monoubiquitination 
occurs during mitotic Golgi disassembly and is required for subsequent Golgi reassembly [35]. 
Second, the p97/p47 complex binds to monoubiquitin through the UBA domain of the adaptor 
protein p47. Inhibition of the p47-ubiquitin interaction suppresses p97-mediated Golgi 
membrane fusion [35]. Third, VCIP135, a cofactor of the p97/p47 complex, is a deubiquitinating 
enzyme whose activity is required for post-mitotic Golgi reassembly [36]. Finally, proteasome 
activity is not involved in either Golgi disassembly or reassembly [36]. These data suggest that 
cycles of addition and removal of ubiquitin to and from substrates is necessary for Golgi 
reassembly. The role of ubiquitination in Golgi membrane fusion is likely not restricted to the 
p97/p47 complex, as it has been shown that another required ATPase, NSF, binds to GATE-16, a 
ubiquitin-like protein [40, 137]. These results suggest that ubiquitination may operate as a 
general mechanism to regulate Golgi membrane dynamics during the cell cycle. Both NSF- and 
p97-mediated Golgi reassembly require syntaxin 5, but these two pathways contribute non-
additively to cisternal regrowth [132]. This suggests that they may have distinct roles in post-
mitotic Golgi membrane fusion, but the coordination between the two pathways has not been 
elucidated. 
 
Further understanding of the underlying mechanism of ubiquitin in the regulation of Golgi 




Golgi membranes. Here, we show that HACE1, a HECT domain (Homologous to the E6-AP 
Carboxyl Terminus)-containing ubiquitin ligase, is involved in this process. HACE1 is recruited 
to the Golgi membrane via interaction with Rab1, and regulates Golgi membrane fusion both in 
vitro and in vivo. The identification of HACE1 as a Golgi-localized ubiquitin ligase provides 








Identification of HACE1 as a Rab interacting protein 
Rab proteins have been shown to be important for membrane organization [138]. In an 
effort to identify Rab-interacting proteins using an affinity chromatography-based proteomic 
approach [139], we identified HACE1, which binds specifically to the GTP-bound state of Rab4 
(Figure 4.1A). The HACE1 cDNA was cloned from a human cDNA library. It consisted of 909 
amino acids and migrated at 100 kDa on an SDS-PAGE gel. HACE1 contains six ankyrin repeats 
and a HECT domain [140], a defining feature of one family of ubiquitin E3 ligases. Using a 
thioester bond formation assay containing ubiquitin, an E1 activating enzyme, the E2 
conjugating enzyme UbcH7 and recombinant HACE1, we demonstrated that wild-type (WT) 
HACE1 is capable of catalyzing the formation of thioester bonds, but the inactive C876A (CA) 
mutant is not (Figure 4.1B). This result is consistent with previous reports that HACE1 functions 
as an active ubiquitin ligase [38, 140].  
 
When examined by fluorescence microscopy, both Rab4 and HACE1 were concentrated in 
the perinuclear region, which appeared to be the Golgi apparatus (Figure 4.1C). In addition to the 
Golgi, Rab4, but not HACE1, was also found on endosomal membranes that were irregularly 
shaped and dispersed throughout the cytosol (Figure 4.1C). Because HACE1 binds to Rab4, 
which is only partially localized to the Golgi, we examined whether HACE1 also interacts with 
other Rabs, including those localized on the Golgi, using a well-established Rab pull-down assay 
[11, 139]. Immobilized GST-tagged Rab proteins were incubated with purified recombinant 
HACE1 in the presence of GDP or GTPS and the presence of HACE1 in the bound fraction was 




in a GTP-dependent manner, but not to Rab2, 5, 6 and 7 irrespective of the nucleotide used. To 
confirm the interaction, we tested HACE1 binding to the GDP- (Rab1S25N, Rab4S22N and 
Rab11S25N) and GTP-restricted (Rab1Q67L, Rab4Q67L and Rab11Q70L) mutants of Rab1, 4 
and 11. As shown in Figure 4.1F, HACE1 bound to the wild-type and QL-forms of all three Rabs 
but not their inactive mutants. Using HeLa cell lysate, we further showed that endogenous 
HACE1 bound to Rab1-GTP in a similar pattern as p115, a protein known to interact with Rab1. 
A strong interaction was also observed for Rab11, but no interactions were detected for Rab5 or 
Rab6 (Figure 4.1G). These results demonstrate that HACE1 interacts with Rab1, Rab4 and 





Figure 4.1. HACE1 binds to Golgi-associated Rab proteins.  
(A) HACE1 binds Rab4–GTP. Immobilized GST-tagged Rab4 was incubated with bovine brain cytosol in the 
presence of GDP or GTPS. After washing, the bound proteins were eluted and analysed by SDS–PAGE and 
coomassie blue staining. Specific bands in the GTPS lane were excised and identified by mass spectrometry. The 
arrow indicates HACE1. (B) HACE1 exhibits ubiquitin ligase activity in vitro. A thioester bond formation assay was 
performed using the C876A (CA) point mutant and WT recombinant HACE1 protein, ubiquitin, E1-activating 
enzyme and the E2-conjugating enzyme UbcH7. Following incubation, the reactions were mixed with SDS buffer ± 
DTT and boiling. HACE1 was detected by western blot. The arrows indicate HACE1 and the arrowhead indicates 
Ub-HACE1. Note that the Ub-HACE1 band was observed in the absence of DTT with WT HACE1. (C) HACE1 
colocalizes with Rab4 in the perinuclear region. Immunofluorescence images of A431 cells expressing GFP–Rab4 
(in green) and stained for HACE1 (in red). Note that HACE1 colocalizes with Rab4 in the perinuclear region, while 
additional Rab4 signal is found in the cytoplasm. Scale bar, 20 μm. (D) HACE1 directly binds Rab4–GTP but not 
Rab7. Immobilized GST-tagged Rab4 and Rab7 were incubated with purified recombinant HACE1 in the presence 




HACE1 binds Rab1 and 11 but not Rab2, 5 and 6. Input, 5%. (F) HACE1 interacts with Rabs in a nucleotide-
dependent manner. Same as in (E) but with the WT Rab1, 4 and 11 (WT, lanes 1–3), and their ‘GDP’ (SN mutant, 
lanes 4–6) and ‘GTP’ (QL mutant, lanes 7–9) locked forms. Input, 5%. (G) Endogenous HACE1 binds Golgi-
associated Rabs. As in (D) but using HeLa cell lysates instead of purified HACE1 protein. Input, 10%. Lines on the 
left of the blots in (D–G) indicate the molecular weight marker of 95 kDa. 
 
HACE1 is associated with Golgi membranes 
HACE1 lacks a transmembrane domain and has been shown to be associated, at least in 
part, with the endoplasmic reticulum (ER) in NIH3T3 cells [140]. NIH3T3 cells are not often 
used in studies of Golgi proteins partially because of their relatively small size. Considering the 
interactions of HACE1 with Rab1, Rab4 and Rab11, which are at least partially localized to 
Golgi membranes [8, 11, 17, 141, 142], we determined whether HACE1 localizes to the Golgi 
during interphase in normal rat kidney (NRK) cells. A fraction of HACE1 co-localized with 
GRASP65, a Golgi marker, and the rest of the protein appeared to be cytosolic (Figure 4.2A), 
similar to the results observed in A431 cells (Figure 4.1C). Both the Golgi and cytosolic signals 
were diminished by the addition of recombinant HACE1 protein to displace the antibodies 
(Figure 4.2B, anti-HACE1+peptide), suggesting that the antibody had high specificity.  
 
We then treated the cells with chemicals known to affect the Golgi structure. Nocodazole 
treatment leads to fragmentation of the Golgi ribbon. After nocodazole treatment, HACE1 
colocalized with the Golgi remnants indicated by GM130 (Figure 4.2C). Brefeldin A (BFA) 
treatment leads to Golgi membrane fusion with the ER. In the presence of BFA, Golgi remnants, 
marked by GRASP65, were dispersed throughout the cell along with HACE1 (Figure 4.2D). 
After BFA was washed out, HACE1 accumulated in perinuclear regions where the Golgi 




membranes, HACE1 associated with mitotic Golgi clusters, as determined by the presence of 
GM130 (Figure 4.2F).  
 
Figure 4.2. HACE1 is concentrated on the Golgi apparatus.  
(A) HACE1 is concentrated on the Golgi in interphase cells. NRK cells were immunostained with an affinity-
purified polyclonal antibody to HACE1 (left panel, in red) and a monoclonal antibody to GRASP65 (middle panel, 
in green). (B) The HACE1 antibodies are specific. Same as in (A), except the HACE1 antibodies were pre-incubated 
with purified HACE1 recombinant protein to quench the antibodies. Note that the HACE1 fluorescence was 
displaced by the recombinant HACE1. (C) HACE1 is associated with Golgi fragments after nocodazole treatment. 
NRK cells were treated with 0.5 μg/ml nocodazole for 2 h and stained for HACE1 and GM130. (D) Brefeldin A 
(BFA) treatment leads to the dispersal of HACE1 in the cell. NRK cells were treated with 5 μg/ml BFA for 2 h and 
analysed as in (A). (E) BFA washout. After the removal of BFA, cells were further incubated in growth media for 2 
h and stained for HACE1 and GRASP65. (F) HACE1 is partially associated with the Golgi fragments in 
prometaphase cells. Prometaphase NRK cells stained for HACE1 (red), GM130 (green) and DNA (blue). Note that 
HACE1 is localized on the mitotic Golgi fragments (indicated by arrows). Scale bars in all panels, 10 μm. 
 
Further microscopic analysis indicated that HACE1 co-localized well with the cis-Golgi 
markers GRASP65, and GM130 (Figure 4.2) and with GalNac-T2-GFP (N-
acetylgalactosaminyltransferase 2), a Golgi enzyme localized throughout the Golgi stack (Figure 
4.S1) [143]. HACE1 also co-localized with the medial and trans Golgi markers -mannosidase 
II (ManII) [144] and syntaxin 6 [145], though to a lesser extent compared to the cis-Golgi 
markers. In addition, it showed partial co-localization with the ER-Golgi intermediate 




concentrated. Co-localization of HACE1 with cis-Golgi markers, compared to other Golgi 
compartment markers, was more evident when the Golgi apparatus was fragmented by 
nocodazole treatment (Figure 4.2C, 4.S1).  
 
 
Figure 4.S1. HACE1 co-localizes with cis-Golgi markers. 
(A) Co-localization of HACE1 with ERGIC53, an endoplasmic reticulum-Golgi intermediate compartment (ERGIC) 
marker. Untreated (upper panels) and nocodazole-treated (lower panels) NRK cells were immunostained with an 
affinity-purified HACE1 polyclonal antibody (left panels, in red) and a monoclonal ERGIC53 antibody (middle 
panel, in green). The overlay is shown on the right. Lower panels are enlarged images of the boxed regions. (B) Co-
localization of HACE1 with GFP-tagged N-acetylgalactosaminyltransferase 2 (GalNAc-T2-EGFP). Same as in A 
but with the EGFP signal from stably expressed GalNac-T2-EGFP. (C) Co-localization of HACE1 with 
mannosidase II (ManII), an enzyme localized in the medial-Golgi. (D) Co-localization of HACE1 with syntaxin 6, a 
trans-Golgi-localized SNARE protein. Scale bars in all panels: 10 µm. 
 
Biochemical analysis also confirmed the association of HACE1 with Golgi membranes. 
Western blot of cell lysate prepared from unsynchronized interphase NRK cells and nocodazole 




membrane organelles were separated using equilibrium sucrose gradients, the distribution of 
HACE1 was similar to the Golgi markers GM130, GRASP65, syntaxin 5 and Gos28 but was 
different from the ER markers Sec61 and protein disulfide isomerase (PDI) (Figure 4.3B). Taken 
together, these results show that HACE1 is associated with Golgi membranes.  
 
 
Figure 4.3. HACE1 is a ubiquitin ligase bound to Golgi membranes.  
(A) The affinity-purified HACE1 antibody recognizes one major band in NRK cells. Western blot of non-
synchronized interphase and nocodazole-treated mitotic NRK cell lysates for HACE1 and tubulin. (B) HACE1 
colocalizes with the Golgi in sucrose gradients. Post nuclear supernatant (PNS) from interphase NRK cells was 
fractionated by equilibrium centrifugation on a sucrose gradient (0.5–1.6 M). Membranes from each fraction were 
pelleted and equal volumes were analysed by western blot for the indicated proteins. Golgi membranes were 
enriched in fraction 5 (with about 0.8 M sucrose), while ER membranes are more widely distributed and 









Figure 4.4. Expression of an inactive Rab1 mutant interrupts HACE1 localization and Golgi structure. 
HeLa cells expressing GFP (A and H), YFP-Rab1 wild-type or mutant constructs (B-D, I-K), GFP-Rab4 wild-type 
or mutant constructs (E-G, L-N) as indicated were immunostained for HACE1 (A-G) or GRASP65 (H-N). The 
overlays with the YFP or GFP signals (in green) are shown on the right. Asterisks indicate cells expressing the Rab1 
(SN) mutant, which have HACE1 dispersed from the Golgi membranes (D) and fragmented Golgi (K). Scale bars in 





Figure 4.S2. Expression of Rab5 and Rab11 does affect HACE1 Golgi localization and Golgi organization. 
(A-H) HeLa cells expressing the indicated Rab constructs (GFP-Rab5, GFP-Rab11 and mutants) were 
immunostained for HACE1 (A-D) or GRASP65 (E-H). Scale bars in all panels: 20 µm. (I-J) Western blots of cells 
described in Figure 4.3 and Figure 4.S4A-H. Cells were lysed in SDS buffer followed by Western blot to detect 
indicated proteins. The split of the GFP blot (lane 5 in I) from the same gel was due to the different sizes of GFP and 
GFP-Rab. 
 
If Rabs target HACE1 to the Golgi, inhibition of Rab activity may affect HACE1 Golgi 
localization. We therefore used wild-type and mutant Rabs to test this hypothesis. Expression of 
wild-type Rabs did not affect HACE1 Golgi localization or Golgi structure (Figure 4.4, 4.S2). In 




membranes (Figure 4.1C, 4.4, 4.S2). Expression of the active Rab1 Q67L mutant had no effect 
on HACE1 localization or Golgi morphology. In contrast, expression of the S25N mutant at a 
relatively low level (Figure 4.S2I, lane 2 vs. other lanes) disrupted HACE1 Golgi localization 
(Figure 4.4D). Furthermore, expression of the Rab1 S25N mutant also caused Golgi 
fragmentation (Figure 4.4K), which is consistent with previous reports [147] and suggests that 
HACE1 may serve as a Rab1 effector required for Golgi integrity. Expression of Rab4, Rab11 
and their mutants had no effect on HACE1 Golgi localization or the Golgi organization (Figure 
4.4, 4.S2). Taken together, our data suggest that the interaction of HACE1 with Rab1 is 
important for HACE1 Golgi localization and function. 
 
HACE1 is required for post-mitotic Golgi membrane fusion 
To test the role of HACE1 in the formation of Golgi structure, we expressed myc-tagged 
wild-type (WT) and mutant HACE1 in HeLa cells and examined Golgi morphology. Deletion of 
the HECT domain (aa 1-553 lacking the HECT domain, designated HACE1 ∆C) or mutation of 
cysteine 876 to analine (the CA mutant, Figure 4.5A) abolished the ubiquitin ligase activity [38]. 
The exogenously expressed proteins were partially localized on the Golgi examined by 
fluorescence microscopy (Figure 4.5B). Expression of the WT HACE1 did not affect the 
integrity of the Golgi structure. However, expression of the CA or the ∆C mutant led to Golgi 
fragmentation; with 33.4 ± 1.4% and 49.8 ± 0.1% of the cells had fragmented Golgi, 
respectively, which was significantly higher than cells transfected with WT HACE1 (9.6 ± 1.0%) 
or with the vector alone (8.9 ± 0.1%) (Figure 4.5). These results suggest that HACE1 ubiquitin 






Figure 4.5. Expression of HACE1 mutants leads to Golgi fragmentation.  
(A) Schematic structure of HACE1. It contains six ankyrin repeats at the Nterminus and a HECT domain at the C 
terminus. Cysteine 876 has been shown to be essential for the ubiquitin ligase activity. A construct with the HECT 
domain deleted (C, amino acids 1–553) was used in this study. (B) HeLa cells expressing myc-tagged WT HACE1 
protein, the inactive C876A (CA) mutant and the C mutant. Mock transfection with the empty vector. Asterisks 
indicate transfected cells. Note that expression of the CA and C mutants leads to Golgi fragmentation. Scale bar, 
20 μm. (C) Western blots illustrating that the correct proteins were expressed. Endo HACE1 refers to endogenous 
HACE1. (D) Quantification of Golgi fragmentation in 300 myc-tagged HACE1-expressing cells for each set of 
experiments. Shown are representative results (mean ± s.e.m.) from three independent experiments. Statistical 
significance was assessed by comparison to the mock transfection. P-value was determined by Student’s t-test; **P 
< 0.005; ***P < 0.001. 
 
Previous experiments have suggested that ubiquitin plays a role in p97/p47-mediated post-
mitotic Golgi membrane fusion [35, 36], it is possible that HACE1 functions in the same 
ubiquitination-deubiquitination pathway. Therefore, we used the standard Golgi disassembly and 
reassembly assay [8] to test the role of HACE1 in regulation of Golgi membrane dynamics. We 




These mitotic Golgi fragments were further treated with interphase cytosol. After incubation, 
membranes were examined by electron microscopy (EM) and the percentage of membranes in 
cisternae was quantified [11, 36]. To manipulate HACE1 activity, we added affinity purified 
anti-HACE1 antibodies, or purified wild-type HACE1 or C876A mutant proteins into either the 
disassembly or the reassembly reactions. As shown in Figure 4.6, manipulation of HACE1 
activity in the Golgi membrane disassembly reaction alone (Figure 4.6A) or in the reassembly 
alone (Figure 4.6B) had no effect. 
 
Our previous results have demonstrated that ubiquitination occurs during Golgi disassembly 
and is required for subsequent reassembly [36]; therefore, HACE1 may function in disassembly, 
which impacts subsequent Golgi reassembly. To test this idea, we first treated purified Golgi 
membranes with mitotic cytosol in the presence of either HACE1 recombinant protein or 
HACE1 antibodies and used the resulting Golgi fragments for reassembly. The addition of anti-
HACE1 antibodies or the inactive HACE1 C876A mutant protein inhibited subsequent Golgi 
membrane reassembly. In contrast, the addition of wild-type HACE1 protein enhanced the 
subsequent Golgi membrane reassembly (Figure 4.6C). These results suggest that the HACE1 
ubiquitin ligase activity in mitotic Golgi membrane disassembly is required for subsequent post-





Figure 4.6. HACE1 regulates p97/p47-mediated post-mitotic Golgi membrane reassembly in vitro. 
(A-B) HACE1 in mitotic Golgi disassembly or post-mitotic reassembly. Purified rat Golgi were treated with mitotic 
cytosol (mit. cyt.), then with interphase cytosol. Control rabbit IgG, affinity purified anti-HACE1 antibodies or 
purified proteins of wild-type HACE1 or the C876A mutant were added into the disassembly (A) or reassembly (B) 
reactions, as indicated. Membranes were processed for EM, and the results were quantified to estimate the 
percentage of cisternal membranes. Mitotic Golgi fragments (none, 23.6 ± 1.1% membranes in cisternae) were 
normalized to 0%. Reassembly in interphase cytosol without any additional components (none, 57.1 ± 0.5% 
membranes in cisternae) was normalized to 100%. (C) HACE1 ubiquitin ligase activity in mitotic Golgi disassembly 
is required for subsequent post-mitotic Golgi membrane reassembly. Golgi membranes were fragmented by mitotic 
cytosol in the presence of the indicated reagents and incubated with interphase cytosol (int. cyt.). (D) HACE1 ligase 
activity levels correlate with the efficiency of post-mitotic Golgi membrane assembly in a dose-dependent manner. 
Same as in (C) except with a serial increasing amount (0.1 – 1 µM) of purified wild-type HACE1 or C876A mutant 
included in the reassembly reactions. 0% represents mitotic Golgi fragments treated with mitotic cytosol and then 
fixed (24.1 ± 0.6% membranes in cisternae), and 100% represents membranes reassembled in interphase cytosol 
(58.5 ± 0.5% membranes in cisternae). (E) HACE1 affects p97/p47-mediated membrane fusion. Same as in (D), 
except that mitotic Golgi membranes were subsequently incubated with the purified p97/p47 proteins instead of 
interphase cytosol. 0% represents mitotic Golgi fragments treated with mitotic cytosol and then fixed (26.5 ± 0.1% 
membranes in cisternae), and 100% represents membranes reassembled with p97/47 (53.6 ± 1.1% membranes in 
cisternae). The results represent the mean of three independent experiments ± SEM. P-value was determined by 
Student’s t-test; *, p<0.05; **, p<0.005; ***, p<0.001. 
 
To ensure that the observed effects resulted from the addition of HACE1, we titrated 
different amounts of HACE1 recombinant protein into the disassembly reaction and used the 




increased the stimulatory effects, whereas increasing the amount of HACE1 C876A mutant 
increased the inhibitory effects (Figure 4.6D). These results show that HACE1 ligase activity 
levels are correlated with the efficiency of post-mitotic Golgi membrane assembly in a dose-
dependent manner. 
 
We then used the defined Golgi disassembly and reassembly assay [8] to determine whether 
HACE1 functions through p97/p47-mediated membrane fusion. Similar to the experiments 
described above, HACE1 antibodies and purified proteins were added to the disassembly 
reactions, and the generated mitotic Golgi membranes were subsequently incubated with purified 
p97/p47 proteins. As shown in Figure 4.6E, the addition of anti-HACE1 antibodies or the 
purified HACE1 C876A mutant protein inhibited Golgi membrane reassembly, in contrast with 
the stimulatory effect of the WT protein. Because the experimental conditions were optimized 
for Golgi membrane fusion, the increased reassembly efficiency caused by the addition of wild-
type HACE1 strengthened the conclusion that HACE1 is involved in the regulation of Golgi 
membrane dynamics. Taken together, these results strongly suggest that HACE1 ubiquitin ligase 
activity in mitotic Golgi disassembly is required for p97/p47-mediated post-mitotic Golgi 
membrane reassembly in vitro. 
 
HACE1 regulates Golgi membrane fusion in cells 
To determine whether HACE1 is needed for Golgi integrity in vivo, we reduced cellular 
HACE1 level using small interfering RNAs (siRNA) (Figure 4.7A-B). Four pairs of RNA oligos 
were tested, and the most efficient pair was selected. HACE1 mRNA levels determined by real-




transfection, respectively (Figure 4.7C). At the protein level, there was a 62.0 ± 4.8% reduction 4 
days after transfection (Figure 4.7D). These results indicate that endogenous HACE1 is a 
relatively stable protein. Indeed, when cells were treated with the protein synthesis inhibitor 
cycloheximide (CHX) for 24 hours, HACE1 protein levels were not significantly affected; in 
contrast, the same treatment caused a noticeable reduction of GRASP65 (Figure 4.S3A). To 
confirm the specificity of our siRNA oligos, HeLa cells were transiently transfected with a 
HACE1-myc cDNA and HACE1 or control siRNA oligos. HACE1-myc was expressed well 
when co-transfected with the control siRNA but not with the HACE1 siRNA (Figure 4.S3B). 
These results confirmed that the siRNA used to deplete the HACE1 mRNA and protein is 
specific and, to some degree, effective.  
 
Figure 4.S3. HACE1 depletion in cells.  
(A) HACE1 protein levels do not significantly decrease 24 h after cycloheximide (CHX) treatment. NRK cells were 
incubated in growth media with 20 µg/ml CHX for the indicated time periods (0-24 hours). Cells were lysed in SDS 
buffer and analyzed for the indicated proteins by Western blot. Note that HACE1 levels remained relatively 
unchanged 24 h after treatment, while GRASP65 levels reduced. (B) Exogenous HACE1 is readily depleted by 
siRNA treatment. HeLa cells were treated with HACE1 or control siRNA oligos for 3 days followed by transient 
transfection with a HACE1-myc cDNA. Cells were lysed, and HACE1 and tubulin were detected by Western blot. 
Note that HACE1-myc expression was reduced in the presence of HACE1 siRNA (lane 2). (C) Depletion of HACE1 
by lentiviral infection. HeLa cells were infected by control or HACE1 shRNA lentiviral particles followed by 
Western blot for HACE1 and tubulin. 
 
We then analyzed the Golgi morphology in HACE1-depleted cells. These cells had reduced 




HACE1 led to Golgi fragmentation using GM130 (Figure 4.7 B vs. A), GRASP65 or syntaxin 5 
(data not shown) as Golgi markers; 83.0 ± 0.9% of the HACE1-depleted cells exhibited Golgi 
fragmentation, a significant increase compared to control siRNA transfected cells (4.8 ± 0.2%, 
Figure 4.7E). Since in vitro experiments indicate that HACE1 is involved in post-mitotic Golgi 
reassembly, we monitored the reformation of Golgi ribbon in control or HACE1-depleted cells 
using time-lapse microscopy. We infected HeLa cells by lentivirus packaged either an empty 
vector or a vector encoding HACE1 shRNA and generated stable cells. The knockdown 
efficiency of the HACE1 protein in these cells was similar to HACE1 siRNA transfection, as 
assessed by Western blot (Figure 4.S3C). Control cells or HACE1 shRNA-expressing cells were 
then co-transfected with cDNAs encoding ManII-mCherry to label the Golgi membranes and 
Histone H2B-GFP to visualize the morphology of the chromosomes in the cells. Metaphase cells 
with aligned chromosomes were then analyzed by time-lapse microscopy for post-mitotic Golgi 
formation. The frame right before chromosome separation (the onset of anaphase) was set to 0 
time point. Golgi reassembly was completed within 80 ± 5 min in control siRNA treated cells; 
while in HACE1 knockdown cells, the Golgi remained fragmented 180 min after mitosis (Figure 
4.7F-G, Supplementary Movies 4.1-4.2). These results demonstrate that HACE1 depletion 





Figure 4.7. Depletion of HACE1 leads to Golgi fragmentation. 
(A-B) Confocal fluorescence images of HACE1 knockdown cells. HeLa cells transfected with the indicated siRNA 
oligos were fixed and stained for HACE1 and GM130. Scale bars in all panels: 20 µm. (C) Knockdown efficiency 
of HACE1 mRNA on days 2 and 4 quantified by RT-PCR. The results presented are the percent reduction in the 
HACE1 mRNA in HACE1 knockdown cells compared to cells treated in parallel with a control siRNA. (D) 
Immunoblots of HeLa cells described in (A-B). The knockdown efficiency of HACE1 protein was 62.0% ± 4.8% 
from three independent experiments. (E) Quantitation of the fluorescence images in A-B from three independent 
experiments. Shown is the percentage of cells with fragmented Golgi, and 300 cells were counted for each 
experiment. The results expressed are the means ± SEM. (F-G) HACE1 depletion delays post-mitotic Golgi 
formation. HeLa cells were infected by control lentivirus (F) or lentivirus that expresses HACE1 shRNA (G). Cells 
were then co-transfected with cDNAs for Histone H2B-GFP (in green) and Man II-mCherry (in red) followed by 
time-lapse microscopy in 10 min intervals over 3 h (see Supplementary Movies S1-2). Metaphase cells with aligned 
chromosomes were set to 0 time point. Scale bar, 10 µm. (H-I) Representative EM micrographs of the cells 
described in A-B. The arrowheads indicate Golgi stacks, and asterisks indicate fragmented cisternal membranes. 
Scale bar, 1 µm. Note that the Golgi ribbon in HACE1-depleted cells is disorganized, and the cisternae are shorter 
compared to control siRNA-treated cells. (J) Quantitation of the EM images in F-G from three independent 
experiments. Note that cisternal length is reduced by HACE1 depletion. Statistical significance was assessed by 
comparison to the control siRNA-treated cells. ***, p <0.001.  
 
We then examined the Golgi structure more closely by EM. Control siRNA transfected 
cells showed well-organized stacks, which often aligned in parallel to form a ribbon. In contrast, 




cisternae were relatively short, while a large part of the membranes were vesiculated, and small 
stacks or single cisterna were dispersed throughout the cells and did not form a ribbon (Figure 
4.7, I vs. H). The average cisternal length was reduced from 1.01 ± 0.04 µm in control siRNA 
transfected cells to 0.53 ± 0.04 µm in HACE1-depleted cells (Figure 4.7J). These results suggest 
that HACE1 depletion reduces membrane fusion activity, which may subsequently impair Golgi 
ribbon linking observed as fragmented Golgi under the light microscope (Figure 4.5B, D; 4.7B, 
E and G). 
 
 
Figure 4.8. The Golgi apparatus is fragmented in SK-NEP-1 cells that have reduced HACE1 expression.  
(A-B) Representative fluorescence images of SK-NEP-1 cells showing that the Golgi indicated by GRASP65 is 
fragmented compared with HeLa cells. Arrows indicate isolated Golgi fragments. Scale bar, 10 μm. (C) HACE1 
expression is reduced in SK-NEP-1 cells. Western blot detecting HACE1, tubulin, p97 and p47 in HeLa cells and 




(E-F) EM images of (E) HeLa and (F) SK-NEP-1 cells. Scale bar, 1 μm. Note that SK-NEP-1 cells have isolated 
stacks with relatively short cisternae. (G) Quantification of the EM images in (E-F) from three independent 
experiments. The average length of the cisternae in HeLa cells was 1.12 ± 0.05 μm (mean ± s.e.m.), while in SK-
NEP-1 cells it was 0.63 ± 0.02 μm. P-value was determined by Student’s t-test; ***P < 0.001. 
 
It has been previously observed that the SK-NEP-1 cell line expresses relatively low level 
of HACE1 protein [140]; therefore, we examined the Golgi morphology in these cells in 
comparison with HeLa cells (Figure 4.8A-B). Indeed, HACE1 protein level in this cell line was 
30.9 ± 3.1% compared to HeLa cells as determined by Western blots (Figure 4.8C). The 
expression levels of HACE1 were similar in several cell lines, such as HeLa, A431 and NRK 
cells (data not shown). When analyzed by fluorescence microscopy, a large number of SK-NEP-
1 cells showed fragmented Golgi. Compared to HeLa cells (Figure 4.8B) and several other cell 
lines in which the Golgi membranes were well organized into a perinuclear ribbon-like structure, 
the Golgi membranes in SK-NEP-1 cells were disconnected, not localized to the perinuclear 
region and dispersed throughout the cell. Fragmented Golgi structures were observed in 34.9 ± 
2.2% of the SK-NEP-1 cells compared to 5.6 ± 1.0% in HeLa cells (Figure 4.8A, D), suggesting 
that these cells had a possible Golgi membrane fusion defect.  
 
The SK-NEP-1 cells were then analyzed by EM in parallel with HeLa cells. HeLa cells 
contained well-organized stacks that often aligned into a ribbon-like structure (Figure 4.8E), 
whereas in SK-NEP-1 cells the Golgi structure was less well organized. The cisternae were often 
not aligned into stacks, and the stacks were often more dispersed. More importantly, cisternae 
were shorter compared to those in HeLa cells. The average length of the SK-NEP-1 cisternae 
was 0.63 ± 0.02 µm, a significant reduction compared to that (1.12 ± 0.05 µm) found in HeLa 




NRK and CHO cells (data not shown). These results agree with the HACE1 knockdown 
experiment, suggesting that HACE1 regulates Golgi membrane fusion. Taken together, these 





We have identified the ubiquitin ligase HACE1 that interacts with Rab1 and is targeted to 
the Golgi membrane. Its activity in mitotic Golgi disassembly is required for subsequent post-
mitotic Golgi reassembly mediated by the p97/p47 complex. Depletion of HACE1, or expression 
of inactive HACE1 mutants, reduced the length of cisternae in the stacks and affected the overall 
Golgi structure. HACE1 depletion had stronger effect on the Golgi structure than the expression 
of inactive HACE1; this is likely due to three possible reasons. First, the mutants of HACE1 may 
not function as strong dominant negative mutants to inhibit the endogenous HACE1. Second, the 
effect of the exogenous protein may be concentration dependent and the expression level in the 
cells is heterogeneous. Third, HACE1 exhibits its activity during mitotic Golgi disassembly, 
which is required for the subsequent Golgi reassembly. Therefore, the effect on the Golgi 
morphology may require one or more cycles of cell division. The cells transfected with siRNA 
were examined 96 hours after transfection, whereas the cells expressing the mutant proteins were 
examined about 16 h after transfection. Most of the siRNA transfected cells should have gone 
through at least one cell cycle, whereas the percentage of mutant HACE1-expressing cells that 
went through mitosis was much lower. Nevertheless, these findings provided evidence that 
HACE1 is a key regulator of Golgi membrane dynamics during the cell cycle. The tight 
interaction between HACE1 and Rab1 also suggests that HACE1 is an effector of Rab1 
GTPases. The expression of Rab1 inactive mutant caused dissociation of HACE1 from the Golgi 
membranes and Golgi fragmentation, suggesting that Rab1 plays a critical role for HACE1 
function on the Golgi membranes. This result is consistent with the requirement of a functional 





HACE1 was previously identified as a critical tumor suppressor involved in multiple 
cancers, such as sporadic Wilms’ tumor [38, 140, 148]. The mechanism by which HACE1 
depletion leads to cancer formation, however, remains elusive. One attractive hypothesis is that 
the role of HACE1 in cell proliferation is related to its role in regulating Golgi biogenesis during 
the cell cycle. The Golgi is the central machinery for protein modification, processing, 
trafficking and secretion. Defects in the Golgi structure and function may directly affect cell 
growth and proliferation. Golgi defects may also impair the accuracy of protein glycosylation, 
including cell adhesion molecules on cell surface, which may lead to metastasis. Indeed, 
abnormal Golgi division has been observed in cancer cells [149], and defects in protein 
processing and secretion have been related to cancer cell metastasis [150-152]. 
 
The mechanism by which ubiquitination and deubiquitination regulate Golgi dynamics 
remains elusive. It has been shown that the activity of the VCIP135 deubiquitinating enzyme is 
required for post-mitotic Golgi membrane fusion [36]. Therefore, it is likely that at least one 
Golgi membrane protein is ubiquitinated by HACE1 at the onset of mitosis when the Golgi 
undergoes mitotic fragmentation. Monoubiquitination does not result in the degradation of the 
substrate; instead, it recruits the p97/p47 complex to the Golgi membrane through interaction 
between the p47 UBA domain and ubiquitin [35, 36]. Subsequently, the p97/p47 complex 
recruits VCIP135 to the membrane. When the ubiquitin is removed from the substrate(s) by 
VCIP135, the membranes are subjected to p97/p47-mediated fusion. Consistently, our in vivo 
and in vitro experiments demonstrate that the lack of HACE1 activity reduces Golgi membrane 
fusion and results in short cisternae, possibly because of the reduced recruitment of the p97/p47 




depletion also suggests that membrane fusion mediated by NSF, another machinery in post-
mitotic Golgi membrane fusion, cannot compensate the loss of p97 (and ubiquitin)-mediated 
membrane fusion activity. Consistent with this, it has been shown that NSF- and p97-mediated 
Golgi reassembly pathways contribute non-additively to cisternal regrowth [132], but the 
coordination between two pathways has not been fully elucidated.  
 
Our results suggest a mechanism by which ubiquitination functions as a signal that 
regulates Golgi reassembly after cell division. The key question for understanding the 
mechanism requires the identification of the ubiquitinated substrate(s), which will help determine 
whether the lack of Golgi membrane fusion activity during mitosis is due to ubiquitination of 
Golgi membrane proteins. It is tempting to speculate that the target in this pathway is part of the 
membrane fusion machinery that includes SNAREs and SNARE interacting proteins as well as 
the key Golgi structural proteins such as Golgins and GRASP proteins. Further experiments are 
necessary to identify these substrates on the Golgi membrane and to determine how HACE1 





Materials and Methods 
Reagents 
All reagents were purchased from Sigma-Aldrich, Roche or Calbiochem, unless otherwise 
stated. The following antibodies were used: monoclonal antibodies against ERGIC53 (P. Arvan), 
Gos28 and GM130 (Transduction Laboratories), myc (D. Sheff), syntaxin 6 (BD Biosciences) 
and -tubulin (Developmental Studies Hybridoma Bank University of Iowa); polyclonal 
antibodies against PDI (P. Arvan), GFP [16], GM130 [17], rat GRASP55 [16], GRASP65 [14], 
-mannosidase II (G. Warren), p47 and p97 [36], Rab1A, , Rab6 and Rab11 [121], sec61 
(Upstate). The HACE1 antibody was generated in rabbits using recombinant GST-HACE1 (aa 1-
548) as the immunogen and subsequently affinity purified; it was used at 1:1000 dilution for 
Western blot and 1:100 for fluorescence microscopy. The GalNAc-T2-GFP cDNA was a gift 
from G. Warren. Secondary antibodies were from Jackson Lab and Invitrogen. The GST-Rab1a 
(WT, Q67L and S25N) and GST-Rab2 cDNA constructs were kindly provided by Dr. Graham 
Warren. The GST-Rab5, GST-Rab6 and GST-Rab11 plasmids were a gift from Dr. Suzanne 
Pfeffer. GFP-tagged Rab4 (WT, Q67L and S22N) constructs were from Dr. Stephen Ferguson. 
GFP-Rab11 (WT, Q70L and S25N) constructs were from Dr. David Sheff. 
 
HACE1 identification and Rab interaction 
To purify Rab4 effectors, GST-Rab4 was expressed in 20 L of DH5 cells and bound to 2 
ml of glutathione beads (GE Healthcare). The sample was equally divided into two tubes and 
incubated with nucleotide-exchange buffer (NE buffer; 20 mM Hepes-KOH, pH 7.5, 100 mM 
NaCl, 10 mM EDTA, 5 mM MgCl2 and 1 mM DTT), containing 1 mM GTPS in one tube and 1 




three times. GST-Rab4 bound to beads was then stabilized with nucleotide-stabilization buffer 
(NS buffer; 20 mM Hepes-KOH, pH 7.5, 100 mM NaCl, 5 mM MgCl2 and 1 mM DTT) in the 
presence of 1 mM GTPS or GDP for 20 min at room temperature with rotation. Beads were 
then incubated with 50 ml of bovine brain cytosol (20 mg/ml) [139] for 2 h at 4°C. After 
incubation, the beads were washed with 10 column volumes of NS buffer with 10 µM GTPS or 
GDP; 10 volumes of NS buffer containing 250 mM NaCl and 10 µM GTPS or GDP and 1 
volume of 20 mM Hepes-KOH, pH 7.5, 250 mM NaCl and 1 mM DTT. To elute the bound 
proteins, the beads were incubated with 1.5 column volumes of elution buffer (20 mM Hepes-
KOH, pH 7.5, 1.5 M NaCl, 20 mM EDTA, 1 mM DTT and 5 mM GDP) for 20 min at room 
temperature with rotation. Eluted proteins were analyzed by SDS-PAGE and coomassie blue 
staining. The bands in the GTPS lane were excised and analyzed by mass spectrometry. The 
generated peptide sequences were used to search NCBI EST database.  
 
HACE1 cloning 
The ILTSLAEVA peptide identified by mass spectrometry was found in a HACE1 EST 
clone (NCBI accession no. AI130909). This EST clone was sequenced, and the translated 
sequence contained three other peptides identified by mass spectrometry: VLEHLSQQE, 
QNEDLR and DTAQILLLR. The full-length HACE1 cDNA clone was isolated by screening the 
SUPERSCRIPT HeLa cDNA library (Life Technologies) using a primer derived from the 5' end 
of this EST sequence. The HACE1 coding sequence was amplified by PCR using primers that 
contained EcoRI and BamHI sites at the 5'- or 3'-ends and inserted into pcDNA3.1/myc-His(-)A 
(Invitrogen) for mammalian expression or and a EcoRI and XhoI fragment into pGEX-6p-1 (GE 




QuikChange mutagenesis kit (Stratagene). The HACE1 ∆C construct was generated by inserting 
an EcoRI/BamHI fragment (aa 1-553) into pCDNA3.1 or an EcoRI/SalI fragment (aa 1-548) into 
pGEX-6p-1 for antigen preparation. All of the constructs were confirmed by DNA sequencing. 
 
Preparation of HACE1 fusion proteins 
GST-HACE1 proteins were expressed in BL21 (DE3) Gold bacteria and purified on 
glutathione Sepharose beads (GE Healthcare). For the HACE1-Rab interaction assay, the 
HACE1 protein on glutathione Sepharose beads was cleaved from the tag by PreScission 
protease, and the supernatant was further incubated with glutathione beads to remove GST-
tagged proteins. Untagged HACE1 protein in the supernatant was used to assay binding to Rab 
proteins. 
 
Thioester bond formation assay 
To test whether HACE1 is an active ubiquitin ligase, 60 nM recombinant human ubiquitin 
activating enzyme E1 (Biomol International), 200 nM recombinant human UbcH7 (Biomol 
International) [140], 19 µM biotinylated ubiquitin and 600 nM recombinant GST-tagged WT or 
mutant HACE1 were mixed in 40 µl reactions in reaction buffer that contained 20 mM Tris-HCl, 
pH 7.4, 50 mM KCl, 5 mM MgCl2, 2 mM ATP, 0.2 M sucrose and protease inhibitors (Roche). 
Reactions were incubated at 30°C for 60 min and mixed with SDS-PAGE sample buffer with or 
without DTT followed by detection of HACE1 by Western blot.  
 




The interactions between HACE1 and Rab were determined by a pull-down assay following 
a previously established procedure [11]. For each reaction, GST-tagged Rabs were expressed in 
BL21 (DE3) bacteria with 125 ml of LB media. The GST-Rabs were immobilized on 25 µl of 
glutathione beads (bed volume) in a 1.5 ml Eppendorf tube. The beads were washed with 1 ml of 
NE buffer containing 10 μM GDP or GTPγS and incubated two times with NE buffer containing 
1 mM GDP or GTPγS at RT for 30 min. The beads were then washed with 1 ml of NS buffer 
containing 10 μM GDP or GTPγS and incubated with NS buffer containing 1 mM GDP or 
GTPγS at room temperature for 30 min.  
 
Five micrograms of HACE1 protein (without a tag) prepared above was incubated with the 
GDP or GTPγS charged beads in 150 µl of cytosol buffer (20 mM Hepes-KOH pH 7.4, 250 mM 
NaCl, 5 mM MgCl2, 1 mM DTT, 1% Triton X-100 and protease inhibitors) containing 1 mM 
GDP or GTPγS at 4ºC for 2 h. The beads were washed three times with cytosol buffer containing 
10 µM GDP or GTPγS at 4ºC for 10 min. To elute the bound proteins, the beads were incubated 
with 12.5 µl of elution buffer (20 mM Hepes-KOH, pH 7.4, 1.5 M NaCl, 20 mM EDTA, 1 mM 
DTT, 1% Triton X-100 and protease inhibitor cocktail) for 10 min at room temperature. Elution 
was repeated three times, and the elutions were pooled. Equal volumes were analyzed by 
Western blot. 
 
To test the interaction between endogenous HACE1 and Rabs, cell lysates were prepared as 
previously described [28]. Briefly, cells were grown in 10 X 15 cm dishes to 80% confluency, 
washed with PBS three times, and harvested with 3 ml of homogenization buffer (20 mM Hepes-




were cracked with a ball bearing homogenizer to reach 75-80% breakage determined by Trypan 
blue exclusion. The homogenate was centrifuged for 10 min at 1000 g and 4˚C. The post-nuclear 
supernatant (PNS) was supplemented with 1% Triton X-100 and rotated at 4˚C for 30 min. 
Solubilized proteins were exchanged into cytosol buffer (20 mM Hepes-KOH pH 7.4, 100 mM 
NaCl, 5 mM MgCl2, 1 mM DTT, 1% Triton X-100 and protease inhibitors) using the BIO-RAD 
Econo-Pac® 10DG column following the manufacturer’s instructions. Five milligrams of cell 
lysate was incubated with GDP or GTPγS charged beads in 800 µl of cytosol buffer containing 1 
mM GDP or GTPγS at 4ºC overnight. The beads were washed three times with cytosol buffer 
containing 10 µM GDP or GTPγS at 4ºC for 10 min and once with cytosol buffer containing 250 
mM NaCl and eluted with 80 µl of elution buffer for 20 min at RT and subjected to Western blot 
analysis.  
 
Cell culture  
HeLa and NRK cells were routinely cultured in DMEM supplemented
 
with 7.5% fetal calf 
serum, 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin
 
(100 µg/ml). SK-NEP-1 cells 
were cultured in McCoy’s medium with 15% FCS. For nocodazole treatment, cells were treated 
with 0.5 µg/ml nocodazole for 2 hours followed by fluorescence microscopy. For BFA treatment 
and washout, cells were treated with 5 µg/ml BFA for 2 hours, washed twice with PBS and 
further incubated in growth media for 2 hours. siRNA oligos were designed using the Invitrogen 
BLOCK-iT™ RNAi Designer software according to the human HACE1 sequence (sense: UAU 
AGC GCU GAU GUC AAC A(TT), antisense: UGU UGA CAU CAG CGC UAU A(TT)). In a 
previous report [38], three pairs of RNA oligos from Invitrogen were used to deplete HACE1. 





HeLa and HEK 293T cells were transfected using Lipofectamine RNAiMAX (Invitrogen) 
following the manufacturer’s instructions. Control transfections were performed simultaneously 
using non-specific siRNA oligos purchased from Ambion. Assays were performed 96 h after 
transfection unless otherwise stated. Depletion efficiency of endogenous HACE1 was quantified 
from the Western blot results using the NIH ImageJ software and normalized to tubulin levels. 
To construct HACE1 knockdown stable cell lines, HeLa cells were infected by MISSION 
HACE1 shRNA lentiviral particles (Sigma, product # SHCLNV-NM_020771, contains 5 shRNA 
lentiviral clones) and transduced cells were selected by the addition of 1 g/ml puromycin into 
the culture medium. Among the 5 HACE1 shRNA lentiviral clones, clone TRCN0000003414 
gave the best knockdown efficiency examined by Western blots (Figure 4.S3C). Lentivirus 
packaged with the pLentilox3.7-GFP vector was obtained from the University of Michigan 
Vector Core and used as a control. For expression of exogenous HACE1, HeLa cells were 
transfected with the indicated HACE1 constructs using Lipofectamine 2000 (Invitrogen).  
 
RT-PCR 
mRNA was purified from a 6-cm dish of HeLa cells using RNeasy columns (QIAGEN 
Inc.). First-strand cDNA was synthesized using Superscript III RT (Invitrogen) and utilized for 
semi-quantitative real-time PCR using IQ SYBR Green Supermix (Bio-Rad). A Bio-Rad IQ 
iCycler was used to measure the expression levels of transcripts. The HACE1 mRNA level was 
normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Intron-spanning primers 
are designed using the “Primer 3” software. The following primer sequences were used for 




AGTCATTCCCGGAGGCATCT. The GAPDH primers were provided by Dr. Haoxing Xu 
[153].  
 
Subcellular fractionation and equilibrium gradients 
NRK cells at 80% confluency were scraped and resuspended in 800 µl of homogenization 
buffer (0.25 M sucrose, 1 mM EDTA, 1 mM Mg acetate, 10 mM Hepes-KOH, pH 7.2 and 
protease inhibitors). Cells were cracked with a ball-bearing homogenizer to a breakage of 75-
80%. The homogenate was centrifuged for 10 min at 1000 g, 4°C. The postnuclear supernatant 
(PNS) was removed and subjected to ultracentrifugation in a TLA55 rotor at 120,000 g for 60 
min. The supernatant (cytosol) was removed, and the membranes in the pellet were resuspended 
in homogenization buffer. Equal volumes of the PNS, cytosol and membrane fractions were 
analyzed by SDS-PAGE and Western blot. The PNS was also fractionated on a sucrose gradient 
as previously described [7, 8, 28].  
 
Microscopy, quantitation and statistical analyses 
Immunofluorescence microscopy and the electron microscopy are performed as described 
[8, 18]
,11
, collection of mitotic cells were previously reported [28]. For SK-NEP-1 cells, cells 
were grown on collagen coated glass plate for 24h and processed for immunofluorescence. For 
antibody displacement, diluted HACE1 antibodies were pre-incubated with 50 µg/ml 
recombinant HACE1 for 1 h before incubation with the cells. Pictures were taken with a Leica 
SP5 laser-scanning confocal microscope using a 100X oil lens or a Zeiss Observer Z1 
epifluorescence microscope with a 63X oil lens. In interphase cells, fragmented Golgi was 




membranes were concentrated near the nucleus in SK-NEP-1 cells, multiple miniGolgi (isolated 
dots detected by fluorescence microscopy) were observed to be dissociated from the major Golgi 
apparatus. These cells were categorized as containing fragmented Golgi. To quantify the 
percentage of cells with fragmented Golgi, more than 300 cells transfected with control or 
HACE1 siRNAs, or with wild type or mutant HACE1 cDNA constructs, were counted, and the 
results are presented as mean ± SEM (n=3).  
 
For live cell imaging, cells infected with control or HACE1 shRNA lentivirus were co-
transfected with cDNAs for ManII-mCherry and H2B-GFP (Addgene) for 16 h. Mitotic cells 
were analyzed by time-lapse microscopy with 10 min intervals using a Zeiss Axio Observer Z1 
epifluorescence microscope with a 63X oil lens and an AxioCam CCD camera using the AV 
Rel4.8 software (Zeiss). Temperature (37ºC), humidity and CO2 concentration (5%) were 
maintained using a Tokai Hit Stage Top Incubator (Tokai Hit) during recording.  
 
Electron microscopy  
For EM analysis, Golgi stacks and clusters were identified using morphological criteria and 
quantified using standard stereological techniques [8, 18]. Interphase cells were defined as 
profiles that contained an intact nuclear envelope. Only stacked structures containing three or 
more cisternae were measured for cisternal length. Golgi stack images were captured at 11000x 
magnification to obtain a better view of the stacks. The longest cisterna was measured as the 
cisternal length of a Golgi stack using the ruler tool in the Photoshop CS3 software or the line 




in each experiment, and the results represent at least three independent experiments. Statistical 
significance was assessed by Student’s t-test. 
 
Golgi disassembly and reassembly assay and quantitation 
Golgi membranes were purified from rat liver [154]. Interphase (IC) and mitotic (MC) 
cytosols were prepared from HeLa S3 cells [129]. His-tagged p47 was expressed in bacteria and 
purified using nickel beads [35]. p97 was prepared using a bacterial expression system or 
purified from rat liver cytosol by gel filtration [35, 134]. The Golgi disassembly assay was 
performed as described previously [7]. Briefly, purified Golgi membranes (20 g) were mixed 
with 2 mg of mitotic cytosol, 1 mM GTP and an ATP-regenerating system (10 mM creatine 
phosphate, 1 mM ATP, 20 µg/ml creatine kinase and 20 ng/ml cytochalasin B) in MEB buffer 
(50 mM Tris-HCl, pH 7.4, 0.2 M sucrose, 50 mM KCl, 20 mM -glycerophosphate, 15 mM 
EGTA, 10 mM MgCl2, 2 mM ATP, 1 mM GTP, 1 mM glutathione and protease inhibitors) in a 
final volume of 200 µl. In some reactions, 1 µM or an increasing amount (0.1-1 µM) of wild-
type or mutant HACE1 recombinant proteins or 10 ng/µl anti-HACE1 antibodies were added 
into the disassembly assay as indicated. After incubation for 60 min at 37°C, mitotic Golgi 
fragments (MGF) were isolated and
 
soluble proteins were removed by centrifugation (135,000 g 
for 30 min in a TLA55 rotor) through a 0.4 M sucrose
 
cushion in KHM buffer (20 mM Hepes-
KOH, pH 7.0, 0.2 M sucrose, 60 mM KCl, 5 mM Mg(OAc)2, 2 mM ATP, 1 mM GTP, 1 mM 
glutathione and protease inhibitors) onto a 6-µl 2 M sucrose cushion.
 
The membranes were 
resuspended in KHM buffer and were either fixed and processed for EM [7, 14, 28] or used in 
reassembly reactions. For Golgi reassembly, 20 µg of Golgi fragments were resuspended in 




the presence of an ATP regeneration system in a final volume of 30 µl and incubated at 37°C for 
60 min. The membranes were pelleted by centrifugation, and processed for EM.  
 
For EM analysis, the percentage of membranes in cisternae or in vesicles was determined 
by the intersection method [14, 128]. Cisternae were defined as long membrane profiles with a 
length greater than four times their width, and the latter did not exceed 60 nm. Normal cisternae 
ranged from 20-30 nm in width and were longer than 200 nm. Stacks were defined as two or 
more cisternae that were separated by no more than 15 nm and overlapped in parallel by more 
than 50% of their length. All experiments were repeated at least 3 times; statistical significance 
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ARF1, ADP-ribosylation factor 1; BFA, Brefeldin A; BSA, bovine serum albumin; EM, 
electron microscopy; ER, endoplasmic reticulum; ERGIC, endoplasmic reticulum-Golgi 
intermediate compartment; GalNAc-T2, N-acetylgalactosaminyltransferase 2; GFP, enhanced 
green fluorescent protein; GRASP65, Golgi reassembly stacking protein of 65 kDa; HACE1, 
HECT domain and ankyrin repeat-containing E3 ubiquitin protein ligase 1; HECT, Homologous 
to the E6-AP Carboxyl Terminus; IC, interphase cytosol; Man II, -mannosidase II; MC, mitotic 
cytosol; NEM, N-ethylmaleimide; NRK, normal rat kidney cells; NSF, N-ethylmaleimide-
sensitive factor; PBS, phosphate-buffered saline; PDI, protein disulfide isomerase; plk, polo-like 

















Chapter 5 . Identification of GRASP65-interacting proteins in the cytosol that 
facilitate Golgi assembly  
Abstract 
The Golgi peripheral protein GRASP65 was identified as a Golgi stacking factor that links 
adjacent Golgi cisternae by forming mitotically regulated trans-oligomers. Later, GRASP65 was 
also found required for Golgi ribbon connectivity. Biochemical experiments indicate that 
GRASP65 function is regulated by proteins in the cytosol. In this study, we have applied 
biochemical approaches to identify GRASP65-interacting proteins. HeLa cell cytosol was 
subjected to fractionations using standard biochemical methods followed by affinity 
chromatography. Proteins that bind to GRASP65 were identified by mass spectrometry and 
further characterized. Among the identified proteins, clathrin heavy chain, MENA, SHIP2 and 
Dja1 were confirmed for their interaction with GRASP65 and recruitment to the Golgi 
membranes. Depletion of these GRASP65-interacting proteins by small interference RNA 
(siRNA) from HeLa cells resulted in Golgi fragmentation. Interphase cytosol with GRASP65-
interacting proteins depleted or inhibited had a reduced activity to enhance GRASP65 
oligomerization in a GRASP65-coated aggregation assay, and to promote Golgi reformation in 
an in vitro Golgi reassembly assay. Our study has identified potential cytosolic factors that play 






In mammalian cells, the Golgi apparatus displays a unique ribbon-like structure which 
occupies the cell center and locates adjacent to the centrosome. The Golgi consists of dozens of 
stacked Golgi cisternae, which are aligned parallel to each other tightly. Golgi stacks are further 
connected laterally into a ribbon [155]. During cell division, the Golgi apparatus is equally 
partitioned into the two daughter cells through a unique disassembly and reassembly process. At 
the onset of mitosis, the Golgi complex undergoes ribbon unlinking, cisternae unstacking and 
membrane vesiculation, yielding thousands of vesicles that are dispersed throughout the 
cytoplasm and partitioned into the two daughter cells. During telophase and cytokinesis, the 
Golgi is reassembled by vesicle fusion to generate new cisternae, cisternae restacking and ribbon 
linking [4, 5]. During Golgi disassembly and reassembly, one of the Golgi matrix proteins, 
GRASP65 (Golgi ReAssembly Stacking Protein, 65kD), has been demonstrated to play 
significant roles in Golgi cisternal stacking and ribbon linkage [13, 14, 17, 18]. 
  
GRASP65, together with its homolog GRASP55, are the only two proteins that have been 
shown to direct participate in Golgi cisternae stacking [12, 13]. GRASP65 localizes to the cis-
Golgi while GRASP55 localizes to the medial/trans-Golgi [12]. Depletion of either GRASP65 or 
GRASP55 reduced the number of Golgi cisternae in Golgi stacks, possibly due to losing the cis- 
or the medial/trans-Golgi cisternae respectively. Simultaneously depleting both GRASPs led to 
complete disassembly of the Golgi stacks [15-17]. GRASPs from adjacent Golgi cisternae form 
trans-oligomers therefore zip the cisternae into a stack [14, 16, 17]. During mitosis, GRASPs are 
phosphorylated by mitotic kinases. The phosphorylation of GRASPs inhibits their 




dephosphorylated by phosphatases, which allows the reformation of GRASP trans-oligomers and 
restacking of Golgi cisternae [7, 14, 16-18].  
 
GRASP65 and GRASP55 are also involved in Golgi ribbon formation. Depletion of either 
GRASP causes Golgi ribbon break down [49-51]. It has been suggested that GRASPs link Golgi 
stacks into a ribbon through forming trans-oligomers from the rim of neighboring Golgi stacks, 
similarly to their mechanism in cisternae stacking. However, since the gaps between Golgi stacks 
in the ribbon are always larger and relatively more heterogeneous (10s to 100s nm) compared to 
the gaps between Golgi cisternae in the stack (11nm, [156]), it is also possible that GRASPs 
tethers Golgi stacks via the bridging of some GRASP- interacting proteins. For example, golgins 
that mediate membrane tethering by their long coiled-coil rod domain are ideal candidates [55]. 
A good example is GM130, a golgin that interacts with GRASP65 [103]. Depletion of GM130 
from the cells leads to Golgi fragmentation, similarly to the effect of GRASP65 knock down, 
suggesting that GRASP65 may tether Golgi stacks through GM130 [57].    
     
In this study, we have applied biochemical approaches to identify GRASP65-interacting 
proteins by affinity chromatography and mass spectrometry. Among the identified proteins, 
clathrin heavy chain (CHC) [157, 158], mammalian enabled homologue (MENA) [159], SH2-
containing inositol phosphatase 2 (SHIP2, also known as INPPL1, inositol polyphosphate 
phosphatase-like 1) [160, 161] and heat shock protein DnaJA1 (Dja1) [162] were confirmed for 
their interaction with GRASP65 and recruitment to the Golgi membranes. Depletion of these 
GRASP65-interacting proteins by small interference RNA (siRNA) from HeLa cells led to Golgi 




GRASP65-coated bead aggregation assay and facilitate Golgi reassembly in an in vitro Golgi 
reassembly assay. Therefore, our study has identified cytosolic GRASP65-interacting proteins 






Identification of GRASP65-interacting proteins in the cytosol 
In our previous work, Dynal M-500 magnetic beads that were coated with purified 
GRASP65 were used as a model system to mimic the tethering of Golgi membrane mediated by 
GRASP65 oligomerization [14, 17, 18]. When GRASP65 coated beads were incubated with 
either interphase cytosol or buffer containing some BSA, the beads were able to form aggregates, 
suggesting that GRASP65 oligomerization acts to link neighboring surface together. It is worth 
to note, that the aggregation was more dramatic when the beads were incubated with interphase 
cytosol, suggesting that interphase cytosol contains components that facilitate GRASP65 
oligomerization [14]. In this study, we first confirmed this previous finding. Aggregation 
efficiency of GRASP65-coated beads after incubation with interphase cytosol vs. equal 
concentration of BSA was first determined. As shown in Figure 5.1A, purified HeLa cytosol 
significantly enhanced the aggregation efficiency of GRASP65 coated beads (92.7 ± 3.5%) 
compared to buffer containing BSA (34.2 ± 2.8%) (Figure 5.1B), consistent with our previous 
report [14]. To further confirm that interphase cytosol contains GRASP65 oligomerization 
enhancing factors, GRASP65 coupled beads that were dispersed by mitotic kinases treatment 
were incubated with either purified PP2A which dephosphorylates GRASP65 or interphase 
cytosol. When the aggregates of GRASP65 beads were treated with mitotic kinases cdc2 and 
plk1, phosphorylation and de-oligomerization of GRASP65 disassemble the bead aggregates into 
single beads. Dephosphorylation of GRASP65 by subsequent PP2A treatment allowed 
GRASP65 beads to tether as clusters, which, however, were much smaller compared to the ones 




confirmed the existence of interphase cytosolic components that facilitate GRASP65 
oligomerization.  
 
To determine the biochemical property of these factors, we treated the interphase cytosol 
with high salt, heat and protease. All these treatments abolished the activity of interphase cytosol 
to enhance GRASP65-coated beads aggregation, suggesting that the cytosolic factors are proteins 
in nature (Figure 5.S1B). Furthermore, experiments using a variety of nucleotides or their 
analogues showed that these factors require ATP but not ATP hydrolysis for their activity 
(Figure 5.S1C). We then tried to enrich the GRASP65-oligomerization-enhancing factors from 
interphase cytosol by sequential ammonium sulfate precipitation followed with a glycerol 
velocity gradient. Enrichment of these factors was followed by GRASP65 bead aggregation. As 
shown in Figure 5.S2, the factors were enriched in 10-20% and 20-30% ammonium sulfate 
precipitants (Figure 5.S2A). When the 15-30% ammonium sulfate precipitants of cytosol were 
further fractionated by the velocity gradient, the enhancing factors were enriched in the 9
th
 
fraction out of 12 fractions from top to the bottom of the gradient. This result suggested that the 
factors that enhance GRASP65 oligomerization form big protein complexes of approximately 






Figure 5.1. Identification of cytosolic factors that enhance GRASP65 oligomerization.  
(A) GRASP65 pre-coupled Dynal M-500 beads were incubated with either buffer containing BSA or HeLa 
interphase cytosol (IC). After incubation, the beads were placed on glass slides and random fields were 
photographed. A representative image of each condition is shown. Scale bar, 100 µm. Note that interphase cytosol 
greatly enhanced GRASP65 beads to form large aggregates. (B) Quantification of the percentage of GRASP65 
coupled beads in aggregation after incubated with BSA and interphase cytosol. P-value was determined by Student’s 
t-test; ***, p<0.001. (C) Affinity purification of GRAS65-interacting proteins. Interphase cytosol fractionated by 
15-30% ammonium sulfate precipitation was incubated with either BSA or His-GRASP65 coupled beads, the bound 
proteins were analyzed by SDS-PAGE and coomassie blue staining. Arrows indicate the bands that were excised 






 Figure 5.S1. Biochemical properties of the cytosolic factors that enhance GRASP65 oligomerization. 
(A) GRASP65 coupled beads incubated with interphase cytosol (IC), then isolated and treated with kinases 
(IC→kinases), and further treated with either interphase cytosol (IC→kinases→IC) or PP2A (IC→kinases→PP2A) 
(B) GRASP65 coupled beads incubated with interphase cytosol that was treated with indicated conditions. (C) 
GRASP65 coupled beads incubated under indicated conditions, with or without interphase cytosol, plus ATP or 







Figure 5.S2. Enrichment of cytosolic proteins that enhance GRASP65 beads aggregation. 
(A) Proteins from interphase cytosol were fractionated by sequential ammonium sulfate precipitation. Proteins that 
precipitated at indicated ammonium sulfate cut were dissolved and dialyzed into KHM buffer, analyzed by SDS-
PAGE and coomassie blue staining (left panel) and tested for activity in GRASP65 bead aggregation assay (right 
panel). (B) Cytosolic protein that were precipitated at 15-30% ammonium sulfate cut were dissolved and dialyzed 
then further separated by a 15-35% glycerol gradient. The gradient was then fractionated from top to the bottom into 
12 fractions. The proteins in each fraction were analyzed by SDS-PAGE PAGE and coomassie blue staining (left 
panel) and  tested for activity in GRASP65 bead aggregation assay (right panel). 
 
To identify these cytosolic proteins that enhance GRASP65 beads aggregation, proteins 
enriched from HeLa cell cytosol by 15-30% ammonium sulfate cut was subjected to affinity 




collected, dissolved, dialyzed and then incubated with GRASP65 or BSA cross-linked cyanogens 
bromide (CNBr) beads. After extensive washing, the bound proteins were analyzed by SDS-
PAGE and coomassie blue staining. A number of protein bands that specifically bound to 
GRASP65 but not to BSA were excised and analyzed by mass spectrometry (Figure 5.1C).  
 
Table 5.S1. Proteins identified from affinity chromatography of GRASP65 
1 Clathrin heavy chain 190KD a  
2 Matrin-3 93KD f  
3 SHIP2 (INPPL1) 139KD a c 
4 SFPQ (splicing factor, proline and glutamine-rich) 76KD f  
5 RAVER1 70KD f  
6 UBASH3A (ubiquitin-associated and SH3 domain-containing protein A) 76KD e  
7 HERC6 112KD a e 
8 MENA (ENAH, enabled homolog) 89KD d  
9 BAG3 62KD b  
10 ALS2 (Alsin) 88KD b  
11 Hsc70 (HSPA8) 71KD a b 
12 Hsp70-2 (HSPA2) 72KD b  
13 poly(rC) binding protein 40KD f  
14 RING finger protein C14orf4 84KD e  
15 APPBP1 (Amyloid beta precursor protein binding  protein 1) 61KD e  
16 Pyruvate kinase 59KD   
17 DCLK2 (serine/threonine-protein kinase) 85KD   
18 GCC1 (GRIP and coiled-coil domain containing protein, GCC88) 88KD c  
19 EEF1A1 (Elongation factor 1-alpha) 48KD d f 
20 Dja1 (DNAJA1) 46KD a b 
21 ACTB, ACTG 42KD d  
22 CTBP2 (C-terminal binding protein 2) 47KD f  
23 HNRPA (heterogeneous nuclear ribonucleoprotein A) 34KD f  
Categories of identified proteins: (a) clathrin associated; (b) chaperone; (c) membrane trafficking related; (d) actin 





As listed in Table 5.S1, twenty-three proteins were identified, which can be categorized into 
6 groups: 1) clathrin heave chain and its associated proteins, 2) protein chaperones ; 3) 
membrane trafficking related proteins; 4) actin associated proteins; 5) ubiquitin conjugating 
enzymes; and 6) DNA binding proteins. To further select possible candidates, we performed in 
vitro binding assay to test the interaction of each candidate with GRASP65, as well as depleting 
each candidate by RNAi from HeLa cells to examine their effect on the Golgi structure. Those 
candidates that have high affinity with GRASP65 and caused Golgi morphological change upon 
depletion were further characterized (see below and Table 5.S2), including clathrin heavy chain 
(CHC) [157, 158], a J-domain heat shock protein Dja1 [162], actin nucleation promoting factor 
MENA [159], and inositol 5-phoaphatase SHIP2 [160, 161]. 
 
Table 5.S2. Characters of identified GRASP65-interacting candidate proteins 
Protein Name 
Interaction with 
GRASP65 (in vitro) 




Clathrin heavy chain +++++ Golgi fragmentation Lots of 
SHIP2 (INPPL1) ++ Golgi fragmentation some 
HERC6 +++ No effect some 
MENA (ENAH) ++ Golgi fragmentation Lots of 
BAG3 - No effect some 
Hsc70 +/- Golgi fragmentaion little 
Hsp70-2 +/- No effect little 
GCC88 N/A N/A Lots of 
EEF1A1 or 2 +/- Golgi fragmentation little 
DjA1 (DNAJA1) +++++ Golgi fragmentation little 
/-actin +/- Golgi fragmentation Lots of 
 
 




We first confirmed the interactions between the candidates and GRASP65 by affinity 
chromatography. Interphase cytosolic proteins that were enriched by a 15-30% ammonium 
sulfate precipitation were incubated with either BSA or GRASP65 immobilized CNBr beads. 
After washing, the bound proteins were analyzed by western blotting. As shown in Figure 5.2A, 
CHC, Dja1, MENA and SHIP2 all interact with GRASP65 but not BSA. In contrast, Hsc70, 
which was found in the pull-down and identified by mass spec (Figure 5.1C), did not 
demonstrate a strong interaction with GRASP65, suggesting its binding with GRASP65 shown 
in the mass spectrometry result was either trivial or non-specific. 
 
Figure 5.2. GRASP65 interacts with CHC, Dja1, MENA and SHIP2. 
(A) GRASP65 interacts with CHC, Dja1, MENA and SHIP2 in the interphase cytosol. BSA or His-GRASP65 
coupled CNBr beads were incubated with interphase cytosol fractionated by 15-30% ammonium sulfate 
precipitation. After extensive washing, bound proteins were analyzed by SDS-PAGE and probed for indicated 
proteins. (B) Purified full length clathrin or His-Dja1 was incubated with BSA or MBP-GRASP65 coupled CNBr 
beads which were pre-blocked by BSA. Indicated proteins were detected from the bound fraction. 
 
Next we examined whether the interaction between the candidates and GRASP65 is direct 
by using purified recombinant proteins. Instead of proteins that were precipitated from the 
cytosol, purified recombinant CHC or His-tagged Dja1 proteins were tested in GRASP65 affinity 





CHC, Dja1, MENA and SHIP2 are recruited to the Golgi membranes 
Among the four candidates we tested, only CHC is known as a protein locates on the Golgi 
complex. CHC is enriched on the trans-Golgi network (TGN), and is required for TGN to 
endosomal/lysosomal transport which is mediated by clathrin coated vesicles [48]. In 
collaboration with Dr. Frances Brodsky lab and Dr. Bo Huang lab, we also found that CHC 
colocalized with GM130 on the cis-Golgi using STORM microscopy (shown in Chapter 6, 
Figure 6.4). We then examined whether Dja1, MENA and SHIP2 also localize on the Golgi 
complex in HeLa cells. By immunostaining, we found that a fraction of MENA and SHIP2 
colocalized with GRASP65 on the Golgi, while the rest appeared to be cytosolic (Figure 5.3A). 
Exogenously expressed GFP-tagged MENA or SHIP2 also partially localized on the Golgi 
apparatus (Figure 5.3B). However, GFP-Dja1 was not enriched on the Golgi. Due to the lack of 
good antibodies for Dja1, we were unable to achieve a conclusion whether endogenous Dja1 is 
on the Golgi by immunofluorescence microscopy (not shown).  
 
Since cytosolic proteins such as Dja1 may be too abundant in the cytosol to present a clear 
enrichment on the Golgi, we then tested whether Dja1 binds Golgi membranes using an in vitro 
Golgi recruitment assay. Purified rat liver Golgi (RLG) membranes were incubated with 
interphase or mitotic cytosol, or sequentially treated with mitotic cytosol followed by interphase 
cytosol to mimic the change in the cell cycle (Figure 5.3C). The membrane bound proteins were 
analyzed by Western blotting. As a Golgi protein, CHC was found on purified RLG and after 
cytosol incubations. Hsc70 and its co-chaperon Dja1 were not found on the purified RLG, but 




were recruited to the membrane from both interphase and mitotic cytosol. These results indicated 
that GRASP65 binding proteins can be recruited to the Golgi and play a role there.      
 
 
Figure 5.3. CHC, Dja1, MENA and SHIP2 can be recruited to the Golgi membrane. 
(A) Endogenous MENA and SHIP2 partially localize to the Golgi. HeLa cells were immunostained with indicated 
antibodies. Scare bar, 20 m. (B) Exogenous MENA and SHIP2 are concentrated on the Golgi. HeLa cells 
expressing indicated GFP-tagged constructs were fixed and stained with indicated Golgi marker. Scare bar, 20 m. 
(C) Purified rat liver Golgi membranes with no treatment (─), incubated with interphase cytosol (IC), mitotic cytosol 
(MC), or subsequently incubated with mitotic cytosol and then interphase cytosol (MC→IC), were analyzed by 
SDS-PAGE and western blotting for indicated proteins.   
 
CHC, Dja1, MENA and SHIP2 are required for Golgi ribbon integrity 
We then asked whether the four candidates play a role in maintaining Golgi structure in the 
cells. We depleted CHC, Dja1, MENA or SHIP2 from cells by RNA interfernce (RNAi) and 
examined Golgi morphology by immunofluorescence and electron microscopy (EM) (Figure 
5.4). All four proteins were effectively knocked down after 96 hrs siRNA transfection (Figure 
5.4, A-D, L-O). Under fluorescence microscope, depletion of CHC, Dja1, MENA and SHIP2 all 
led to Golgi fragmentation, with GRASP65 (Figure 5.4, A & C) or GM130 (Figure 5.4, B & D) 
as Golgi maker. In control siRNA transfected cells, only 9.0 ± 0.2% of the cells had fragmented 
Golgi. Conversely, in CHC, Dja1, MENA and SHIP2 depleted cells, the percentage of cells with 
fragmented Golgi increased significantly to 68.2 ± 6.0%, 92.3 ± 1.4%, 78.2 ± 1.5% and 72.9 ± 






Figure 5.4. Knock down of CHC, Dja1, MENA or SHIP2 leads to Golgi fragmentation. 
(A-D) HeLa cells transfected with control or indicated siRNA were fixed 96 h after transfection, immunostained by 
indicated antibodies. Note the fragmented Golgi in the knock down cells. Scale bar, 20 m. (E-I) HeLa cells 
transfected with indicated siRNA were fixed and processed for EM. Note that the Golgi stacks in CHC, Dja1, 
MENA and SHIP2 depleted cells were disconnected, shorter in length and more vesiculated. Scale bar, 500 nm.  (J) 
Quantification of percentage of cells with fragmented Golgi among 300 siRNA transfected cells for each set of 
experiments. Statistical significance was assessed by comparison to the negative siRNA transfection. P-value was 
determined by Student’s t-test; ***, p<0.001. (K) Quantification of average length of Golgi stacks in 20 siRNA 
transfected cells. Statistical significance was assessed by comparison to the negative siRNA transfection. P-value 
was determined by Student’s t-test; ***, p<0.001. (L-O) Western blot illustrating that the indicated protein was 
depleted from the cell. Actin or tubulin was used as loading control. 
We then examined Golgi morphology in the knockdown cells more closely by EM. In 




laterally into a ribbon. However, in cells with CHC, Dja1, MENA or SHIP2 depleted, the lateral 
linkage of Golgi ribbon was disrupted, with each Golgi stack shorter in length and decorated 
with many local vesicles (Figure 5.4E-I). Quantification of the EM images showed that the 
average length of each Golgi stack notably reduced from 1.23 ± 0.08 m as in control siRNA 
transfected cells to 0.66 ± 0.04, 0.60 ± 0.04, 0.72 ± 0.05, and 0.59 ± 0.02 m in CHC, Dja1, 
MENA and SHIP2 depleted cells, respectively (Figure 5.4K). These results suggested that these 
GRASP65 binding proteins participate in Golgi structure organization. 
 
CHC, Dja1, MENA and SHIP2 enhance GRASP65 oligomerization 
Since interphase cytosol greatly enhanced GRASP65 oligomerization as shown in the bead 
aggregation assay (Figure 5.1A). We then asked whether the identified cytosolic GRASP65-
interacting proteins contribute to this activity. To test this possibility, CHC or MENA was 
immuno-depleted from interphase cytosol, which resulted in significant reduction of CHC or 
MENA level from the cytosol (Figure 5.5A). The immuno-depleted cytosol was then used to 
incubate GRASP65 coated beads in the bead aggregation assay. Depletion of CHC or MENA 
had notably decreased the activity of interphase cytosol in enhancing GRASP65-coated beads 
aggregation (40.5 ± 2.5% and 33.9 ± 2.4% of the beads in aggregation, respectively) compared to 
control IgG depleted cytosol (84.2 ± 3.9% of the beads in aggregation) (Figure 5.5 B-D, H). Due 
to incomplete immuno-precipitation abilities of the antibodies, SHIP2 or Dja1 in the interphase 
cytosol was immuno-blocked by polyclonal antibodies against them. The pre-treated cytosol was 
then used in the bead aggregation reactions. Inhibition of SHIP2 or Dja1 led to reduced of the 
aggregation efficiency of GRASP65 coated beads (48.6 ± 2.1% and 43.5 ± 2.5%, respectively), 




results confirmed that CHC, Dja1, MENA and SHIP2 enhance GRASP65 bead aggregation, 
possibly by enhancing or stabilizing GRASP65 oligomerization, or cross-link GRASP65 
oligomers.   
 
 
Figure 5.5. CHC, Dja1, MENA and SHIP2 enhance GRASP65 coated beads aggregation. 
(A) Immuno-depletion of CHC or MENA from interphase cytosol. Interphase cytosol immuno-depleted by indicated 
IgG was analyzed by Western blot for indicated proteins. (B-D) GRASP65 coated Dynal M-500 beads were 
incubated with interphase cytosol that was immuno-depleted by indicated antibodies. Note that the GRASP65 coated 
beads incubated with interphase cytosol depleted by control IgG form large aggregates, while the beads incubated 
with CHC or MENA-depleted cytosol only form small aggregates. Scale bar, 100 m. (E-G) GRASP65 coated 
Dynal M-500 beads were incubated with interphase cytosol that was pre-immunoinhibited by indicated antibodies. 
GRASP65 beads incubated with anti-Dja1 or anti-SHIP2 formed less aggregates comparing to the ones incubated 
with interphase cytosol incubated with control IgG. Scale bar, 100 m. (H) Quantification of percentage of beads 
aggregation in B-D. Statistical significance was assessed by comparison to the interphase cytosol depleted by 
control IgG. P-value was determined by Student’s t-test; ***, p<0.001. (I) Quantification of E-G. Statistical 
significance was assessed by comparison to the interphase cytosol pre-incubated with control IgG. P-value was 








Depletion of GRASP65-interacting proteins led to Golgi fragmentation in HeLa cells. It is 
possible that the depletion of these proteins impaired Golgi post-mitotic reassembly, therefore 
left the Golgi remaining fragmented during interphase. To test this possibility, the function of 
GRASP65-interacting proteins in post-mitotic Golgi reassembly was examined in an in vitro 
Golgi disassembly/reassembly assay. Purified Golgi stacks were first disassembled into vesicles 
and short tubular structures (referred to as mitotic Golgi fragments, or MGFs) by treatment with 
mitotic cytosol (Figure 5.6C). These MGFs were re-isolated and further incubated with 
interphase cytosol with GRASP65-interacting proteins immuno-depleted (for CHC or MENA), 
or immuno-inhibited (for Dja1 and SHIP2). When MGFs were incubated with interphase cytosol 
that were depleted or pre-blocked by control IgG, long and stacked Golgi cisternae were 
reassembled (Figure 5.6, D & G). However, immuno-depletion of CHC or MENA, or immuno-
inhibition of Dja1 or SHIP2, significantly reduced Golgi reassembly, leaving a great amount of 
vesicles not fused (Figure 5.6, E-F, H-I). Further quantification results confirmed that the relative 
Golgi membrane fusion efficiency was reduced to 47.1 ± 4.2, 56.4 ± 4.5, 35.1 ± 7.1, 32.7 ± 






Figure 5.6. CHC, Dja1, MENA and SHIP2 are required for post-mitotic Golgi reassembly. 
(A) Quantification of relative Golgi membrane fusion rate in the in vitro reassembly assay using interphase cytosol 
that was immuno-depleted by indicated antibodies. Golgi fusion by the control interphase cytosol was normalized to 
100%. Statistical significance was assessed by the comparison to the interphase cytosol depleted by control IgG. P-
value was determined by Student’s t-test; ***, p<0.001. (B) Quantification of relative Golgi membrane fusion in the 
in vitro reassembly assay using interphase cytosol that was immuno-inhibited by indicated antibodies. Golgi fusion 
by the control was normalized to 100%. Statistical significance was assessed by comparison to the interphase 
cytosol inhibited by control IgG. P-value was determined by Student’s t-test; ***, p<0.001. (C) EM image of mitotic 
Golgi fragments. Purified rat liver Golgi stacks were disassembled by incubation with mitotic cytosol. Note that the 
Golgi stacks were disassembled into vesicles and few single cisternae. Scale bar, 500 nm. (D-F) Mitotic Golgi 
fragments reassembled by interphase immuno-depleted by indicated antibodies. (G-I) Mitotic Golgi fragments 





In this study we have identified and characterized several cytosolic proteins that interact 
with the Golgi matrix protein GRASP65 and function in Golgi structural organization. We 
validated the binding of CHC, Dja1, MENA and SHIP2 with GRASP65, especially confirmed 
the direct interaction of CHC and Dja1 with GRASP65 in the pull-down assay using purified 
proteins. We also showed for the first time that MENA and SHIP2 partially localized on the 
Golgi, while Dja1 together with Hsc70 could be recruited to the Golgi membranes when purified 
Golgi membranes were incubated with interphase cytosol. Depletion of CHC, Dja1, MENA or 
SHIP2 from cells led to Golgi fragmentation, with Golgi mini-stacks unlinked and vesiculated. 
GRASP65-interacting proteins activity was required to enhance GRASP65 bead aggregation, 
suggesting that they may stabilize or cross-link GRASP65 oligomers. Finally, inhibition of CHC, 
Dja1, MENA and SHIP2 reduced post-Golgi reassembly in vitro.  
 
Among the four GRASP65-interacting proteins we characterized, CHC is the only one 
shown by previous studies to be involved in Golgi reassembly during cell division [157, 158]. 
CHC is best characterized as a membrane coat protein that mediates endocytosis and trafficking 
between TGN and endosomes. In addition, clathrin has several other functions in the cell. On 
endosomes, flat clathrin pits mediate sorting of degradative proteins into microdomains of 
endosomes [163, 164]. Clathrin also participates in a complex comprised of the microtubule-
binding proteins TACC3 and ch-TOG [165], which localizes to kinetochore microtubule and 
centrosomes and contributes to their stability during mitosis [165-168]. Furthermore, clathrin is 
also found in lamellipodia, associated with the Scar/Wave complex, and is required for Rac-




GRASP65, facilitates its oligomerization and Golgi ribbon integrity. GRASP65 has been 
suggested playing a role functioning in Golgi ribbon linkage. We speculate that CHC triskelia 
cross-link GRASP65 oligomers on the cis-Golgi, therefore connect Golgi mini-stacks as a 
ribbon, similarly to the function of CHC triskelia in cross-linking TACC3/ch-TOG complex and 
bridging microtubules of the kinetochore fibers [170]. Our finding indentified a new localization 
of clathrin in the cell and provided molecular explanations to the previous finding that clathrin 
functions in Golgi reassembly.  
 
Little is known about Dja1 (DNAJA1), except that it is a co-chaperone of Hsc70 that 
mediates cytosolic protein folding. Due to its molecular weight (40kD), it is also referred to as 
Hsp40 family protein [162]. Several other J-domain proteins are known to function with Hsc70 
and directc clathrin vesicle uncoating. One of the best characterized J-domain proteins is auxilin 
(DNAJC6) [171]. The nerve-specific auxilin and its ubiquitous expressed homologue GAK 
(cyclin G associated kinase, or DNAJC26) function with Hsc70 not only to uncoat clathrin 
coated vesicles but also to regulate the rebinding of clathrin to the membrane [171]. Another J-
domain protein, RME-8 (DNAJC13), regulates clathrin uncoating in endosome-to-Golgi 
retrograde transport which is mediated by the endosomal clathrin and retromer [172]. Similarly 
to these J-domain proteins, it is possible that Dja1 together with Hsc70 regulate CHC function on 
the cis-Golgi. Dja1 directly interacts with GRASP65. Also, it is recruited to the Golgi membrane 
under interphase condition with Hsc70. Therefore, Dja1 and Hsc70 may associate with clathrin 
triskelia through GRASP65 and regulate CHC function in cross-linking GRASP65 and 





MENA is the mammalian homolog of Drosophila enabled (Ena), which belongs to the 
Ena/VASP family that directly enhance actin filament elongation by interacting with the barbed 
end of actin filament and recruiting monomeric actin for polymerization [173]. The function of 
MENA has been determined in filopodia and lamellipodia formation [174-176]. In this study we 
showed that MENA also localizes on the Golgi membranes, facilitates GRASP65 
oligomerization and is required for Golgi ribbon integrity. MENA may regulate Golgi mini-stack 
linkage by promoting the formation of local short actin filaments. So far, how actin regulates 
Golgi structure is still unclear. Treating the cells with either actin filament disrupting drug or 
stabilizing drug both lead to Golgi condensation, however the mechanisms remain unknown 
[78]. There are indications that actin cytoskeleton is required for Golgi integrity. For example, in 
Drosophila S2 cells, actin depolymerization induces the scission of neighboring Golgi stacks at 
late G2 phase, which is mediated by the inactivation of actin nucleation promoting factors 
WAVE/Scar/Abi  [80]. One more indication that actin is required for Golgi integrity came from 
the study of another actin nucleation factor, WHAMM, which is an Arp2/3 activator on the 
Golgi. WHAMM-depletion led to reduced F-actin level in the Golgi region and dispersed Golgi 
mini-stacksg [177]. MENA may be the third actin nucleation promoting factor that regulates 
Golgi ribbon connection. It probably promotes the formation of actin filament that cross-links 
GRASP65 oligomers from the neighboring stacks. 
 
SHIP2 is originally known as a phosphoinositidylinositol 3,4,5 trisphosphate 
(PtdIns(3,4,5)P3) 5-phosphatase which dephosphorylates PI(3,4,5)P3 to generate PI(4,5)P2. Later 
researches indicate that SHIP2 can also use PI(4,5)P2 as a substrate and generate PI(4)P [178]. 




regulates clathrin coated vesicle formation by controlling PI(4,5)P2 level. Other than its kinase 
activity, SHIP2 is also a docking protein for cytoskeletonal proteins, focal adhesion proteins, 
adaptors, scaffold proteins and other phosphatases [161]. For example, SHIP2 binds filamin and 
regulates the formation of submembranous actin filaments [179]. It directly binds and recruits 
RhoA to the cell edges, thus regulates lamellipodia protrusions, as well as cell polarity and 
migration [180]. A similar inositol 5-phosphatase which is better known is OCRL1, whose 
mutation results in Lowe syndrome. OCRL1 catalyzes the formation PI(4)P from PI(4,5)P2 
similar to SHIP2. OCRL1 localizes on plasma membrane, clathrin coated vesicles and especially 
enriched on the Golgi complex. It is incorporated into clathrin coated pits by interacting with 
clathrin and clathrin adaptors, thus regulates clathrin mediated trafficking between endosomes 
and TGN, as well as between endosomes and plasma membrane [181]. It also modulates the 
local actin filament density by controlling PI(4,5)P2 level [182]. Similar to OCRL1, SHIP2 is 
also found recruited onto the Golgi membrane in this study. It is required for Golgi integrity and 
enhances GRASP65 oligomerization. Therefore, we speculate that SHIP2 links Golgi mini-
stacks via GRASP65 oligomers, through either CHC triskelia or actin filaments.  
 
In conclusion, we have identified CHC, Dja1, MENA and SHIP2 that interact with 
GRASP65 and function in Golgi assembly. It is possible that these proteins cross-link GRASP65 
(e.g. through clathrin triskelia or short actin filaments) from the rim of neighboring Golgi stacks 
and link the stacks into a ribbon. The molecular mechanisms underlying the function of each 
protein requires further investigation.   




Materials and Methods 
Reagents, plasmids, antibodies and siRNA 
All reagents were purchased from Sigma-Aldrich, Roche or Calbiochem, unless otherwise 
stated. The following antibodies were used: monoclonal antibodies against GM130 
(Transduction Laboratories), clathrin heavy chain (X22 [183], and TD.1, gifts from Hong Chen, 
OMRF), MENA (gift from Frank Gertler, MIT), Hsc70 (gift from Xunqun Chen, Wayne State 
University), -tubulin (Developmental Studies Hybridoma Bank University of Iowa) and -actin 
(AC-15, Sigma); polyclonal antibodies against human GRASP65 (gift from Joachim Seemann, 
UT Southwestern), Dja1 (gift from Jason C. Young, McGill University) and SHIP2 (gift from 
Stuart J. Decker, University of Michigan).    
 
His-tagged and MBP-tagged GRASP65 were prepared as described previously [14]. cDNA 
constructs used in this study include GFP-tagged CHC (Frances Brodsky, UCSF), GFP-tagged 
SHIP2 (Christina A. Mitchell, Monash University). GFP-tagged MENA cDNA was excised from 
a construct of pMSCV-EGFP-MENA (gift from Frank B. Gertler, MIT) and re-ligated into the 
pcDNA pcDNA™3.1(-)/myc-His vector.  
 
Control siRNA (SilencerÂ® Select Negative Control #1 siRNA) was purchased from 
Applied Biosystem. CHC, Dja1, MENA, and SHIP2 specific siRNAs were synthesized by 
Sigma. The sequences of sense chain were UAAUCCAAUUCGAAGACCAA for CHC17 [184, 
185], GGACAUACAGCUCGUUGAA(TT) for Dja1 [186], 
GCCAUUCCUAAAGGGUUGAAGUACA for MENA [159], and 





Ammonium sulfate precipitation 
Interphase cytosol purified from HeLa S3 cells [8, 133] was first precipitated with indicated 
concentration (percentage saturation) of ammonium sulfate. After centrifugation, the ammonium 
sulfate concentration in the supernant was further increased to another concentration. The 
precipitants were collected by centrifugation, dissolved and dialyzed into KHM buffer (20 mM 
Hepes-KOH, pH 7.0, 0.2 M sucrose, 60 mM KCl, 5 mM Mg(OAc)2, 2 mM ATP, 1 mM GTP, 1 
mM glutathione and protease inhibitors). The dissolved proteins were used for SDS-PAGE and 
in other assays.  
 
Velocity gradient 
Protein samples were loaded onto a 15-35% glycerol gradient, then centrifuged in a VT165 
rotor, at 65 000 rpm for 80 min. After centrifugation, the gradient was fractionated from the top 
to the bottom into 12 fractions. Proteins from each fraction were concentrated for further 
analysis. 
 
Identification of GRASP65-interacting proteins and in vitro binding assay 
Interphase cytosol was diluted and fractionated with 15-30% ammonium sulfate 
precipitation. Proteins in the pellet were dissolved and dialyzed into KHM buffer. Dissolved 
proteins were incubated with BSA or His-GRASP65 pre-coupled Cyanogen bromide-activated 
(CNBr) beads in the presence of an ATP-regenerating system (10 mM creatine phosphate, 1 mM 
ATP, 20 µg/ml creatine kinase and 20 ng/ml cytochalasin B) in KHM buffer at 4ºC overnight. 
The beads were washed extensively. Bound proteins were boiled in SDS buffer followed by 




GRASP65 lane but not in the BSA lane were excised and analyzed by mass spectrometry 
(University of Michigan, Proteomics & Peptide Synthesis Core). 
 
To test whether CHC and Dja1 directly binds GRASP65, purified CHC or His-tagged Dja1 
full length proteins were incubated with BSA or MBP-GRASP65 coupled to CNBr beads (pre-
blocked with BSA) in the presence of an ATP-regenerating system in KHM buffer at 4ºC 
overnight. The beads were washed extensively and then analyzed by SDS-PAGE and 
immunoblotting for CHC and Dja1. 
 
Preparation of recombinant proteins 
His-tagged (in pET30a, Novagen) and MBP-tagged (in pMAL-2CX, NEB) GRASP65 were 
expressed and purified on nickel (Qiagen) or amylase (NEB) agarose as previously described 
[14]. Purified full length CHC was a gift from Dr. Frances Brodsky (UCSF). His-tagged Dja1 
was expressed in BL21(DE3)Gold bacteria and purified on nickel (Qiagen) agarose.  
 
In vitro Golgi recruitment assay 
Golgi membranes were purified from rat liver [16]. Interphase (IC) and mitotic (MC) 
cytosols were prepared from HeLa S3 cells [8, 133]. Purified Golgi membranes (20 g) were 
mixed with 2 mg of interphase in KHM buffer or mitotic cytosol in MEB buffer (50 mM Tris-
HCl, pH 7.4, 0.2 M sucrose, 50 mM KCl, 20 mM -glycerophosphate, 15 mM EGTA, 10 mM 
MgCl2, 2 mM ATP, 1 mM GTP, 1 mM glutathione and protease inhibitors) in a final volume of 
200 µl. After 60 min incubation at 37°C, Golgi membranes were isolated by centrifugation 




6-µl 2 M sucrose cushion and soluble proteins that did not bind to the Golgi membranes were 
removed (same method used in other steps and experiments). For the sequential treatments, 
Golgi membranes were first incubated with mitotic cytosol for 20 min, re-isolated, resuspended 
and mixed with 2 mg of interphase cytosol and incubated at 37°C for 60 min. The membranes 
were reisolated, suspended in KHM buffer and analyzed by SDS-PAGE and Western blotting.  
 
Cell culture and microscopy 
HeLa cells were routinely cultured in DMEM supplemented with 10% donor bovine serum 
(Gibco/Invitrogen), 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 µg/ml). 
For knock down experiments, HeLa cells were transfected using Lipofectamine RNAiMAX 
(Invitrogen) following the manufacturer’s instructions. Assays were performed 96 h after 
transfection unless otherwise stated. For expression of GFP-tagged proteins, HeLa cells were 
transfected with indicated constructs using Lipofectamine 2000 (Invitrogen), fixed and analyzed 
by immunofluorescence microscopy 16h after transfection.  
 
Immunofluorescence microscopy and the electron microscopy are performed as previously 
described [8, 18]. Images were taken with a Zeiss Observer Z1 epifluorescence microscope with 
a 63X oil lens. In interphase cells, fragmented Golgi was defined as disconnected or scattered 
dots. To quantify the percentage of cells with fragmented Golgi, more than 300 cells transfected 






For EM analysis, Golgi stacks were identified using morphological criteria and quantified 
using standard stereological techniques [8, 18]. Golgi stack images were captured at 11,000x 
magnification. Interphase cells were defined as profiles that contained an intact nuclear envelope. 
The longest cisterna was measured as the cisternal length of a Golgi stack using the ruler 
function in Photoshop CS3. At least 20 cells were quantified in each experiment, and the results 
represent at least three independent experiments. Statistical significance was assessed by 
Student’s t-test. 
 
Immuno-depletion and immuno-inhibition of GRASP65-binding proteins in interphase cytosol 
Interphase cytosol prepared from HeLa S3 cells was incubated with unspecific control 
mouse IgG, anti-CHC IgG or anti-MENA IgG and protein-G agarose at 4ºC overnight. The 
beads were pelleted and the supernatant analyzed by immunoblotting for CHC or MENA. Equal 
amount of cytosol immuno-depleted by control IgG, anti-CHC or anti-MENA IgG was used in 
bead aggregation assay and Golgi disassembly and reassembly assay described below. 
 
For immuno-inhibition of the cytosol, interphase cytosol was pre-incubated with unspecific 
control rabbit IgG, anti-SHIP2 or anti-Dja1 IgG at 4ºC for 30 min. Equal amount of cytosol pre-
incubated with control IgG, anti-SHIP2 or anti-Dja1 IgG was used in bead aggregation assay and 
Golgi disassembly and reassembly assay described below. 
 
Bead aggregation assay 
Bead aggregation assay were performed as previously described [8, 14, 18]. For 




reaction were captured by Zeiss Observer Z1 epifluorescence microscope with a 10X lens. 
Images were analyzed with the MATLAB7.4 software to determine the surface area of objects, 
which was used to calculate the number of beads in the clusters. Aggregates were defined as 
those with ≥ 6 beads. Only those beads on the surface were counted; therefore, the number of 
beads in large aggregates was underestimated. Results were expressed as the mean ± SEM from 
one representative experiment out of 3 independent experiments; statistical significance was 
assessed by student’s t-test. 
 
Golgi disassembly and reassembly assay and quantification 
The Golgi disassembly assay was performed as described previously [8]. Briefly, purified 
Golgi membranes (20 g) were mixed with 2 mg of mitotic cytosol, 1 mM GTP and an ATP-
regenerating system in MEB buffer in a final volume of 200 µl. After incubation for 60 min at 
37°C, mitotic Golgi fragments (MGF) were isolated and soluble proteins were removed by 
centrifugation (135,000 g for 30 min in a TLA55 rotor) through a 0.4 M sucrose cushion in 
KHM buffer onto a 6-µl 2 M sucrose cushion. The membranes were resuspended in KHM 
buffer, either fixed or processed for EM [8], or used in reassembly reactions. For Golgi 
reassembly, 20 µg of mitotic Golgi fragments were resuspended in KHM buffer, mixed with 400 
µg interphase cytosol either immuno-depleted or immuno-inhibited as described above in the 
presence of an ATP regeneration system in a final volume of 30 µl in KHM buffer and incubated 
at 37°C for 60 min. The membranes were pelleted by centrifugation, and processed for EM.  
 
To quantify the reassembly of Golgi, EM images of Golgi membranes were captured at 




by the intersection method [8, 128]. All experiments were repeated at least 3 times; statistical 
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Chapter 6 . Clathrin directly binds GRASP65 providing glue for Golgi ribbon 
integrity  
Abstract 
Reassembly of the Golgi following fragmentation in mitosis requires clathrin. Here we 
establish the molecular basis for this phenomenon.  The cis-Golgi stacking factor GRASP65 is 
directly bound by the clathrin N-terminal domain and thereby clathrin crosslinking promotes 
Golgi fragment assembly in vitro. In cells, Golgi ribbon connectivity after disassembly required 
only a truncated, trimeric form of clathrin, demonstrating that clathrin acts in this capacity as 
molecular glue, not by vesicle formation. Golgi clathrin is not preferentially derived from 
spindle-associated clathrin, which is rapidly exchanging, but STORM imaging identified a 
candidate pool of crosslinking clathrin in the cis-Golgi. Acute inactivation of clathrin in 
interphase generated Golgi fragments indicating that Golgi ribbons are labile and clathrin 
maintains their integrity.  Clathrin depletion also eliminated Golgi-derived microtubules leading 
to loss of Golgi polarization. Thus, a non-conventional role for clathrin in promoting GRASP65 
oligomerization, independent of its mitotic or vesicle-forming functions, is required for 







Mammalian cells display a unique Golgi architecture comprising stacks of tightly aligned 
flat cisternal membranes through which secreted proteins traffic for sequential exposure to 
processing enzymes. Golgi stacks are laterally connected into cisternal ribbons. Although the 
exact morphology and mechanisms of traffic through the interphase Golgi are debated [187, 
188], it is clear that lateral Golgi connectivity contributes to optimal cargo processing in the 
secretory pathway [155]. 
 
In the late G2 phase of mitosis the Golgi architecture is disassembled. First, Golgi ribbons 
are dissolved, generating individual stacks that are distributed throughout the cell. In prophase 
and prometaphase, the dispersed Golgi stacks are further disassembled into tubulovesicular 
structures that are equally distributed into the emerging daughter cells [4]. Subsequent Golgi 
reformation is initiated in telophase with fusion of Golgi vesicles to generate small Golgi 
cisternae that stack into ministacks. The ministacks then move towards each other and to the cell 
center to form characteristic Golgi “twins” during cytokinesis, before assuming the final 
interphase morphology comprised of stacked pericentriolar ribbons [189-191]. Golgi formation 
has not been fully characterized but it has been shown to involve membrane fusion machinery 
and microtubules, as well as Golgi tethering and stacking factors including golgins and the 
GRASP proteins. The homologues GRASP55 and GRASP65 mediate Golgi stack and ribbon 
formation via homo-oligomerization, with GRASP65 operating in the cis-Golgi and GRASP55 
in the medial and trans-Golgi cisternae [13, 155, 190]. Importantly, while GRASP65’s ability to 
homo-oligomerize has been demonstrated [16, 192], this activity is promoted by cytosolic 




spindle-associated in mitosis and thereby actively distributed to emerging daughter cells [193]. 
These factors are also yet to be defined, as GRASP proteins are not spindle-associated. 
 
Among the proteins suggested to support Golgi biogenesis is clathrin [190] because clathrin 
depletion by RNAi was shown to prevent Golgi reassembly after fragmentation in mitosis or by 
nocodazole treatment [157, 158]. The major clathrin isoform, consisting of clathrin heavy chain 
CHC17 with bound clathrin light chains (CLCs), is best understood as a membrane coat 
component that mediates vesicle formation at the plasma membrane, endosomes and the TGN. 
The CHC17 subunits trimerize to form a soluble triskelion, the building block of polyhedral 
clathrin coats that capture cargo via adaptor molecules [194, 195]. CHC17 clathrin also 
participates in a complex comprising the microtubule-binding proteins TACC3 and ch-TOG 
[165].  The clathrin-TACC3-ch-TOG complex is mitotic spindle-associated and required for 
kinetochore microtubule stability [166, 167].  The complex also localizes to centrosomes and 
contributes to centrosome integrity during early mitosis [168].  These particular cell cycle 
functions of clathrin are independent of clathrin’s membrane traffic function.  Both spindle-
associated [190] and membrane-bound forms of clathrin have been suggested to support Golgi 
biogenesis [158]. 
 
Here we define the origin and required properties of the clathrin involved in Golgi 
morphogenesis, and its mechanism of action. Using live cell imaging, we observe that spindle-
associated clathrin is rapidly exchanging and is not preferentially recruited to the post-mitotic 
Golgi.  Instead, clathrin laterally interconnects Golgi fragments through a crosslinking, but non-




fragmentation occurs within two hours of acute clathrin inactivation in interphase, suggesting 
Golgi ribbon connections are labile and maintained by clathrin. As a consequence of this role, 
clathrin also regulates Golgi-derived microtubule formation by promoting Golgi integrity. This 
trafficking-independent contribution to Golgi architecture represents an unconventional function 







Loss of Golgi Ribbon Connectivity Upon Clathrin Depletion 
The involvement of clathrin in Golgi reformation after mitosis and drug-induced 
fragmentation has been indicated by RNAi-mediated depletion experiments. In the absence of 
clathrin the Golgi does not reform properly in either circumstance. Rather, the Golgi was 
reported as having a range of altered morphologies in interphase after treatment of NRK cells 
with siRNA targeting clathrin for 72-96 h [157, 158]. Phenotypes included persistent 
fragmentation but also a more tightly clustered appearance. In interphase HeLa cells depleted of 
clathrin for 96 h, we observed a phenotype of persistent Golgi fragmentation without the tight 
clustering, possibly reflecting a cell type difference (Figure 6.S1). To better characterize Golgi 
disruption in HeLa cells following clathrin depletion, we analyzed post-mitotic Golgi 
reformation using an unbiased quantitative approach.  Golgi twin formation during cytokinesis 
was analyzed by measuring the average angle between the GM130 or GS27 signals and the axis 
of division from the center of the cells (Figure 6.1A, B). As expected, Golgi reformation was 
morphologically abnormal in cells depleted of clathrin for 72 h. Golgi twins did not properly 
form and fragments staining for GM130 or GS27 were scattered throughout the cell, as indicated 
by a wider angle of distribution compared to the division access. To further characterize and 
quantify the Golgi fragmentation phenotype, we analyzed cells after clathrin depletion for 96 h 
by electron microscopy.  In CHC17-depleted interphase cells, we observed that the lateral 
linkage of Golgi ribbons was disorganized and the length of cisternae in each Golgi stack 
significantly shorter than in control-treated interphase cells (Figure 6.1C-E). These short Golgi 
stacks were also characterized by more local vesicles.  To assess loss of Golgi connectivity upon 




(GalT) by fluorescence recovery after photobleaching (FRAP) in cells transiently expressing 
GalT-GFP (Figure 6.1F-H).  In cells treated with non-silencing (control) siRNA, photobleached 
GalT-GFP in intact Golgi ribbons was rapidly replaced by diffusion of fluorescent GalT, leading 
to quick recovery in FRAP experiments. In clathrin-depleted cells little fluorescence recovery 
was observed after photobleaching, consistent with nearby stacks not being laterally connected to 
one another, thereby preventing diffusion. Notably, the reduced cisternae length and inhibition of 
intra-Golgi diffusion were observed for interphase Golgi, indicating the connectivity defect from 
clathrin depletion persists following disrupted reassembly. 
 
 
Figure 6.S1: Golgi Dispersion Upon Prolonged Clathrin Depletion. 
(A) HeLa cells treated with control or siRNA targeting CHC17 were lysed and analyzed by immunoblotting for 
CHC17 protein. (B-C) HeLa cells treated with (B) control siRNA or (C) siRNA targeting CHC17 for 96h were 
stained for CHC17 (green), GM130 (red) and DNA (DAPI, blue). Bar, 20μm. (D) The number of cells with 






Figure 6.1: Clathrin Requirement for Normal Golgi Morphology and Stack Connectivity.  
(A) HeLa cells treated with control or siRNA targeting CHC17 were stained for GM130 (green) and DNA (TO-
PRO, magenta). Cells in cytokinesis were identified by Golgi twin formation and the presence of an adjacent 
daughter cell with Golgi twins. A solid crosshair was overlaid to mark the cell center along the vertical axis of 
division from the neighboring cell. The average angle of the Golgi signal, measured from the center relative to the 
division axis, is indicated by dashed line. Bar, 5m. (B) HeLa cells were processed as in (A) and stained for GM130 
(cis-Golgi marker) and GS27 (medial-Golgi marker). Average angles of Golgi staining to division axis are plotted 
for siRNA treatments. (C, D) HeLa cells treated with (C) control or (D) siRNA targeting CHC17 were processed for 
electron microscopy and imaged. The Golgi region was identified by characteristic stacked cisternal membranes 
(arrows) and surrounding vesicles (arrowheads). Note that the Golgi ribbon is disorganized in CHC17 depleted cells, 
the Golgi stacks are shorter and more vesiculated compared to control siRNA treated cells. Bars, 500nm. (E) 
Cisternae length was measured in cells processed as in (C, D) and plotted. (F, G) GalT-GFP was transfected into 
HeLa cells treated with control (F) or siRNA targeting CHC17 (G) and imaged live. Regions marked by red square 
were photobleached and recovery imaged for three minutes. (H) Fluorescent intensity plots of GalT-GFP signal as in 





Rapid Exchange of Spindle Clathrin Without Enrichment in the Golgi 
Golgi reformation after mitosis has been shown to require two activities [193].  We 
addressed whether clathrin accounts for either. The first activity comes from at least one 
unknown Golgi ribbon formation factor that is present in the Golgi/TGN in interphase and on the 
spindle in mitosis. Segregation of this unknown factor with the spindle into the two daughter 
cells is essential for Golgi ribbon formation [193]. Clathrin is a good candidate for this factor 
given its reported presence on the spindle and implication in Golgi reassembly [158, 190] 
(Figure 6.1). To address its potential recruitment from the spindle, we first used super-resolution 
Stochastic Optical Reconstruction Microscopy (STORM) [196] to visualize the forms of clathrin 
in mitotic cells. We observed a large, diffuse cytoplasmic pool of clathrin mixed with vesicle-
like clathrin structures, as well as a strong clathrin signal decorating spindle microtubules (Figure 
6.2A). Consistent with its participation in a microtubule-binding complex [167], the spindle 
clathrin signal cluster was much smaller in size than typical for vesicles (Figure 6.2A). We then 
generated cells expressing Dendra2-CLC to mark spindle clathrin with a photo-convertible 
fluorescent tag and tested whether it is first present on the spindle in mitosis and then in the 
Golgi of daughter cells, fulfilling the criteria of a spindle-associated Golgi formation factor.  The 
fate of the photoconverted mitotic spindle-associated CLC pool (emitting red fluorescence in 
contrast to non-spindle associated CLC emitting green fluorescence signal) was followed in a 
pulse chase experiment (Figure 6.2 B & C). During the observation time, spindle-associated CLC 
mixed with previously non-spindle-associated CLC and after 2 hours complete overlap between 
both pools was seen throughout the cell such that their distribution was indistinguishable. Note 
that CLC is a stable subunit of clathrin [195], so this represents whole clathrin mixing. This 




setup to increase the frequency of detection (at a cost of increased photobleaching) and 
photoconverted CLC on one of the two halves of the mitotic spindle (Figure 6.2 D & E). The 
spindle-associated clathrin dissociated rapidly to the cytosol with similar kinetics to clathrin 
turnover at other cellular locations in interphase (Figure 6.S2). Photoconverted CLC from one 
half of the spindle was recruited to the other half within 90 seconds. This indicates that spindle-
derived clathrin is not distinguishable from total clathrin during late stages of cell division and 
argues against clathrin as a spindle-associated factor required in subsequent Golgi formation. 
 Figure 6.S2: 
Clathrin Turnover at Various Cellular Membranes  
(A-F) Cells were transfected with either GFP-uLCa (A, C, E, upper panels) or GFP-CHC17 (A, C, E, lower panels) 
and subjected to FRAP analysis in the indicated areas. Quantifications of recovered fluorescence are shown in B, D, 
F. The focal plane was set on the plasma membrane near the coverslip (PM bottom, A, B), the media-facing plasma 





Figure 6.2: Rapid Turnover and Uniform Dispersion of Spindle-Associated Clathrin  
(A) Fixed RPE1 cells were stained for microtubules (-tubulin, gray, conventional resolution) and CHC17 (green, 
STORM resolution). Clathrin can be seen on the spindle along microtubules and in vesicle form (boxes 1, 1’ and 
compare image from cell adjacent to mitotic cell, box 2). Bars, 5m, 1m (1), 200nm (1’, 2).  (B, C) A HeLa cell 
expressing Dendra2-uLCa was photoconverted in the indicated area containing the mitotic spindle. Green (non-
converted, upper panel in (B)) and red (converted, lower panel in (B)) Dendra2-uLCa signal was followed 
throughout cytokinesis. Note mixing of spindle associated and cytosolic clathrin pools. Left panel in (C) shows 
overlay of non-converted (green) and converted (red) Dendra2-uLCa. Areas of extensive colocalization are marked 
by arrowheads. Right panel in (C) shows overall colocalization of Dendra2-CLC pools throughout the cell. Bars, 
5m. (D) A HeLa cell expressing Dendra2-uLCa was photoconverted in the area indicated by the solid line 
containing one mitotic spindle. Green (non-converted, upper panel) and red (converted, middle panel) signals were 
collected at high frequency for 2 minutes. Colocalizing green and red signal is indicated in the lower panel. Note 
rapid mixing of photoconverted with non-converted protein pools with proteins from one spindle concentrating on 
the other indicating rapid exchange. Bar, 5m. (E) Plots of experiments as in (D). Non-converted, green signal from 
converted spindle (solid green line) and non-converted spindle (dashed green line) was normalized to prebleach 
levels (T = 0sec.). Converted red signal from converted spindle (solid red line) and non-converted spindle (dashed 
red line) was normalized to postbleach levels indicated by black dashed line 8 sec. into the measurements. 






Clathrin Requirement for Interphase Golgi Connectivity 
The RNAi experiments implicating clathrin in Golgi reformation require depletion over the 
course of at least 2 cell cycles.  During this period continuous loss of clathrin could compound 
membrane traffic defects that indirectly affect Golgi reassembly. To investigate a direct 
involvement of clathrin in post-mitotic Golgi reassembly, we tested its function in an in vitro 
Golgi reassembly assay that measures the regrowth of Golgi cisternae from fragments produced 
by mitotic disassembly [8] (Figure 6.3A-D). When mixed with interphase cytosol depleted by 
non-specific control IgG, Golgi membranes readily reassembled. In contrast cytosol depleted by 
clathrin-specific IgG was significantly reduced in its ability to support Golgi membrane 
reassembly. Efficient clathrin depletion from interphase cytosol was confirmed by 
immunoblotting (Figure 6.S3). We also assessed whether interphase Golgi structure in cells was 
affected after acute clathrin inactivation, which can be achieved within 2 hours. This was 
possible using a cell line expressing CLC subunits tagged with a SNAP sequence that can be 
chemically crosslinked by the membrane-permeable compound BG-GLA-BG [168].  Rapid 
clathrin inactivation caused Golgi ribbon disintegration, similar to the defect in Golgi appearance 
observed in cells depleted of clathrin by RNAi (Figure 6.3E, F compared to Figure 6.S1C).  
Additionally, intra-Golgi diffusion, measured by recovery of photobleached GalT-GFP, was 
impaired after acute clathrin inactivation (Figure 6.3G, H). Thus, clathrin’s role in Golgi 
assembly is not confined to cell cycle recovery, but clathrin also contributes to maintenance of 





Figure 6.3: Golgi Ribbon Formation By Clathrin  
(A-D) Purified rat liver Golgi membranes (see methods) were disassembled by treatment with mitotic cytosol (A), 
then isolated and further incubated with interphase cytosol depleted by (B) non-specific control IgG or (C) anti-
CHC17 IgG. Membranes were processed for electron microscopy and imaged. Relative membrane fusion was 
calculated and plotted in (D). Note strong cisternae formation (arrows) in (B) in comparison to remaining vesicles 
(arrowheads) in (C). (E, F) HeLa cells stably expressing SNAP-uLCa were rapidly inactivated for clathrin function 
using a chemical dimerizer (BG-GLA-BG, F) or mock-treated (DMSO, E) 2 hours after inactivation cells were 
processed for immunofluorescence using anti-GM130 and imaged. Bars, 5m. (G) HeLa cells stably expressing 
SNAP-uLCa were transfected with GalT-GFP and clathrin was rapidly inactivated using a chemical dimerizer (BG-
GLA-BG) or mock-treated. 2 hours after inactivation cells were subjected to FRAP assay. Bar, 5m. (H) 








Figure 6.S3: Efficient Removal of CHC17 from Cytosol by Immunodepletion  
Cytosol harvested from cells in interphase was exposed to beads with either control IgG or anti-CHC17 antibody.  
The exposed cytosol (A) and bead-bound protein (B) were analyzed by immunoblotting for the presence of CHC17 
to confirm depletion from cytosol. 
 
Clathrin as Glue for GRASP65-Mediated Golgi Ribbon Formation 
It has long been established that clathrin is not involved in trafficking cargo within the 
Golgi [197], raising the question of how clathrin exerts its function on Golgi ribbon formation. In 
an effort to visualize clathrin at the Golgi we disassembled the Golgi using nocodazole and 
washed out the drug for 5 min to produce cis-to-trans ministacks. This allowed for detailed 
analysis of Golgi clathrin using STORM (Figure 6.4A). Opposite to the clathrin-rich TGN side 
of the ministacks (arrows in Figure 6.4A) we observed linear clathrin labeling immediately 
adjacent to the cis-Golgi marker GM130 (arrowheads in Figure 6.4A). This resembles a minor 
site of Golgi clathrin localization previously observed in this area using immuno-electron 
microscopy [198].  
 
Cis-Golgi ribbon formation involves the protein GRASP65 [13] and GRASP65 depletion 
leads to cis-, medial and trans-Golgi ribbon disintegration comparable to that seen upon clathrin 
depletion [15, 17, 199]. Therefore we addressed whether there might be a connection between 
GRASP65 and clathrin by testing for their interaction.  First, recombinantly-expressed 
GRASP65 immobilized on beads was exposed to cytosolic proteins prepared from interphase or 




captured by GRASP65 beads. Interestingly, recombinantly-expressed GRASP55, the GRASP65 
homologue, did not bind clathrin. To establish whether the GRASP65-clathrin binding is direct, 
we tested recombinant clathrin and clathrin fragments for their ability to bind to immobilized 
GRASP65. Full-length clathrin (aa1-1675), as well as fragments containing aa1-1074 and aa1-
545, bound to GRASP65 (Figure 6.4C). In contrast fragments comprising distal (aa 565-1074) 
and proximal leg (1074-1521) segments or the Hub fragment (aa 1074-1675) did not show 
specific interaction with GRASP65 compared to BSA immobilized on beads (Figure 6.4D). This 
data establishes that clathrin directly binds to GRASP65 specifically via the N-terminal domain 
(aa 1-545). Since clathrin is not needed for vesicular Golgi transport, we addressed whether 
clathrin might function in a complex with GRASP65 independent of its transport activity. To this 
end, we tested whether loss of Golgi connectivity in clathrin-depleted cells could be rescued 
using a mutant clathrin that functions at the spindle, but does not perform in membrane traffic 
pathways (CHC17-stunted; aa1-544, 1431-1675) [200]. This protein is trimerized and has the 
clathrin terminal domain but is missing most of the triskelion leg. Golgi connectivity was 
assessed by FRAP analysis of transiently expressed GalT in cells depleted of clathrin expressing 
RNAi-resistant full-length CHC17 or CHC17-stunted fused to Apple fluorescent protein (Figure 
6.4E,F). Full length CHC17 rescued Golgi-connectivity in the absence of endogenous CHC17, 
while empty vector alone (Apple) did not. Notably, CHC17-stunted was able to largely restore 
Golgi ribbon formation when expressed in a clathrin-depleted background. This indicates that 
trimerized soluble clathrin is sufficient to restore Golgi integrity, independent of clathrin’s ability 





Figure 6.4: Direct binding of the N-terminal Domain of Clathrin to GRASP65 and Promotion of Golgi 
Connectivity by Crosslinking.  
(A) RPE1 cells, treated with nocodazole for 2 hours and recovered for 5 min, were fixed and stained for CHC17 
(red, STORM) and GM130 (green, STORM). Reforming ministacks show cisternal architecture including GM130 
on cis-cisternae and a large pool of clathrin at the TGN (arrows). A small clathrin pool is also associated with cis-
cisternae (arrowheads). Bars, 3m, 1m (box).  (B) Beads coated with BSA or purified GRASP65 and GRASP55 
were incubated with proteins enriched by ammonium sulfate cut (15-30%) from interphase or mitotic cytosol, 
washed and analyzed by western blotting for CHC17 binding. Molecular mass indicated in kilodaltons (kDa). (C, D) 
Beads coated with BSA or recombinant GRASP65 were incubated with recombinant clathrin fragments (amino acid 
(aa) residues indicated). Molecular mass indicated in kilodaltons (kDa). (C) GRASP65-binding clathrin fragments 
including full-length protein (1-1675) and the N-terminal domain (1-545).  (D) Non-binding clathrin fragments. (E, 
F) GalT-GFP and siRNA targeting CHC17 along with Apple empty vector (upper panel), Apple-CHC17-full-length 
(FL, siRNA-resistant, middle panel) or Apple-CHC17-stunted (ST, 1-544,1431-1675; siRNA-resistant, lower panel) 
were transfected into RPE1 and imaged live. Regions marked by red square were photobleached and recovery was 
imaged for three minutes. Pre-bleach images show overlay of GalT-GFP and Apple constructs to demonstrate 
localizations. Subsequent images are GalT-GFP signal only to visualize fluorescence recovery. Bar, 5m. (F) 






GRASP65 contributes to Golgi stack and ribbon formation by homo-oligomerization [14, 
199]. GRASP65 homo-oligomerization can be mimicked in vitro by aggregation of GRASP65-
coated beads and is greatly enhanced in the presence of cytosol (Figure 6.5A), as previously 
shown [14]. When clathrin was depleted from cytosol using specific IgG less aggregation was 
observed than mediated by cytosol exposed to control IgG (Figure 6.5A-C), indicating that 
clathrin promotes GRASP65-mediated crosslinking of beads. To determine whether clathrin is 
sufficient to enhance GRASP65 oligomerization, we incubated GRASP65-coated beads with 
recombinantly-expressed full-length clathrin as well as the trimerized Hub fragment (1074-1675) 
missing the N-terminal domain (Figure 6.5D-G). Full-length clathrin but not Hub promoted bead 
aggregation. This confirms that clathrin promotes clustering of GRASP65-associated structures 
and, together with the cell-based rescue experiments (Figure 6.4E), indicates that clathrin acts as 
molecular glue for GRASP65-decorated Golgi fragments. 
 
Figure 6.5: Homotypic GRASP65 Oligomerization Enhanced by Clathrin  
(A-C) GRASP65-coated beads were incubated with interphase cytosol depleted by (A) non-specific control IgG or 
(B) anti-CHC17 IgG. Beads were imaged by light microscopy and aggregated beads were scored and plotted as a 




recombinant full-length CHC17 (1-1675) (E) or a CHC17 fragment lacking the GRASP65-binding terminal domain 
(F) and imaged and quantified (G) as in (A-C). Bars, 50m. Significance was assessed using Student’s t-test. 
 
Clathrin-dependent Ribbon Formation Needed for Golgi-derived Microtubules and 
Polarization 
The data presented here indicate that clathrin maintains Golgi ribbon integrity through 
binding and crosslinking GRASP65-decorated cis-Golgi fragments.  Our analysis of spindle-
associated clathrin however, suggests that clathrin is not the spindle-derived Golgi formation 
factor defined by the studies of Wei and Seamann, which also define microtubules as a second 
factor needed for Golgi formation [193].  Because clathrin participates in a microtubule-
interacting complex during mitosis [165], we addressed the possibility that clathrin might also 
influence Golgi formation through an effect on microtubules. To test for microtubule function in 
clathrin-depleted cells, we first disrupted microtubules by nocodazole treatment of clathrin-
depleted or non-silenced cells expressing GalT-GFP. As previously reported, nocodazole 
treatment caused fragmentation of the Golgi in both [157].  We then followed Golgi reformation 
by live imaging after drug washout (Figure 6.6A, B). Both control and clathrin-depleted cells 
clustered their Golgi fragments, although clathrin-depleted cells showed slightly delayed and 
incomplete clustering (arrows in Figure 6.6A, B). In clathrin-depleted cells, individual Golgi 
fragments frequently escaped the bulk of Golgi membranes only to rejoin the remaining Golgi 
fragments shortly after (see arrowheads 1 and 2 in Figure 6.4B and high resolution image series). 
This suggests that some functional microtubules were still present after clathrin depletion and 
explains the static phenotypes observed in interphase cells after clathrin depletion, which showed 
varying degrees of Golgi fragment clustering [157] (Figure 6.1), compared to no fragment 





Figure 6.6: Loss of Golgi-derived Microtubules and Centrosomal Concentration of Golgi Fragments Upon 
Clathrin Depletion.  
(A, B) RPE1 cells transfected with GalT-GFP and (A) control or (B) siRNA targeting CHC17 were treated with 
nocodazole for 2 hours and imaged for 2 hours after nocodazole washout. Note slower recovery of Golgi 
morphology in clathrin-depleted cells as well as Golgi fragments (marked by arrows) not joining the main Golgi. 
Also, Golgi fragments frequently escaped the bulk of Golgi signal but were rapidly recaptured (see arrowheads 1, 2 
and corresponding high resolution series). Bars, 20m. (C, D) Fixed RPE1 cells treated with (C) control or (D) 




(pericentrin, blue). Pericentrin-labeled centrosomes are indicated by asterisks in the GM130, -tubulin and merged 
images. Boxes described in F. Bars, 20m. (E) RPE1 cells, treated with nocodazole for 2 hours and recovered for 5 
min, were fixed and stained for microtubules (-tubulin, green, STORM), CHC17 (red, STORM) and the Golgi 
(GM130, blue, conventional). Three examples are shown. Low-magnification field of (1) is shown left and blow-up 
of box shown right (1’). Bars, 2m. (F) Boxed areas of (C) and (D) were overlaid with crosshairs centered on the 
centrosome and the image was rotated to maximize the polarity of the GM130 signal relative to the crosshairs, then 
the fluorescence above the centrosome center was quantified. (G) Golgi polarization and position relative to 
centrosomes was measured in cells as in (C, D and F). Percentages of Golgi polarization in individual cells (percent 
of total Golgi signal offset from centrosome) and average distances of Golgi fragments from the centrosome are 
plotted. Significance was assessed using Student’s t-test. 
 
There are two subpopulations of microtubules that have been implicated in Golgi 
reformation, Golgi-derived and centrosome-derived [66, 70].  Centrosomal microtubules are 
needed for clustering and Golgi-derived microtubules are needed for ribbon formation [70].  The 
phenotype of our live cell images indicates centrosomal microtubules were still functional since 
fragments were able to cluster.  However, Golgi-derived microtubules were apparently impaired, 
since ribbons did not reform and Golgi fragments persisted. Preferential loss of Golgi-derived 
microtubules from clathrin-depleted cells was confirmed by labeling microtubules. Compared to 
cells treated with non-silencing siRNA, which displayed a network of microtubules overlaying 
the Golgi ribbons stained with GM130, clathrin-depleted cells lacked microtubules overlaying 
clusters of GM130-labeled fragments. Microtubules emanating from the pericentrin-labeled 
centrosome were still observed in cells treated with either non-silencing or clathrin-targeting 
siRNA (Figure 6.6C, D).  To determine whether a stabilizing association between clathrin and 
Golgi-derived microtubules might explain their loss upon clathrin depletion, we used STORM 
microscopy. Interphase cells were treated with nocodazole followed by washout of the drug and 
5 minutes recovery time to allow for microtubule formation. Costaining for clathrin and 
microtubules in the vicinity of Golgi fragments (labeled for GM130) that were distant from the 
centrosome did not reveal any colocalization between clathrin and newly emerging Golgi 




observed by STORM for spindle clathrin (Figure 6.2).  In clathrin-depleted cells, turnover of 
remaining cellular microtubules, as measured by FRAP, was only slightly delayed compared to 
turnover of non-Golgi-associated microtubules in cell treated with non-silencing siRNA (Figure 
6.S4A-E). These observations are consistent with biochemical evidence that clathrin participates 
in a microtubule-stabilizing complex only during mitosis [165].   
 
Figure 6.S4: -Tubulin Turnover at the Mitotic Spindle and the Golgi  
(A-D): HeLa cells stably expressing -tubulin-GFP were treated with either control siRNA or CHC17-specific 
siRNA, as indicated, and imaged in a live microscopy setup. Regions representing the mitotic spindle (A) or the 
Golgi (C) marked by red squares were photobleached with a short, high intensity laser pulse and imaged for three 
minutes. (B, D) Fluorescent intensity plots of -tubulin-GFP signal from (A) and (C) are plotted. (E) HeLa cells 
stably expressing -tubulin-GFP were photobleached in areas marked by the red square corresponding to the 
midbody and fluorescence recovery recorded.  Note the complete absence of microtubule nucleation in the midbody, 
contrasting with spindle- and Golgi-associated microtubules. Bars, 5m. 
 
To further characterize the impaired microtubule function in cells lacking clathrin, we 
analyzed the position of clustered Golgi fragments relative to the centrosome. A normal Golgi is 
always polarized to the non-nuclear side of the centrosome and is offset from the centrosome. 
The centrosome in clathrin-depleted and control cells was labeled with pericentrin and the 




the centrosome (Figure 6.6F, G). We observed a loss of Golgi polarization (percent of GM130 
signal offset from the centrosome) and decreased distance of Golgi fragments to the centrosome 
in cells depleted of clathrin when compared to control-treated cells. Closer apposition to the 
centrosome is consistent with a reduction in space constraints upon loss of Golgi connectivity, 
possibly accounting for the “tight Golgi” phenotype produced by clathrin depletion described by 
Radelescu et al (2007). Loss of Golgi polarization is consistent with loss of Golgi-derived 
microtubules. We conclude that these phenotypes following clathrin depletion result from a 
failure to form Golgi-derived microtubules due to persistence of Golgi fragmentation in 






In this study we describe an unexpected role for clathrin as a Golgi ribbon formation factor. 
This function is independent from clathrin-mediated vesicle formation. We demonstrate that the 
N-terminal domain of clathrin directly binds the Golgi-stacking factor GRASP65 and that this 
crosslinking activity is needed for reformation of Golgi ribbons from ministacks generated 
during mitosis or by nocodazole treatment, in vitro and in situ.  Furthermore, upon acute 
inactivation of clathrin in interphase, Golgi ribbon continuity is lost, indicating a role for clathrin 
in maintaining the lateral integrity of Golgi ribbons, which apparently undergo continuous 
dissociation and reassociation. We also show that spindle-associated clathrin is rapidly 
exchanging and does not preferentially associate with the Golgi as a proposed spindle-associated 
Golgi formation factor [158, 190, 193].  By STORM imaging we observe a pool of clathrin 
adjacent to the cis-Golgi where GRASP65 operates, consistent with the biochemical function we 
define.  Lastly, we observe loss of Golgi-derived microtubules upon clathrin depletion, mapping 
clathrin-mediated ribbon formation upstream of nucleation of these important microtubules and 
demonstrating their specific role in Golgi polarization.  Together these observations resolve 
several outstanding issues regarding the molecular mechanism of Golgi formation.  First, the 
debated functions of GRASP65 in stack formation and in ribbon formation can be segregated, 
with the latter being dependent on crosslinking by clathrin. Second, the role and source of 
clathrin in promoting and maintaining Golgi integrity are defined, and ribbon formation is shown 
to be a dynamic process with implications for intra-Golgi cargo transport.  Third, the need for 
ribbon integrity to generate the Golgi-derived microtubules required for polarization is 





 The integrity of the mammalian Golgi apparatus depends on two membrane apposition 
processes. One results in formation of unfused, but organized membrane stacks segregating cis, 
medial and trans processing enzymes. The second involves the formation of lateral contacts 
between the stacks and their fusion into ribbons.  GRASP65 is localized to the cis-Golgi and its 
homologue, GRASP55 is localized to the medial and trans-Golgi regions.  Both GRASP proteins 
are required for stacking and lateral integrity [13, 16, 85, 155]. To facilitate stacking, GRASP65 
initially homo-dimerizes via its membrane-proximal domain and then forms higher order 
oligomers between stacks.  We propose that clathrin is not necessary for this stacking action but 
that clathrin-mediated crosslinking at the edges of ministacks enhances lateral interaction to 
appose membranes for subsequent fusion into ribbons.  This clathrin-mediated enhancement 
could be dependent or independent of higher order GRASP65 homo-oligomerization.  Assays 
defining the need for GRASP65 in ribbon formation have been performed either in the presence 
of cytosol or in a cellular context [16, 192].  Here we show that clathrin is a necessary and 
sufficient factor from cytosol needed for GRASP65 to perform this function. GRASP65 also 
interacts in a complex with the tethering factor GM130 [192, 199] and this interaction is also 
needed for ribbon formation. Consistent with models proposed by others [155, 192] GM130, 
through interactions with the golgin family members p115 and giantin acting as tethering factors, 
is likely to mediate long range capture vesicles for integration into GRASP65-coated cisternae 
and ministacks [4].  We propose that when the latter are sufficiently close, trimeric clathrin 
stabilizes cis-cisternal juxtaposition by crosslinking GRASP65 so that the cis-face of adjacent 
ministacks are close enough to fuse into ribbons, probably requiring additional fusion mediators 
(see model in Figure 6.7).  Another feature of ribbon formation that emerges from our study is 




serves as ribbon glue that could potentially regulate lateral cisternal fusion.  One of the proposed 
mechanisms for cargo transport through the Golgi (cisternal progenitor model) suggests that 
ribbons potentially form between two different types of cisternae, thereby changing cargo 
environment and effectively moving it forward [201], a cross between cisternal maturation [202, 
203] and instant access to all processing enzymes [188].  Glueing and unglueing of labile lateral 
connections by clathrin is consistent with all three proposed mechanisms of intra-Golgi transport.  
Although GRASP55 does not bind clathrin, liberation of GRASP65-cisterna from a clathrin-
glued ribbon could free up a cis-cisterna to form a ribbon with a medial cisterna via other 
crosslinkers, of which there are many in the Golgi.   
 
We observe that disruption of cis-Golgi ribbons by loss of clathrin also disrupts trans-Golgi 
ribbons, as demonstrated by loss of GalT mobility. Thus the glueing function of clathrin on the 
cis-side of the Golgi must lay the foundation for ribbon formation throughout the stack by 
maintaining the juxtaposition of ministacks.  We further observe that Golgi-derived microtubules 
do not form when the Golgi is disrupted by clathrin depletion.  However, clathrin does not 
decorate Golgi-derived microtubules, as we observed for spindle microtubules in STORM.  The 
latter interaction is a function of clathrin’s mitotically regulated participation in a complex with 
the microtubule-binding proteins TACC3 and ch-TOG [165].  Thus, a role in interphase 
microtubule stability would not be expected, consistent with our findings.   Therefore, clathrin’s 
role in lateral Golgi integrity cannot be ascribed to a loss of Golgi-derived microtubule stability. 
The converse seems to be the case and we propose that Golgi-derived microtubules cannot form 
if Golgi architecture is disrupted by loss of clathrin function at the cis-Golgi. We suggest that 




organized Golgi structure for microtubule nucleation (see model in Figure 6.7). Though we 
cannot rule out that clathrin plays an additional role in membrane traffic pathways that contribute 
to nucleation of Golgi-derived microtubules, disruption of clathrin-mediated Golgi traffic by 
knockout of the 1A subunit of the AP1 adaptor does not affect Golgi architecture [204]. 
Notably our data further establish a role for Golgi-derived microtubules in Golgi polarization and 
demonstrate that centrosomal microtubules are not sufficient, in agreement with the work of 
Kaverina and colleagues [70]. Loss of Golgi polarization upon clathrin depletion likely 






Figure 6.7: Model for role of the clathrin-GRASP65 interaction in Golgi formation 
Steps 1-4:  GRASP65 forms dimers which homo-oligomerize and stabilize cis-medial stacking while GRASP55 dimer homo-oligomerization stabilizes medial 
and trans-stacking to form ministacks. Centrosome-derived microtubules contribute to Golgi fragment and ministack clustering.  Steps 5 and 6: Clathrin triskelia 
glue GRASP65 into a meshwork that facilitates and maintains transient cis-Golgi ribbon formation. Steps 7-9: The foundation of cis-Golgi ribbon formation 
promotes Golgi-derived microtubule formation and ultimately leads to medial and trans-Golgi ribbon formation. GM130 interaction with GRASP65 and golgins 
captures pre-Golgi fragments to support fusion of cis-Golgi membranes. In their conventional function, polymerized clathrin triskelia form lattices to coat 
transport vesicles and tubules for membrane traffic at the trans-Golgi network. Golgi stack and ribbon formation occurs in a matrix of tethering golgins that 






Clathrin’s function in Golgi ribbon formation can be reconstituted with a trimeric version of 
clathrin with short legs that is non-functional for vesicle formation.  While exploiting clathrin’s 
three-fold symmetry, this glueing activity represents a significant expansion of clathrin’s 
functionality beyond membrane coating and its participation in a mitotic complex with TACC3 
and ch-TOG.  In the latter function, clathrin crosslinking stabilizes spindle microtubules and 
centrosomes [168, 206], but in the case of crosslinking GRASP65, clathrin contributes to the 
formation of Golgi ribbons, as well as stabilizing them.  Similarly to the clathrin-TACC3-ch-
TOG complex, clathrin’s interaction with GRASP65 might be regulated to coordinate with the 
cell cycle.  Here we show that GRASP65 binds clathrin from protein fractions prepared from 
either interphase or mitotic cytosol and that clathrin from interphase cytosol can crosslink 
mitotically generated Golgi ministacks in vitro.  However, both of these assays could bypass 
modifications that regulate clathrin function at the cis-Golgi in situ.   
 
 All of clathrin’s activities – membrane coating, spindle microtubule and centrosome 
stabilization, as well as Golgi glueing described here – depend on the special three-legged 
structure of the clathrin triskelion. The most evolutionarily conserved clathrin function as a 
membrane coat makes use of clathrin’s ability to self-assemble into a lattice and this function is 
conserved in all eukaryotes in which clathrin has been characterized [195]. Golgi ribbons are 
unique to vertebrates, perhaps reflecting the need for a more efficient secretory pathway in 
complex organisms. Likewise, spindle clathrin is not a feature of all eukaryotes [165]. Notably, 
clathrin’s functions in microtubule stabilization and facilitating Golgi ribbon formation only 
require trimerization of clathrin’s versatile protein-interacting N-terminal domain [207] and 




clathrin functions seem to derive from selection of convenient terminal domain variants that 
confer a moonlighting function on the clathrin triskelion.  
 
In conclusion, this study defines a function for clathrin in Golgi ribbon formation by 
directly binding GRASP65 and thereby glueing and facilitating lateral fusion of Golgi 
membranes.  This represents a previously un-described moonlighting function of clathrin in 
Golgi integrity, which is required for formation of Golgi-derived microtubules and consequent 





Materials and Methods 
Plasmids, antibodies and siRNA 
His-tagged CHC17 fragments (aa1-1074 in pET23d, aa1074-1521 in pET15b, aa1-545, 
564-1074, and 1074-1675 in pET21a) as well as GFP-uLCa, GFP-CHC17, Dendra2-uLCa, 
SNAP-uLCa, Apple-CHC17 and Apple-CHC17-stunted (1-544, 1431-1675) were cloned using 
standard methods and some previously described [208, 209]. The CHC17 full-length cDNA was 
cloned into the baculovirus transfer vector pAcSG2 (BD Biosciences) and expressed in Hi5 cells 
with the baculovirus expression system (Expression Systems). 
 
Antibodies used were monoclonal anti-CHC17 X22 [183], monoclonal anti-GM130 (BD 
Biosciences), rabbit polyclonal anti-GM130 (Santa Cruz), rabbit polyclonal anti-GS27 (gift from 
Regis Kelly, UCSF)), goat polyclonal anti-pericentrin (Santa Cruz), anti--tubulin (Sigma), anti-
-tubulin (Cytoskeleton). 
 
Control and CHC17 specific siRNAs were synthesized by QIAGEN. DNA sequences 
targeted were AATTCTCCGAACGTGTCACGT for non-targeting control and 
AAGCAATGAGCTGTTTGAAGA for CHC17 [210-212]. 
 
Cell culture 
HeLa and RPE1 cells were grown in DMEM supplemented with 10% FBS, 50U/ml 
penicillin and 50 mg/ml streptomycin. HeLa cells stably expressing Dendra2-uLCa and SNAP-




Cells were transfected with 5 nM siRNA using HiPerfect (Qiagen) and expression plasmids 
using Lipofectamine 2000 (Invitrogen) according to manufacturer’s instructions. Cells were 
treated with siRNA for 72 hours with expression plasmids transfection after 48 hours.  
 
Preparation of recombinant proteins 
His-tagged CHC17 fragments were expressed in BL21-CodonPlus(DE3)RILP bacteria and 
purified on nickel beads (Qiagen). His-tagged (in pET30a from Novagen) and MBP-tagged (in 
pMAL-2CX from NEB) GRASP65 were expressed in BL21(DE3)Gold bacteria and purified on 
amylase (NEB) or nickel (Qiagen) agarose  [14]. Purification of CHC17 expressed in Hi5 cells 
was by self-assembly from cell lysate based on a published protocol [213]. 
 
CHC17 depletion from cytosol 
Interphase cytosol prepared from HeLa cells [8, 133] was incubated with non-specific 
control IgG or anti-CHC17 IgG (X22) and protein-G agarose beads at 4ºC overnight. The beads 
were pelleted and supernatant analyzed by immunoblotting for CHC17. Equal amount of cytosol 
immunodepleted by control IgG or anti-CHC17 IgG was used in the bead aggregation assay and 
Golgi disassembly and reassembly assay described below. 
 
In vitro binding assays 
To test for CHC17 - GRASP65 interaction, proteins were concentrated from interphase or 
mitotic cytosol by a sequential 15-30% ammonium sulfate precipitation. Precipitated proteins 
were dissolved and dialyzed into KHM buffer (20 mM Hepes-KOH, pH 7.0, 0.2 M sucrose, 60 




for interphase cytosol) or MEB buffer (50 mM Tris-HCl, pH 7.4, 0.2 M sucrose, 50 mM KCl, 20 
mM -glycerophosphate, 15 mM EGTA, 10 mM MgCl2, 2 mM ATP, 1 mM GTP, 1 mM 
glutathione and protease inhibitors, for mitotic cytosol), then incubated with BSA or His-
GRASP65 pre-coupled cyanogen bromide-activated beads (CNBr agarose, Sigma-Aldrich) in the 
presence of an ATP-regenerating system (10 mM creatine phosphate, 1 mM ATP, 20 µg/ml 
creatine kinase and 20 ng/ml cytochalasin B) at 4ºC overnight. After washing, bound proteins 
were analyzed by immunoblotting. 
 
To test whether CHC17 directly binds GRASP65 and to determine the binding site, purified 
CHC17 full length protein or fragments were incubated with BSA or MBP-GRASP65 pre-
coupled to cyanogen bromide-activated (CNBr) beads (pre-blocked with BSA), in the presence 
of ATP-regenerating system in KHM buffer at 4ºC overnight. The beads were washed 
extensively and then analyzed by SDS-PAGE and immunoblotting for CHC17. 
 
Bead aggregation assay 
Bead aggregation assays were performed as previously described [8, 14, 18]. For 
quantification of the aggregation efficiency, 10-20 random phase contrast digital images of each 
reaction were captured by Zeiss Observer Z1 epifluorescence microscope with a 10X lens. 
Images were analyzed with the MATLAB7.4 software to determine the surface area of objects, 
which was used to calculate the number of beads in the clusters. Aggregates were defined as 
those with ≥ 6 beads. Only visible surface beads were counted; therefore, the number of beads in 
large aggregates was underestimated. Results were expressed as the mean ± SEM from 3 





Golgi disassembly and reassembly assay and quantification 
Golgi membranes were purified from rat liver [16]. Interphase (IC) and mitotic (MC) 
cytosols were prepared from HeLa S3 cells [8, 133]. The Golgi disassembly assay was 
performed as described previously [8]. Briefly, purified Golgi membranes (20 g) were mixed 
with 2 mg of mitotic cytosol, 1 mM GTP and an ATP-regenerating system in MEB buffer in a 
final volume of 200 µl. After incubation for 60 min at 37°C, mitotic Golgi fragments (MGF) 
were isolated and soluble proteins were removed by centrifugation (135,000 g for 30 min in a 
TLA55 rotor) through a 0.4 M sucrose cushion in KHM buffer onto a 6-µl 2 M sucrose cushion. 
The membranes were resuspended in KHM buffer, either fixed and processed for EM [8], or 
used in reassembly reactions. For Golgi reassembly, 20 µg of mitotic Golgi fragments were 
resuspended in KHM buffer, mixed with 400 µg interphase cytosol immunodepleted using either 
non-specific IgG or anti-CHC17 IgG as described above in the presence of an ATP regeneration 
system in a final volume of 30 µl in KHM buffer and incubated at 37°C for 60 min. The 
membranes were pelleted by centrifugation, and processed for EM.  
To quantify the reassembly of Golgi, EM images of Golgi membranes were captured at 
11000x magnification. The percentage of membranes in cisternae or in vesicles was determined 
by the intersection method [8, 128]. Cisternae were defined as long membrane profiles with a 
length greater than four times of their width, and the latter did not exceed 60 nm. Normal 
cisternae ranged from 20-30 nm in width and were longer than 200 nm. Stacks were defined as 
two or more cisternae that were separated by no more than 15 nm and overlapped in parallel by 
more than 50% of their length. All experiments were repeated at least 3 times; statistical 





Electron microscopy  
For EM analysis, Golgi stacks and clusters were identified using morphological criteria and 
quantified using standard stereological techniques [8, 18]. Golgi stack images were captured at 
11000x magnification. Interphase cells were defined as profiles that contained an intact nuclear 
envelope. The longest cisterna was measured as the cisternal length of a Golgi stack using the 
ruler function in Photoshop CS3. At least 20 cells were quantified in each experiment, and the 
results represent at least three independent experiments. Statistical significance was assessed by 
Student’s t-test. 
 
Immunofluorescence and image analysis 
For fixed cell analysis, cells grown on coverslips were washed in warm PBS, fixed in warm 
PFA (3.7% in PBS, 10 min), then washed (2x, 5 min, PBS), permeabilized (4 min, 3% BSA, 
0.5% Triton X-100 in PBS), and blocked in blocking solution (3% BSA in PBS, 30 min). 
Antibody labeling was performed by inversion of coverslips on 20 μl blocking solution with 
primary or secondary antibodies (1–5 μg/ml), DAPI, or TO-PRO3 on parafilm and washing with 
PBS. Samples were mounted in the Prolong Antifade kit (Invitrogen). 
 
Measurements of Golgi angles to division axis were performed on fixed cells. Cells in 
cytokinesis were identified by Golgi twin formation, slightly condensed DNA and neighbouring 
corresponding daughter cell. A solid crosshair was overlaid to mark the cell center along the 




thresholded and angles for every pixel containing Golgi labeling were calculated from the center 
relative to the division axis. The average angle of the Golgi signal per cell is shown.  
 
Golgi distances from centrosomes were measured as above with the average distance of 
Golgi labeled pixels to pericentrin staining being shown. 
 
Colocalization of green and red Dendra2 signal was plotted using NIH Image J’s 
colocalization highlighter plugin. 
 
Polarization of the Golgi from centrosomes was measured by applying a crosshair through 
pericentrin staining and rotating Golgi labeling around the centrosome such that the maximal 
difference between the areas separated by the horizontal line was achieved. The percentage of 
Golgi labeling on the side containing more labeling is shown. Therefore, complete loss of 
polarization results in a percentage of 50 while complete segregation of labeling to one side, 
corresponding to maximum polarization would lead to a value of 100.  
 
Live cell imaging 
Live imaging was carried out at 37°C in 5% CO2 on a Leica SP5 or a Zeiss LSM 510 
confocal microscopes. GFP and green Dendra2 were excited by 488nm lasers and emissions 
were collected from 495-550nm (Leica SP5) as well as a BP500-550 (Zeiss LSM 510). Apple 
and red Dendra2 were excited by 543 or 561nm lasers and emissions were collected from 555-
650nm (Leica SP5) as well as a LP575 (Zeiss LSM 510). Imaging was performed using 63x, 





For FRAP analysis GFP was photobleached in the indicated regions using 80-100% laser 
power for 10-15 iterations. Fluorescence in regions of interests was measured using Leica and 
Zeiss software respectively and analyzed in Microsoft Excel and GraphPad Prism software. 
Photoconversion of Dendra2 was achieved with a 405nm laser at 15-30% output for 5-10 
iterations. Analysis was as for FRAP experiments.  
 
Rapid inactivation experiments were performed in HeLa clone 3.3 that stably expresses 
SNAP-uLCa by addition of 10 M benzylguanine-glutaric acid-benzylguanine (BG-GLA-BG) 
crosslinking dimerizer for two hours, a condition shown to functionally inactivate the CHC17 in 
these cells by crosslinking associated SNAP-uLCa (Foraker et al, 2012). 
 
STORM imaging 
Sample preparation for STORM imaging was similar to that described above for 
immunofluorescent labeling, except for two steps: the fixation was done using 3% PFA + 0.1% 
glutaraldehyde, followed by treatment of 1% sodium borohydride, and the sample was post-fixed 
with PFA + glutaraldehyde after the second washing step. Secondary antibodies were labeled 
with a mixture of two fluorophores, either Alexa Fluor 405 and Alexa Fluor 647, or Cy3 and 
Alexa Fluor 647. This use of activator / reporter dye pairs allows two-color STORM 
measurement [214]. 
 
Acquisition of STORM images was performed on a home-built super-resolution 




fluorescence microscope (Nikon Ti-E) with an oil immersion objective (100x Plan Apo VC NA 
1.4, Nikon). Four excitation/activation lasers (642 nm, Stradus 642, Vortran; 561 nm, Sapphire 
561-200-CW, Coherent; 488 nm, Stradus 488, Vortran; 405 nm, Stradus 405, Vortran) were 
combined and sent into the microscope through a home-built epi/TRIF illuminator that can adjust 
the incident angle of the excitation laser beam at the sample. The on/off state and the power of 
the three diode lasers (642, 488 and 405 nm) were directly controlled by the computer, whereas 
the 561 nm laser beam was controlled through an acoustic optical modulator (Crystal 
Technology). A quad-band dichroic mirror (zt405/488/561/640rpc, Chroma) and a bandpass 
filter (ET705/70m, Chroma) were used for fluorescence detection in STORM. A different 
bandpass filter (ET525/50m, Chroma) was used for conventional fluorescence imaging of GFP. 
The images were recorded by and EMCCD camera (Ixon+ DU897E-CS0-BV, Andor). A 
cylindrical lens (f = 700 mm, Thorlabs) was inserted between the image plane of the microscope 
side-port and the microscope body to create the astigmatism for three-dimensional STORM 
(Huang et al., 2008). The instrument was controlled through custom software written in Python 
and Visual Basic, whereas image analysis was done with the same software (written in Visual 
C++) as in previous publications [216]. Crosstalk in the two-color STORM images was 
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GRASP65, Golgi reassembly stacking protein, 65kDa; CHC17, clathrin heavy chain, 
isoform 1 encoded by the gene on chromosome 17;  CLC, clathrin light chain; STORM, 
stochastic optical reconstruction microscopy; RNAi, RNA interference; siRNA, small 
interference RNA; NRK, normal rat kidney; GalT, galactose-1-phosphate uridylyltransferase; 




Chapter 7 . Conclusion 
The Golgi apparatus is the central conduit of the secretary pathway. Proteins and lipids that 
are newly synthesized in the ER are transported to the cis-side of the Golgi apparatus by COPII 
vesicles and then through the stacked Golgi membranes. In the Golgi, the proteins receive a 
series of modifications such as glycosylation, phosphorylation and sulfation. At the trans-side of 
the Golgi apparatus, the proteins are sorted to their destinations including plasma membrane, 
endosomal/lysosomal system, and secretary granules by different transport carriers. These 
functions require proper structure formation of the Golgi. In mammalian cells, the Golgi 
complex exhibits a very unique structure. It consists of dozens of stacks of flattened membrane 
cisternae with the stacks laterally linked into a ribbon [218]. Despite its important function, little 
is known about how and why the Golgi forms this unique structure.  
 
During cell division, the biogenesis of the Golgi apparatus occurs through a highly dynamic 
disassembly and reassembly process which facilitates the inheritance of this organelle and also 
allows the cell cycle progression [2, 10]. Mitotic disassembly of the Golgi complex can be 
dissected into three steps: (1) Golgi ribbon breaking down into stacks; (2) cisternae unstacking; 
and (3) cisternae vesiculation. Conversely,  post-mitotic reassembly includes (1) vesicle fusion 
into cisternae; (2) cisternae stacking; and (3) ribbon formation. However, the factors that regulate 




new information for better understanding these three processes in Golgi inheritance during cell 
division: (1) unstacking and re-stacking, (2) cisternae vesiculation and regrowth, and (3) ribbon 
formation.     
 
GRASP65 regulates Golgi stacking and unstacking 
Golgi stacks are the basic structural and functional units of the Golgi. In chapter II and III, I 
studied the function and mechanism of GRASP65 (Golgi Re Assembly Stacking Protein, 65kD) 
in regulating Golgi stack formation. GRASP65 is one of the only two known proteins directly 
involved in Golgi stacking; the other one, GRASP55, is a homolog of GRASP65 [12, 13]. These 
proteins function as a glue that sticks Golgi cisternae into stacks. The initial studies identified 
GRASP65 as a Golgi stacking factor because inhibiting its function by adding anti-GRASP65 
antibodies in the in vitro Golgi reassembly assay or microinjection of GRASP65 antibodies into 
mitotic cells both abolished Golgi stack reformation [13, 14]. However, other studies involving 
RNA interference in cells [15, 49-51] or with other model organisms [88, 89, 102, 109, 110, 219-
222] raised controversial results and suggested other functions for GRASP65, which include 
linking Golgi stacks into a ribbon, maintaining spindle stability, unconventional secretion and 
cell cycle regulation [22, 23, 223]. To address this controversy, I optimized the experimental 
condition to knockdown GRASP65 and analyzed the structural change of Golgi stacks by 
systematic electron microscopy. I found that although the overall Golgi morphology under light 
microscopy is not obviously altered upon GRASP65 deletion, under the electron microscopy the 
number of cisternae in each Golgi stack significantly reduced to 4.0 ± 0.1 from 5.9 ± 0.2 in 




GFP-tagged rat GRASP65 construct in the knock down cells. These results confirmed that 
GRASP65 plays essential roles in Golgi cisternal stacking.  
 
I also studied the mechanism of GRASP65 in mediating Golgi stacking. Based on previous 
in vitro biochemical experiments, it has been proposed that GRASP65 stacks Golgi cisternae by 
forming trans-oligomers from adjacent cisternal membranes. Phosphorylation of this protein 
abolishes its oligomerization and allows cisternae separation during mitosis. The N-terminal half 
of the protein, the GRASP65 domain, is required for both GRASP65 homo-dimerization and 
trans-oligomerzation. And the C-terminal SPR domain contains multiple phosphorylation sites 
and regulates the oligomerization state of the N-terminal half [18]. To understand the mechanism 
of Golgi stacking, I further narrowed the oligomerzation domain of GRASP65. The GRASP 
domain contains two PDZ domains that are known to be capable of interacting with proteins. I 
found that the first PDZ domain of GRASP65, aa 1-112, is both necessary and sufficient for 
GRASP65 oligomerization. This first PDZ domain lacks the GM130 binding site that is located 
in the second PDZ domain, is still localized onto the Golgi membrane. This result argues against 
the previous speculation that GRASP65 is targeted to the Golgi through interacting with GM130. 
To examine the hypothesis that phosphorylation of the C-terminal SPR domain of GRASP65 
regulates GRASP65 de-oligomerization and Golgi unstacking, I expressed several non-
phosphorylatable mutant of GRASP65 in the cells and looked for the change in Golgi 
morphology in interphase and mitosis. I found that expressing these phospho-deficient mutants 
enhanced Golgi stacking during interphase and inhibited Golgi disassembly during mitosis, 
therefore confirmed the observation from the in vitro assays that GRASP65 phosphorylation is 





I also inhibited Golgi disassembly during mitosis by expressing GRASP65 phospho-
deficient mutants and thereby studied the significance of mitotic Golgi disassembly. Expression 
of GRASP65 phospho-deficient mutants did not impair the equal partitioning of Golgi 
membranes into the two daughter cells. Instead, inhibition of Golgi disassemble at the onset of 
mitosis delayed mitotic entry of the cells and decreased cell proliferation rates, suggesting that 
the Golgi disassembly during mitosis is required for cell cycle progression [17].   
     
GRASP65 contains at least eight phosphorylation sites [19]. I further examined the mitotic 
kinases that phosphorylate these sites, the tempo relationship and the impacts on Golgi 
disassembly of their phosphorylation. Using phospho-specific mouse monoclonal antibodies that 
are either raised in our lab or human single chain antibodies selected from a phage display library 
in collaboration with Dr. Franck Perez’s lab in France  [94], I was able to follow the 
phosphorylation of three phosphorylation sites on GRASP65: T220/T224, S277 and S376. First, 
I found that the mitotic kinase that phosphorylates all the three sites is cdc2, while plk enhances 
their phosphorylation. S277 is also phosphorylated by MEK/ERK upon growth factor stimulation 
in interphase, which is consistent with previous reports [19, 91].   
 
To determine the tempo relationship of GRASP65 phosphorylation at different sites and 
with cell cycle progression, I co-stained cells with GRASP65 phospho-specific antibodies with 
anti-phospho-Histone H3 to estimate the mitotic stage of the cell, or with three sets of two 
different phospho-specific antibodies. I found that S277 is phosphorylated the earliest in G2 




S277 in late G2 phase, but earlier than T220/T224 which is phosphorylated at prophase. S376 is 
de-phosphorylated earlier than T220/T224, both in cytokinesis earlier than S277 de-
phosphorylation.  
 
Also, from prometaphase to anaphase, antibodies against the phosphorylated-T220/T224 of 
GRASP65 stained the Golgi haze containing the mitotic Golgi vesicles, not only the Golgi 
remnants, suggesting that the phosphorylation of T220/T224 is most critical for Golgi 
vesiculation. To verify this assumption, I constructed and expressed GRASP65 mutants that are 
mutated at T220/T224 (S216A/S217A/T220A/T224A), S277 (S277A) or S376A 
(S367A/S376A). Unlike the S277A or S367A/S376A mutant, expression of the 
S216A/S217A/T220A/T224A mutant significantly inhibited Golgi disassembly under both 
fluorescence microscopy and electron microscopy. These results suggested that 
S216/S217/T220/T224- phosphorylation site is most important for Golgi disassemble, perhaps 
because that this cluster is in closest proximity to the GRASP domain, therefore is critical for 
GRASP65 de-oligomerization. 
 
The Golgi ubiquitin ligase HACE1 regulates Golgi cisternae regrowth during cell division 
After the initial Golgi ribbon breaking down at the onset of mitosis, unstacking and 
vesiculation take place at almost the same time to disassemble the Golgi apparatus completely 
into thousands of vesicles. Vesicle budding and scission in this process require COPI coat and 
active Arf1 [7]. After mitosis, two AAA ATPases, p97/VCP and NSF, mediate the membrane 
fusion for Golgi reassembly [32]. It is also found that mono-ubiquitination of Golgi membrane 




[35]. The deubiquitinating enzyme VCIP135 removes the ubiquitin tag which allows p97/p47 
mediated fusion to take place [36]. In chapter IV, my colleagues and I characterized the newly 
found ubiquitin E3 ligase HACE1 as the ligase in this process [38, 148], which regulates mono-
ubiquitination of Golgi proteins in mitosis.  
 
First of all we determined that HACE1 partially localizes to the Golgi membranes by 
interacting with Golgi Rabs, especially Rab1. Knocking down HACE1 in cells or overexpressing 
an inactive mutant of HACE1 led to Golgi fragmentation. Using live-cell imaging, we found that 
the fragmented phenotype of Golgi in HACE1-knockdown cells was due to a defect of post-
mitotic-Golgi reassembly. Furthermore, in the in vitro Golgi disassembly and reassembly assay, 
inhibition of HACE1 activity highly affected post-mitotic Golgi membrane fusion. It is worth to 
notice that although HACE1 is not required for Golgi disassembly, it needs to be active during 
disassembly to allow Golgi reassembly. These result confirmed the hypothesis that mono-
ubiquitin is added to Golgi membrane during mitosis, later serves as a receptor for the 
p97/p47/VCIP135 complex at the end of mitosis for membrane fusion. Currently, the 
ubiquitinated substrate(s) on Golgi membrane has not been identified. Future work should be 
emphasized on finding the substrate. 
 
Identification of GRASP65 interacting proteins that maintain Golgi ribbon integrity 
How the Golgi stacks laterally connect to form a ribbon is so far not well understood, but 
involves a number of proteins including the microtubule and actin cytoskeleton, as well as 
several golgins [43, 49-51, 63, 80, 130, 224-226]. Golgi stacks are brought to the cell center by 




microtubules [70, 77]. The function of actin cytoskeleton on Golgi organization is unclear, but it 
has been suggested that actin filaments connect Golgi stacks into pairs based on the study in 
Drosophila S2 cells [80]. Depletion of many golgins leads to Golgi fragmentation [1]. Golgi 
ribbon integrity relies on their ability to tether membrane and facilitate continuous membrane 
input [1], interacting with microtubules and centrosome to bring the Golgi stacks together [58, 
66, 67, 70, 72, 227], as well as direct tethering of the membrane from neighboring stacks (e.g. 
GMAP210 and GRASPs) [49, 61]. The Golgi stacking factor GRASPs have been proposed to 
play roles in maintaining ribbon integrity, as depletion of either GRASP65 or GRASP55 led to 
Golgi fragmentation. It was suggested that GRASPs form trans-oligomers from rims of Golgi 
stacks similarly to their function in stacking the cisternae, which is also regulated by mitotic 
phosphorylation. However, the gaps between the stacks in the ribbon are relatively larger and 
more heterogeneous (10s to 100s nm) compared to those between the cisternae in the stack, it is 
also possible that GRASPs are cross-linked by other proteins to connect Golgi stacks. In chapter 
V and VI I attempted to identify GRASP65 binding proteins that play this role.  
 
The idea that cytosolic proteins crosslink GRASP65 came from the observation that 
GRASP65 coated bead form large aggregates when incubated with interphase cytosol compared 
to the ones incubated with buffer. This result indicated the existence of cytosolic factors that 
enhance or stabilize GRASP65 oligomerization. Using affinity chromatography and mass 
spectrometry, we found 23 cytosolic proteins that bind to GRASP65 either directly or indirectly. 
I further selected the ones which showed strong binding with GRASP65 and affected Golgi 
organization when depleted in cells for further characterization, including clathrin heavy chain 




MENA [159], and inositol 5-phoaphatase and scaffold protein SHIP2 [160, 161]. All of them can 
be co-purified with GRASP65 from cytosol, while CHC and Dja1 showed direct interaction with 
GRASP65 in vitro. MENA and SHIP2 have been found for the first time localized on the Golgi 
complex in cells, and Dja1 can also be recruited to the Golgi membrane in vitro. Depletion of 
any of the four proteins led to Golgi fragmentation. Furthermore, inhibiting these four 
GRASP65-interacting proteins in interphase cytosol largely decreased GRASP65 coated beads 
aggregation efficiency, and reduced post-mitotic Golgi reassembly in the in vitro Golgi 
disassembly and reassembly assay. These results suggest the possibility that CHC, Dja1, MENA 
and SHIP2 directly or indirectly crosslink GRASP65 oligomers which is required for Golgi 
biogenesis. 
 
In collaboration with Dr. Frances Brodsky’s lab, we further characterized the function and 
mechanism of clathrin in GRASP65 oligomer crosslinking and Golgi formation. Using STORM 
microscopy, we were able to detect a pool of clathrin at cis-side of the Golgi, localized next to 
GM130, which further supports our finding that GRASP65 directly interacts with CHC and 
recruits it to cis-Golgi. I also mapped the domain of CHC which interacts with GRASP65 to the 
N-terminal domain of CHC (aa1-545). We then determined whether clathrin functions in a 
complex with GRASP65 independent of its function in transport using a CHC mutant which 
trimerizes and has the terminal domain but is missing the most part of the triskelion leg therefore 
does not form the clathrin coat. This mutant rescued the Golgi fragmentation caused by 
endogenous CHC depletion, therefore suggested that binding to GRASP65 and trimerization are 
enough for CHC to maintain Golgi integrity. I further tested whether clathrin triskelions are 




beads to form aggregates, while the triskelion without the N-terminal binding domain had no 
effect. Based on these results, we propose that clathrin triskelions crosslink GRASP65 from the 
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